La O -
reconstrucción O -
con O -
implantes O -
se O -
realiza O -
en O -
la O -
mayoría O -
de O -
las O -
mujeres O -
a O -
las O -
que O -
se O -
les O -
ofrece O -
una O -
reconstrucción O -
primaria O -
por O -
cáncer O -
de O -
mama O -
. O -

Se O -
compararon O -
prospectivamente O -
dos O -
implantes O -
de O -
expansores O -
diferentes. O -

El O -
criterio O -
de O -
valoración O -
principal O -
fue O -
el O -
número O -
de O -
operaciones O -
necesarias O -
en O -
cada O -
grupo O -
para O -
obtener O -
la O -
satisfacción O -
del O -
paciente O -
. O -

Los O -
criterios O -
de O -
valoración O -
secundarios O -
fueron O -
la O -
evaluación O -
del O -
volumen O -
y O -
la O -
forma O -
de O -
las O -
mamas O -
y O -
aspectos O -
de O -
la O -
calidad O -
de O -
vida O -
. O -

Setenta O -
pacientes O -
consecutivas O -
con O -
cáncer O -
de O -
mama O -
fueron O -
aleatorizadas O -
a O -
una O -
reconstrucción O -
en O -
una O -
fase O -
con O -
un O -
implante O -
expansor O -
permanente O -
redondo O -
( O -
Becker O -
25 O -
; O -
n=35 O -
) O -
o O -
a O -
una O -
reconstrucción O -
en O -
dos O -
fases O -
con O -
un O -
expansor O -
en O -
forma O -
de O -
media O -
luna O -
( O -
LV O -
133 O -
; O -
n=35 O -
) O -
, O -
sustituido O -
posteriormente O -
por O -
un O -
implante O -
anatómico O -
de O -
forma O -
estable O -
. O -

Hubo O -
que O -
excluir O -
a O -
30 O -
pacientes O -
y O -
se O -
evaluaron O -
40, O -
20 O -
en O -
cada O -
grupo. O -

La O -
mediana O -
de O -
seguimiento O -
para O -
ambos O -
grupos O -
fue O -
de O -
3,5 O -
años O -
( O -
rango O -
, O -
1,5 O -
a O -
5 O -
años O -
) O -
. O -

Se O -
utilizaron O -
copas O -
de O -
plástico, O -
moldes O -
de O -
plástico O -
y O -
técnicas O -
de O -
escaneo O -
bidimensional O -
y O -
tridimensional O -
para O -
la O -
evaluación O -
objetiva O -
del O -
volumen O -
y O -
la O -
forma O -
de O -
las O -
mamas. O -

El O -
resultado O -
estético O -
fue O -
evaluado O -
por O -
un O -
panel O -
de O -
expertos O -
y O -
legos O -
, O -
y O -
por O -
los O -
pacientes O -
. O -

La O -
calidad O -
de O -
vida O -
se O -
evaluó O -
con O -
un O -
cuestionario O -
validado O -
( O -
36-Item O -
Short O -
Form O -
Health O -
Survey O -
) O -
. O -

De B-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
una I-Premise HighQuality
etapa I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
70 I-Premise HighQuality
por I-Premise HighQuality
ciento I-Premise HighQuality
se I-Premise HighQuality
sometió I-Premise HighQuality
a I-Premise HighQuality
una I-Premise HighQuality
cirugía I-Premise HighQuality
de I-Premise HighQuality
revisión I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
su I-Premise HighQuality
mayoría I-Premise HighQuality
debido I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
plenitud I-Premise HighQuality
del I-Premise HighQuality
polo I-Premise HighQuality
superior I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
mala I-Premise HighQuality
ptosis I-Premise HighQuality
. I-Premise HighQuality

Estos O -
resultados O -
concuerdan O -
con O -
los O -
datos O -
de O -
la O -
exploración O -
bidimensional O -
y O -
del O -
panel O -
de O -
expertos O -
y O -
el O -
juicio O -
subjetivo O -
de O -
los O -
pacientes. O -

La B-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
fue I-Premise HighQuality
similar I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
grupos. I-Premise HighQuality

El B-Claim HighQuality
método I-Claim HighQuality
del I-Claim HighQuality
expansor I-Claim HighQuality
permanente I-Claim HighQuality
fracasó I-Claim HighQuality
significativamente I-Claim HighQuality
como I-Claim HighQuality
procedimiento I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
sola I-Claim HighQuality
etapa I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
método I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
media I-Claim HighQuality
luna I-Claim HighQuality
en I-Claim HighQuality
dos I-Claim HighQuality
etapas I-Claim HighQuality
dio I-Claim HighQuality
los I-Claim HighQuality
resultados I-Claim HighQuality
más I-Claim HighQuality
aceptables I-Claim HighQuality
tanto I-Claim HighQuality
objetiva I-Claim HighQuality
como I-Claim HighQuality
subjetivamente I-Claim HighQuality
. I-Claim HighQuality

Analizar O -
el O -
curso O -
clínico, O -
el O -
tratamiento, O -
las O -
complicaciones, O -
el O -
resultado O -
y O -
la O -
calidad O -
de O -
vida O -
( O -
QOL O -
) O -
en O -
pacientes O -
con O -
rabdomiosarcoma O -
perineal/perianal O -
( O -
PRMS O -
) O -
tratados O -
dentro O -
de O -
los O -
ensayos O -
CWS-86 O -
, O -
-91 O -
, O -
-96 O -
, O -
y O -
-2002P O -
. O -

Aunque O -
existen O -
múltiples O -
ensayos O -
de O -
estudios O -
internacionales O -
para O -
el O -
tratamiento O -
del O -
rabdomiosarcoma, O -
sólo O -
se O -
ofrece O -
una O -
información O -
muy O -
limitada O -
sobre O -
el O -
tratamiento, O -
los O -
resultados O -
y O -
la O -
calidad O -
de O -
vida O -
en O -
el O -
EMRP. O -

Un O -
total O -
de O -
35 O -
pacientes O -
que O -
padecían O -
EMRP O -
fueron O -
tratados O -
con O -
quimioterapia O -
neoadyuvante O -
. O -

Se O -
realizó O -
una O -
terapia O -
local O -
con O -
radiación O -
y/o O -
cirugía, O -
seguida O -
de O -
quimioterapia O -
adyuvante. O -

El O -
seguimiento O -
funcional O -
a O -
largo O -
plazo O -
se O -
evaluó O -
mediante O -
una O -
encuesta O -
gastrointestinal/de O -
calidad O -
de O -
vida. O -

Se O -
evaluaron O -
32 O -
pacientes O -
( O -
exclusión O -
n O -
= O -
3 O -
) O -
. O -

Ocho O -
pacientes O -
presentaban O -
una O -
histología O -
embrionaria O -
y O -
24 O -
una O -
histología O -
alveolar. O -

La O -
mediana O -
de O -
edad O -
era O -
de O -
108 O -
meses O -
( O -
mediana O -
de O -
seguimiento O -
: O -
5,8 O -
años O -
) O -
. O -

La O -
supervivencia O -
global O -
a O -
los O -
5 O -
años O -
fue O -
del O -
47 O -
% O -
( O -
intervalo O -
de O -
confianza O -
del O -
95 O -
% O -
: O -
29-64 O -
) O -
. O -

Dieciséis O -
pacientes O -
del O -
IRS O -
( O -
Intergroup O -
Rhabdomyosarcoma O -
Study O -
) O -
III O -
y O -
IV O -
tenían O -
afectación O -
ganglionar O -
locorregional O -
en O -
el O -
momento O -
del O -
diagnóstico O -
. O -

Siete O -
pacientes O -
fueron O -
tratados O -
sólo O -
con O -
quimioterapia/cirugía O -
[supervivencia O -
libre O -
de O -
eventos O -
a O -
5 O -
años O -
( O -
EFS O -
) O -
: O -
85,7 O -
% O -
] O -
. O -

Once O -
pacientes O -
recibieron O -
sólo O -
radioquimioterapia O -
( O -
SFE O -
a O -
5 O -
años O -
: O -
27,3 O -
% O -
) O -
. O -

En O -
12 O -
pacientes O -
se O -
utilizó O -
la O -
radioquimioterapia/cirugía O -
combinada O -
( O -
SFE O -
a O -
5 O -
años O -
: O -
63,6 O -
% O -
) O -
. O -

Dos O -
pacientes O -
fueron O -
tratados O -
sólo O -
con O -
quimioterapia O -
y O -
murieron. O -

Los B-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
histología I-Premise HighQuality
embrionaria I-Premise HighQuality
tuvieron I-Premise HighQuality
una I-Premise HighQuality
SSC I-Premise HighQuality
a I-Premise HighQuality
5 I-Premise HighQuality
años I-Premise HighQuality
significativamente I-Premise HighQuality
mejor I-Premise HighQuality
( I-Premise HighQuality
87,5% I-Premise HighQuality
) I-Premise HighQuality
que I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
histología I-Premise HighQuality
alveolar I-Premise HighQuality
( I-Premise HighQuality
39,1% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,013 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Algunos B-Premise HighQuality
pacientes I-Premise HighQuality
informaron I-Premise HighQuality
de I-Premise HighQuality
síntomas I-Premise HighQuality
de I-Premise HighQuality
incontinencia I-Premise HighQuality
fecal. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
incontinencia I-Premise HighQuality
fecal I-Premise HighQuality
de I-Premise HighQuality
Wexner I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
9 I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
posible I-Premise HighQuality
: I-Premise HighQuality
0-20 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
90,5 I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
aplicable I-Premise HighQuality
: I-Premise HighQuality
0-144 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Claim HighQuality
resultado I-Claim HighQuality
de I-Claim HighQuality
estos I-Claim HighQuality
pacientes I-Claim HighQuality
sigue I-Claim HighQuality
siendo I-Claim HighQuality
insatisfactorio. I-Claim HighQuality

Los B-Premise HighQuality
factores I-Premise HighQuality
pronósticos I-Premise HighQuality
para I-Premise HighQuality
un I-Premise HighQuality
resultado I-Premise HighQuality
favorable I-Premise HighQuality
son I-Premise HighQuality
el I-Premise HighQuality
tamaño I-Premise HighQuality
del I-Premise HighQuality
tumor I-Premise HighQuality
menor I-Premise HighQuality
de I-Premise HighQuality
5 I-Premise HighQuality
cm I-Premise HighQuality
, I-Premise HighQuality
los I-Premise HighQuality
ganglios I-Premise HighQuality
linfáticos I-Premise HighQuality
locorregionales I-Premise HighQuality
negativos I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
edad I-Premise HighQuality
menor I-Premise HighQuality
de I-Premise HighQuality
10 I-Premise HighQuality
años I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
IRS I-Premise HighQuality
bajo I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
histología I-Premise HighQuality
embrionaria I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
incontinencia I-Claim HighQuality
fecal I-Claim HighQuality
parece I-Claim HighQuality
ser I-Claim HighQuality
un I-Claim HighQuality
problema. I-Claim HighQuality

Los B-Claim HighQuality
estudios I-Claim HighQuality
de I-Claim HighQuality
fase I-Claim HighQuality
II I-Claim HighQuality
y I-Claim HighQuality
III I-Claim HighQuality
han I-Claim HighQuality
demostrado I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
adición I-Claim HighQuality
de I-Claim HighQuality
interleucina-2 I-Claim HighQuality
( I-Claim HighQuality
IL-2 I-Claim HighQuality
) I-Claim HighQuality
e I-Claim HighQuality
interferón I-Claim HighQuality
alfa-2b I-Claim HighQuality
( I-Claim HighQuality
IFN I-Claim HighQuality
alfa-2b I-Claim HighQuality
) I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
quimioterapia I-Claim HighQuality
multiagente I-Claim HighQuality
( I-Claim HighQuality
CT I-Claim HighQuality
) I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
melanoma I-Claim HighQuality
avanzado I-Claim HighQuality
aumenta I-Claim HighQuality
la I-Claim HighQuality
respuesta I-Claim HighQuality
global I-Claim HighQuality
( I-Claim HighQuality
OR I-Claim HighQuality
) I-Claim HighQuality
, I-Claim HighQuality
aunque I-Claim HighQuality
sin I-Claim HighQuality
evidencia I-Claim HighQuality
clara I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
mejora I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
global I-Claim HighQuality
( I-Claim HighQuality
OS I-Claim HighQuality
) I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
tratamiento I-Claim HighQuality
con I-Claim HighQuality
altas I-Claim HighQuality
dosis I-Claim HighQuality
de I-Claim HighQuality
IL-2 I-Claim HighQuality
puede I-Claim HighQuality
causar I-Claim HighQuality
una I-Claim HighQuality
toxicidad I-Claim HighQuality
grave I-Claim HighQuality
y I-Claim HighQuality
normalmente I-Claim HighQuality
se I-Claim HighQuality
administra I-Claim HighQuality
en I-Claim HighQuality
un I-Claim HighQuality
entorno I-Claim HighQuality
de I-Claim HighQuality
hospitalización. I-Claim HighQuality

Realizamos O -
un O -
ensayo O -
clínico O -
prospectivo O -
y O -
aleatorio O -
multicéntrico O -
en O -
pacientes O -
ambulatorios O -
con O -
melanoma O -
metastásico O -
para O -
comparar O -
la O -
TC O -
con O -
la O -
bioquimioterapia O -
( O -
bioCT O -
) O -
utilizando O -
dosis O -
inmunomoduladoras O -
de O -
IL-2 O -
e O -
IFN O -
alfa-2b O -
. O -

Ciento O -
setenta O -
y O -
seis O -
pacientes O -
elegibles O -
con O -
melanoma O -
avanzado O -
fueron O -
aleatorizados O -
para O -
recibir O -
CT O -
( O -
cisplatino O -
y O -
dacarbazina O -
con O -
o O -
sin O -
carmustina O -
cada O -
21 O -
días O -
) O -
o O -
bioCT O -
que O -
comprende O -
el O -
mismo O -
régimen O -
de O -
CT O -
seguido O -
de O -
IL-2 O -
subcutánea O -
a O -
dosis O -
bajas O -
durante O -
8 O -
días O -
y O -
IFN O -
alfa-2b O -
tres O -
veces O -
por O -
semana O -
, O -
ambos O -
durante O -
seis O -
ciclos O -
. O -

En B-Premise HighQuality
una I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
seguimiento I-Premise HighQuality
de I-Premise HighQuality
18 I-Premise HighQuality
( I-Premise HighQuality
TC I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
16 I-Premise HighQuality
( I-Premise HighQuality
bioCT I-Premise HighQuality
) I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SG I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
9,5 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
11,0 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,51 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

En B-Premise HighQuality
los I-Premise HighQuality
89 I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
brazo I-Premise HighQuality
CT, I-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
18 I-Premise HighQuality
OR I-Premise HighQuality
( I-Premise HighQuality
20,2 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
( I-Premise HighQuality
tres I-Premise HighQuality
respondedores I-Premise HighQuality
completos I-Premise HighQuality
[ I-Premise HighQuality
CR I-Premise HighQuality
] I-Premise HighQuality
y I-Premise HighQuality
15 I-Premise HighQuality
respondedores I-Premise HighQuality
parciales I-Premise HighQuality
[ I-Premise HighQuality
PR I-Premise HighQuality
] I-Premise HighQuality
) I-Premise HighQuality
según I-Premise HighQuality
los I-Premise HighQuality
criterios I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
Organización I-Premise HighQuality
Mundial I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
Salud I-Premise HighQuality
. I-Premise HighQuality

En B-Premise HighQuality
los I-Premise HighQuality
87 I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
brazo I-Premise HighQuality
de I-Premise HighQuality
bioCT, I-Premise HighQuality
se I-Premise HighQuality
registraron I-Premise HighQuality
22 I-Premise HighQuality
OR I-Premise HighQuality
( I-Premise HighQuality
25,3 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
( I-Premise HighQuality
tres I-Premise HighQuality
RC I-Premise HighQuality
y I-Premise HighQuality
19 I-Premise HighQuality
RP I-Premise HighQuality
) I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,70 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
toxicidad I-Premise HighQuality
relacionada I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
fue I-Premise HighQuality
bastante I-Premise HighQuality
similar I-Premise HighQuality
en I-Premise HighQuality
ambos I-Premise HighQuality
brazos. I-Premise HighQuality

La B-Claim HighQuality
adición I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
dosis I-Claim HighQuality
baja I-Claim HighQuality
de I-Claim HighQuality
inmunoterapia I-Claim HighQuality
no I-Claim HighQuality
produjo I-Claim HighQuality
una I-Claim HighQuality
ventaja I-Claim HighQuality
estadísticamente I-Claim HighQuality
significativa I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
SG, I-Claim HighQuality
el I-Claim HighQuality
tiempo I-Claim HighQuality
hasta I-Claim HighQuality
la I-Claim HighQuality
progresión I-Claim HighQuality
o I-Claim HighQuality
la I-Claim HighQuality
OR. I-Claim HighQuality

Sin B-Claim HighQuality
embargo, I-Claim HighQuality
la I-Claim HighQuality
mediana I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
SG I-Claim HighQuality
de I-Claim HighQuality
11 I-Claim HighQuality
meses I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
brazo I-Claim HighQuality
del I-Claim HighQuality
bioCT I-Claim HighQuality
no I-Claim HighQuality
difiere I-Claim HighQuality
en I-Claim HighQuality
gran I-Claim HighQuality
medida I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
mejores I-Claim HighQuality
resultados I-Claim HighQuality
con I-Claim HighQuality
regímenes I-Claim HighQuality
que I-Claim HighQuality
contienen I-Claim HighQuality
altas I-Claim HighQuality
dosis I-Claim HighQuality
de I-Claim HighQuality
IL-2 I-Claim HighQuality
que I-Claim HighQuality
se I-Claim HighQuality
han I-Claim HighQuality
reportado I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
literatura. I-Claim HighQuality

Además, O -
nuestro B-Claim HighQuality
programa I-Claim HighQuality
de I-Claim HighQuality
tratamiento I-Claim HighQuality
se I-Claim HighQuality
llevó I-Claim HighQuality
a I-Claim HighQuality
cabo I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
ambulatorios I-Claim HighQuality
y I-Claim HighQuality
tuvo I-Claim HighQuality
un I-Claim HighQuality
nivel I-Claim HighQuality
de I-Claim HighQuality
toxicidad I-Claim HighQuality
aceptable. I-Claim HighQuality

Las O -
microesferas O -
SIR O -
son O -
microesferas O -
radiactivas O -
de O -
itrio O -
90 O -
(SIR-Spheres, O -
Sirtex O -
Medical O -
Limited, O -
Australia) O -
que O -
se O -
utilizan O -
para O -
dirigir O -
selectivamente O -
altos O -
niveles O -
de O -
radiación O -
ionizante O -
a O -
los O -
tumores O -
del O -
hígado. O -

Este O -
ensayo O -
se O -
diseñó O -
para O -
medir O -
cualquier O -
aumento O -
del O -
beneficio O -
para O -
el O -
paciente O -
al O -
añadir O -
una O -
única O -
administración O -
de O -
microesferas O -
SIR O -
a O -
un O -
régimen O -
de O -
quimioterapia O -
regional O -
en O -
la O -
arteria O -
hepática O -
( O -
HAC O -
) O -
administrada O -
como O -
una O -
infusión O -
de O -
12 O -
días O -
de O -
floxuridina O -
y O -
repetida O -
a O -
intervalos O -
mensuales O -
, O -
frente O -
a O -
la O -
misma O -
quimioterapia O -
sola O -
. O -

Se O -
llevó O -
a O -
cabo O -
un O -
ensayo O -
clínico O -
aleatorizado O -
de O -
fase O -
III O -
en O -
el O -
que O -
participaron O -
74 O -
pacientes O -
con O -
metástasis O -
hepáticas O -
bi-lobulares O -
no O -
resecables O -
de O -
adenocarcinoma O -
primario O -
de O -
intestino O -
grueso. O -

Los O -
criterios O -
de O -
beneficio O -
para O -
los O -
pacientes O -
evaluados O -
en O -
el O -
ensayo O -
fueron O -
la O -
respuesta O -
tumoral, O -
el O -
tiempo O -
de O -
progresión O -
de O -
la O -
enfermedad O -
en O -
el O -
hígado, O -
la O -
supervivencia O -
global, O -
la O -
calidad O -
de O -
vida O -
y O -
la O -
toxicidad O -
relacionada O -
con O -
el O -
tratamiento. O -

La O -
respuesta O -
del O -
tumor O -
se O -
midió O -
mediante O -
cambios O -
seriados O -
tanto O -
en O -
las O -
áreas O -
transversales O -
del O -
tumor O -
como O -
en O -
los O -
volúmenes O -
totales O -
del O -
mismo, O -
siempre O -
que O -
cualquier O -
respuesta O -
durara O -
no O -
menos O -
de O -
tres O -
meses, O -
así O -
como O -
los O -
cambios O -
en O -
el O -
antígeno O -
carcinoembrionario O -
( O -
CEA O -
) O -
en O -
suero. O -

La B-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
parcial I-Premise HighQuality
y I-Premise HighQuality
completa I-Premise HighQuality
( I-Premise HighQuality
PR I-Premise HighQuality
+ I-Premise HighQuality
CR I-Premise HighQuality
) I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
mayor I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
microesferas I-Premise HighQuality
SIR I-Premise HighQuality
cuando I-Premise HighQuality
se I-Premise HighQuality
midió I-Premise HighQuality
por I-Premise HighQuality
áreas I-Premise HighQuality
tumorales I-Premise HighQuality
( I-Premise HighQuality
44 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
17,6 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
volúmenes I-Premise HighQuality
tumorales I-Premise HighQuality
( I-Premise HighQuality
50 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
24 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,03 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
CEA I-Premise HighQuality
( I-Premise HighQuality
72 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
47 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,004 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
hígado I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
más I-Premise HighQuality
larga I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
microesferas I-Premise HighQuality
SIR I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
sólo I-Premise HighQuality
HAC I-Premise HighQuality
cuando I-Premise HighQuality
se I-Premise HighQuality
midió I-Premise HighQuality
por I-Premise HighQuality
áreas I-Premise HighQuality
tumorales I-Premise HighQuality
( I-Premise HighQuality
9,7 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
15,9 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
volúmenes I-Premise HighQuality
tumorales I-Premise HighQuality
( I-Premise HighQuality
7,6 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
12,0 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,04 I-Premise HighQuality
) I-Premise HighQuality
o I-Premise HighQuality
CEA I-Premise HighQuality
( I-Premise HighQuality
5,7 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6,7 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,06 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
uno, I-Premise HighQuality
dos, I-Premise HighQuality
tres I-Premise HighQuality
y I-Premise HighQuality
cinco I-Premise HighQuality
años I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
microesferas I-Premise HighQuality
SIR I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
72 I-Premise HighQuality
%, I-Premise HighQuality
39 I-Premise HighQuality
%, I-Premise HighQuality
17 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
3,5 I-Premise HighQuality
%, I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
68 I-Premise HighQuality
%, I-Premise HighQuality
29 I-Premise HighQuality
%, I-Premise HighQuality
6,5 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
0 I-Premise HighQuality
% I-Premise HighQuality
del I-Premise HighQuality
HAC I-Premise HighQuality
solo. I-Premise HighQuality

El B-Premise HighQuality
análisis I-Premise HighQuality
de I-Premise HighQuality
regresión I-Premise HighQuality
de I-Premise HighQuality
Cox I-Premise HighQuality
sugiere I-Premise HighQuality
una I-Premise HighQuality
mejora I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
Esferas I-Premise HighQuality
SIR I-Premise HighQuality
que I-Premise HighQuality
sobreviven I-Premise HighQuality
más I-Premise HighQuality
de I-Premise HighQuality
15 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,06 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
produjo I-Premise HighQuality
un I-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
toxicidad I-Premise HighQuality
relacionada I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3-4 I-Premise HighQuality
ni I-Premise HighQuality
una I-Premise HighQuality
pérdida I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
SIR-Spheres I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
sólo I-Premise HighQuality
recibieron I-Premise HighQuality
HAC I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
combinación I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
única I-Claim HighQuality
inyección I-Claim HighQuality
de I-Claim HighQuality
microesferas I-Claim HighQuality
SIR I-Claim HighQuality
más I-Claim HighQuality
HAC I-Claim HighQuality
es I-Claim HighQuality
sustancialmente I-Claim HighQuality
más I-Claim HighQuality
eficaz I-Claim HighQuality
para I-Claim HighQuality
aumentar I-Claim HighQuality
las I-Claim HighQuality
respuestas I-Claim HighQuality
tumorales I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
libre I-Claim HighQuality
de I-Claim HighQuality
progresión I-Claim HighQuality
que I-Claim HighQuality
el I-Claim HighQuality
mismo I-Claim HighQuality
régimen I-Claim HighQuality
de I-Claim HighQuality
HAC I-Claim HighQuality
solo I-Claim HighQuality
. I-Claim HighQuality

El O -
objetivo O -
del O -
estudio O -
era O -
evaluar O -
la O -
tasa O -
de O -
respuesta, O -
el O -
resultado O -
clínico, O -
la O -
preservación O -
de O -
órganos/funciones O -
y O -
la O -
toxicidad O -
en O -
pacientes O -
con O -
cáncer O -
de O -
cabeza O -
y O -
cuello O -
tratados O -
con O -
quimioterapia O -
de O -
inducción O -
seguida O -
de O -
quimiorradioterapia O -
concomitante O -
y, O -
cuando O -
fuera O -
necesario, O -
cirugía O -
limitada. O -

El O -
diseño O -
del O -
estudio O -
fue O -
un O -
ensayo O -
no O -
aleatorio O -
de O -
fase O -
II O -
en O -
pacientes O -
hospitalizados. O -

El O -
plan O -
de O -
tratamiento O -
consistió O -
en O -
3 O -
ciclos O -
de O -
quimioterapia O -
de O -
inducción O -
con O -
cisplatino O -
, O -
fluorouracilo O -
( O -
5-FU O -
) O -
, O -
l-leucovorina O -
e O -
interferón O -
alfa2b O -
( O -
PFL-IFN O -
) O -
seguido O -
de O -
7 O -
ciclos O -
de O -
5-FU O -
, O -
hidroxiurea O -
y O -
radiación O -
concomitante O -
durante O -
5 O -
días O -
( O -
FHX O -
) O -
para O -
una O -
dosis O -
total O -
de O -
radiación O -
de O -
70 O -
Gy O -
. O -

13 O -
Se O -
añadió O -
ácido O -
cis-retinoico O -
al O -
régimen O -
de O -
tratamiento O -
para O -
la O -
quimioprevención O -
y O -
se O -
administró O -
una O -
profilaxis O -
sistemática O -
de O -
la O -
mucositis O -
a O -
todos O -
los O -
pacientes O -
durante O -
el O -
FHX O -
. O -

La O -
resección O -
quirúrgica O -
conservadora O -
se O -
reservó O -
a O -
los O -
pacientes O -
sin O -
respuesta O -
óptima O -
( O -
PR O -
> O -
o O -
=70 O -
% O -
) O -
, O -
mientras O -
que O -
la O -
cirugía O -
radical O -
se O -
realizó O -
como O -
tratamiento O -
de O -
rescate O -
. O -

Veintiséis O -
pacientes O -
fueron O -
tratados O -
en O -
una O -
institución: O -
más O -
del O -
90 O -
% O -
tenían O -
la O -
enfermedad O -
en O -
estadio O -
IV O -
y O -
sólo O -
el O -
19,2 O -
% O -
tenían O -
cáncer O -
de O -
laringe O -
. O -

El O -
81% O -
de O -
los O -
pacientes O -
tenía O -
un O -
estado O -
de O -
rendimiento O -
0 O -
y O -
el O -
23,1% O -
de O -
los O -
pacientes O -
tenía O -
una O -
pérdida O -
de O -
peso O -
superior O -
al O -
5% O -
al O -
inicio O -
del O -
tratamiento. O -

Se O -
analizaron O -
diecinueve O -
pacientes O -
para O -
determinar O -
la O -
respuesta O -
al O -
PFL-IFN: O -
3/19 O -
( O -
15,8 O -
% O -
) O -
pacientes O -
lograron O -
una O -
RC O -
y O -
7/19 O -
( O -
36,8 O -
% O -
) O -
lograron O -
una O -
RP O -
para O -
una O -
ORR O -
del O -
52,6 O -
% O -
. O -

Se O -
administró O -
FHX O -
según O -
el O -
protocolo O -
a O -
12 O -
pacientes: O -
6 O -
pacientes O -
( O -
50 O -
% O -
) O -
tuvieron O -
RC O -
, O -
1 O -
paciente O -
( O -
8,3 O -
% O -
) O -
tuvo O -
RP O -
para O -
una O -
ORR O -
del O -
58,3 O -
% O -
, O -
2 O -
pacientes O -
( O -
16,7 O -
% O -
) O -
tuvieron O -
SD O -
y O -
3 O -
pacientes O -
( O -
25 O -
% O -
) O -
tuvieron O -
PD O -
. O -

Al O -
finalizar O -
el O -
FHX O -
, O -
ningún O -
paciente O -
fue O -
sometido O -
a O -
terapia O -
local O -
según O -
el O -
plan O -
de O -
tratamiento. O -

En B-Premise HighQuality
una I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
seguimiento I-Premise HighQuality
de I-Premise HighQuality
13,5 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
1-28+ I-Premise HighQuality
) I-Premise HighQuality
en I-Premise HighQuality
junio I-Premise HighQuality
de I-Premise HighQuality
2001 I-Premise HighQuality
, I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
26 I-Premise HighQuality
pacientes I-Premise HighQuality
inscritos I-Premise HighQuality
12 I-Premise HighQuality
( I-Premise HighQuality
46,1 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
seguían I-Premise HighQuality
vivos I-Premise HighQuality
y I-Premise HighQuality
9 I-Premise HighQuality
( I-Premise HighQuality
75 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
ellos I-Premise HighQuality
estaban I-Premise HighQuality
libres I-Premise HighQuality
de I-Premise HighQuality
progresión I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
duración I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
respuesta I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
9 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
0-25+ I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
libre I-Premise HighQuality
de I-Premise HighQuality
progresión I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
10,5 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
0-28+ I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
9 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
rango I-Premise HighQuality
1-22 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
toxicidad I-Premise HighQuality
fue I-Premise HighQuality
significativa I-Premise HighQuality
y I-Premise HighQuality
consistió I-Premise HighQuality
principalmente I-Premise HighQuality
en I-Premise HighQuality
mucositis I-Premise HighQuality
y, I-Premise HighQuality
en I-Premise HighQuality
menor I-Premise HighQuality
medida, I-Premise HighQuality
en I-Premise HighQuality
neutropenia/trombocitopenia. I-Premise HighQuality

En O -
el O -
presente O -
estudio, O -
se B-Claim HighQuality
confirmaron I-Claim HighQuality
los I-Claim HighQuality
bajos I-Claim HighQuality
niveles I-Claim HighQuality
séricos I-Claim HighQuality
de I-Claim HighQuality
leptina I-Claim HighQuality
y I-Claim HighQuality
los I-Claim HighQuality
altos I-Claim HighQuality
niveles I-Claim HighQuality
séricos I-Claim HighQuality
de I-Claim HighQuality
citoquinas I-Claim HighQuality
proinflamatorias I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
en I-Claim HighQuality
fase I-Claim HighQuality
avanzada. I-Claim HighQuality

En O -
conclusión, O -
este B-Claim HighQuality
programa I-Claim HighQuality
secuencial I-Claim HighQuality
de I-Claim HighQuality
quimioterapia I-Claim HighQuality
de I-Claim HighQuality
inducción I-Claim HighQuality
y I-Claim HighQuality
quimiorradioterapia I-Claim HighQuality
ha I-Claim HighQuality
resultado I-Claim HighQuality
ser I-Claim HighQuality
moderadamente I-Claim HighQuality
activo I-Claim HighQuality
y I-Claim HighQuality
significativamente I-Claim HighQuality
tóxico; I-Claim HighQuality
además, O -
hay O -
que O -
tener O -
en O -
cuenta O -
la O -
larga O -
duración O -
global O -
del O -
tratamiento. O -

Por O -
estas O -
razones O -
, O -
este B-Claim HighQuality
régimen I-Claim HighQuality
no I-Claim HighQuality
pudo I-Claim HighQuality
ser I-Claim HighQuality
recomendado I-Claim HighQuality
para I-Claim HighQuality
un I-Claim HighQuality
estudio I-Claim HighQuality
aleatorio I-Claim HighQuality
de I-Claim HighQuality
fase I-Claim HighQuality
III I-Claim HighQuality
. I-Claim HighQuality

La O -
dosificación O -
intermitente O -
puede O -
reducir O -
los O -
efectos O -
adversos O -
(EA) O -
de O -
la O -
terapia O -
de O -
privación O -
de O -
andrógenos O -
(TDA). O -

Comparar O -
la O -
privación O -
intermitente O -
de O -
andrógenos O -
( O -
IAD O -
) O -
y O -
la O -
privación O -
continua O -
de O -
andrógenos O -
( O -
CAD O -
) O -
con O -
respecto O -
a O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
( O -
QoL O -
) O -
. O -

Un O -
total O -
de O -
852 O -
hombres O -
con O -
cáncer O -
de O -
próstata O -
avanzado O -
(CaP) O -
se O -
inscribieron O -
para O -
recibir O -
acetato O -
de O -
goserelina O -
3,6 O -
mg O -
cada O -
28 O -
días O -
durante O -
24 O -
semanas. O -

Un O -
total O -
de O -
554 O -
pacientes O -
cuyo O -
antígeno O -
prostático O -
específico O -
( O -
PSA O -
) O -
disminuyó O -
a O -
< O -
10 O -
ng/ml O -
o O -
en O -
≥50 O -
% O -
( O -
< O -
20 O -
ng/ml O -
en O -
la O -
línea O -
de O -
base O -
) O -
fueron O -
asignados O -
al O -
azar O -
a O -
IAD O -
o O -
CAD O -
. O -

En O -
el O -
brazo O -
de O -
IAD, O -
la O -
ADT O -
se O -
reanudó O -
durante O -
al O -
menos O -
24 O -
semanas O -
siempre O -
que O -
el O -
PSA O -
aumentara O -
> O -
20 O -
ng/ml O -
o O -
por O -
encima O -
del O -
valor O -
inicial. O -

La O -
CdV O -
se O -
controló O -
con O -
un O -
cuestionario O -
Cleary O -
validado O -
de O -
30 O -
ítems O -
y O -
se O -
analizó O -
mediante O -
la O -
prueba O -
U O -
de O -
Mann-Whitney O -
, O -
la O -
regla O -
de O -
la O -
desviación O -
estándar O -
de O -
0,5 O -
y O -
el O -
análisis O -
de O -
varianza O -
de O -
medidas O -
repetidas. O -

Los O -
EA O -
y O -
las O -
reacciones O -
adversas O -
a O -
los O -
medicamentos O -
(RAM) O -
se O -
analizaron O -
mediante O -
la O -
prueba O -
de O -
chi-cuadrado. O -

La O -
mediana O -
de O -
seguimiento O -
fue O -
de O -
65 O -
meses. O -

Surgieron B-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
limitación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
actividad I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
capacidad I-Premise HighQuality
física I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
funcionamiento I-Premise HighQuality
sexual I-Premise HighQuality
, I-Premise HighQuality
favoreciendo I-Premise HighQuality
la I-Premise HighQuality
DAI I-Premise HighQuality
. I-Premise HighQuality

No B-Premise LowQuality
se I-Premise LowQuality
observaron I-Premise LowQuality
diferencias I-Premise LowQuality
significativas I-Premise LowQuality
en I-Premise LowQuality
la I-Premise LowQuality
prevalencia I-Premise LowQuality
de I-Premise LowQuality
los I-Premise LowQuality
EA: I-Premise LowQuality
87 I-Premise LowQuality
pacientes I-Premise LowQuality
del I-Premise LowQuality
brazo I-Premise LowQuality
IAD I-Premise LowQuality
( I-Premise LowQuality
31,8 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
y I-Premise LowQuality
95 I-Premise LowQuality
del I-Premise LowQuality
brazo I-Premise LowQuality
CAD I-Premise LowQuality
( I-Premise LowQuality
33,9 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
tuvieron I-Premise LowQuality
EA I-Premise LowQuality
cardiovasculares I-Premise LowQuality
( I-Premise LowQuality
p=0,59 I-Premise LowQuality
) I-Premise LowQuality
, I-Premise LowQuality
con I-Premise LowQuality
25 I-Premise LowQuality
( I-Premise LowQuality
9,1 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
y I-Premise LowQuality
29 I-Premise LowQuality
( I-Premise LowQuality
10.4 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
que I-Premise LowQuality
se I-Premise LowQuality
retiraron I-Premise LowQuality
( I-Premise LowQuality
p=0,62 I-Premise LowQuality
) I-Premise LowQuality
, I-Premise LowQuality
y I-Premise LowQuality
21 I-Premise LowQuality
( I-Premise LowQuality
7,7 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
y I-Premise LowQuality
24 I-Premise LowQuality
( I-Premise LowQuality
8,6 I-Premise LowQuality
% I-Premise LowQuality
) I-Premise LowQuality
que I-Premise LowQuality
murieron I-Premise LowQuality
a I-Premise LowQuality
causa I-Premise LowQuality
de I-Premise LowQuality
un I-Premise LowQuality
evento I-Premise LowQuality
CV I-Premise LowQuality
( I-Premise LowQuality
p=0,70 I-Premise LowQuality
) I-Premise LowQuality
, I-Premise LowQuality
respectivamente I-Premise LowQuality
; I-Premise LowQuality
se B-Premise HighQuality
produjeron I-Premise HighQuality
fracturas I-Premise HighQuality
óseas I-Premise HighQuality
en I-Premise HighQuality
19 I-Premise HighQuality
( I-Premise HighQuality
6,9 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
15 I-Premise HighQuality
( I-Premise HighQuality
5,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
pacientes I-Premise HighQuality
( I-Premise HighQuality
p=0,44 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. O -

Los B-Premise HighQuality
sofocos I-Premise HighQuality
o I-Premise HighQuality
los I-Premise HighQuality
sudores I-Premise HighQuality
nocturnos I-Premise HighQuality
fueron I-Premise HighQuality
las I-Premise HighQuality
reacciones I-Premise HighQuality
adversas I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
( I-Premise HighQuality
47,1 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
50,4 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
p=0,44 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
disfunción I-Premise HighQuality
eréctil I-Premise HighQuality
( I-Premise HighQuality
15,7 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
7,9 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
p=0,042 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
estado I-Premise HighQuality
de I-Premise HighQuality
ánimo I-Premise HighQuality
deprimido I-Premise HighQuality
( I-Premise HighQuality
2,2 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
0 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
p=0,032 I-Premise HighQuality
) I-Premise HighQuality
fueron I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
brazo I-Premise HighQuality
de I-Premise HighQuality
DAI I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
DAI I-Claim HighQuality
mostró I-Claim HighQuality
beneficios I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
del I-Claim HighQuality
CaP I-Claim HighQuality
avanzado I-Claim HighQuality
con I-Claim HighQuality
respecto I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida. I-Claim HighQuality

La B-Claim HighQuality
prevalencia I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
EA I-Claim HighQuality
no I-Claim HighQuality
fue I-Claim HighQuality
significativamente I-Claim HighQuality
menor I-Claim HighQuality
con I-Claim HighQuality
la I-Claim HighQuality
DAI I-Claim HighQuality
. I-Claim HighQuality

La O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
después O -
del O -
cáncer O -
de O -
mama O -
es O -
hoy O -
en O -
día O -
un O -
gran O -
desafío O -
. O -

Las O -
intervenciones O -
complementarias O -
son O -
necesarias O -
debido O -
a O -
los O -
frecuentes O -
síntomas O -
de O -
depresión O -
después O -
del O -
tratamiento O -
y O -
también O -
para O -
favorecer O -
la O -
vuelta O -
a O -
la O -
actividad O -
. O -

Además, O -
la O -
radioquimioterapia O -
tiene O -
efectos O -
secundarios O -
como O -
el O -
aumento O -
de O -
peso O -
y O -
la O -
fatiga. O -

Se O -
han O -
probado O -
varias O -
estrategias, O -
como O -
las O -
intervenciones O -
conductuales-educativas O -
de O -
grupo, O -
el O -
entrenamiento O -
físico O -
y/o O -
la O -
educación O -
dietética, O -
para O -
responder O -
a O -
estas O -
dificultades O -
con O -
un O -
éxito O -
moderado O -
a O -
largo O -
plazo. O -

Doscientos O -
cincuenta O -
y O -
un O -
pacientes O -
no O -
metastásicos O -
fueron O -
reclutados O -
después O -
de O -
la O -
quimioterapia O -
en O -
un O -
ensayo O -
prospectivo O -
multicéntrico O -
aleatorio O -
entre O -
2008 O -
y O -
2010 O -
, O -
probando O -
una O -
intervención O -
de O -
2 O -
semanas O -
en O -
centros O -
de O -
SPA O -
. O -

La O -
intervención O -
consistió O -
en O -
entrenamiento O -
físico O -
en O -
grupo, O -
educación O -
dietética O -
y O -
fisioterapia. O -

Los O -
pacientes O -
seleccionados O -
estaban O -
en O -
remisión O -
completa. O -

La O -
calidad O -
de O -
vida O -
se O -
evaluó O -
con O -
el O -
cuestionario O -
SF36 O -
y O -
la O -
ansiedad O -
y O -
la O -
depresión O -
con O -
el O -
cuestionario O -
de O -
ansiedad O -
y O -
depresión O -
hospitalaria O -
(HAD). O -

Se O -
obtuvieron O -
medidas O -
antropométricas O -
y O -
evaluaciones O -
de O -
la O -
calidad O -
de O -
vida O -
antes O -
de O -
la O -
aleatorización O -
y O -
cada O -
6 O -
meses O -
durante O -
3 O -
años. O -

Doscientos O -
veinte O -
pacientes O -
fueron O -
evaluables O -
al O -
año. O -

La B-Premise HighQuality
intervención I-Premise HighQuality
aumentó I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
SF36 I-Premise HighQuality
en I-Premise HighQuality
9,5 I-Premise HighQuality
puntos I-Premise HighQuality
( I-Premise HighQuality
p=0,000006 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
4,6 I-Premise HighQuality
( I-Premise HighQuality
p=0,032 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
6,2 I-Premise HighQuality
( I-Premise HighQuality
p=0,028 I-Premise HighQuality
) I-Premise HighQuality
respectivamente I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
, I-Premise HighQuality
12 I-Premise HighQuality
y I-Premise HighQuality
24 I-Premise HighQuality
meses I-Premise HighQuality
. I-Premise HighQuality

El B-Premise HighQuality
tamaño I-Premise HighQuality
del I-Premise HighQuality
efecto I-Premise HighQuality
( I-Premise HighQuality
ES I-Premise HighQuality
) I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
0,63 I-Premise HighQuality
[ I-Premise HighQuality
0,37 I-Premise HighQuality
; I-Premise HighQuality
0,90 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
0,29 I-Premise HighQuality
[ I-Premise HighQuality
0,03 I-Premise HighQuality
; I-Premise HighQuality
0,55 I-Premise HighQuality
] I-Premise HighQuality
y I-Premise HighQuality
0,41 I-Premise HighQuality
[ I-Premise HighQuality
0,04 I-Premise HighQuality
; I-Premise HighQuality
0,78 I-Premise HighQuality
] I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
ansiedad I-Premise HighQuality
se I-Premise HighQuality
redujo I-Premise HighQuality
brevemente I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
intervención I-Premise HighQuality
( I-Premise HighQuality
ES=-0,24 I-Premise HighQuality
[ I-Premise HighQuality
-0,42 I-Premise HighQuality
; I-Premise HighQuality
-0,05 I-Premise HighQuality
] I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
depresión I-Premise HighQuality
de I-Premise HighQuality
forma I-Premise HighQuality
más I-Premise HighQuality
duradera I-Premise HighQuality
: I-Premise HighQuality
ES=-0,45 I-Premise HighQuality
[ I-Premise HighQuality
-0,72 I-Premise HighQuality
; I-Premise HighQuality
-0,18 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
-0,34 I-Premise HighQuality
[ I-Premise HighQuality
-061 I-Premise HighQuality
; I-Premise HighQuality
-0,08 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
-0,26 I-Premise HighQuality
[ I-Premise HighQuality
-0,63 I-Premise HighQuality
; I-Premise HighQuality
0,11 I-Premise HighQuality
] I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
, I-Premise HighQuality
12 I-Premise HighQuality
y I-Premise HighQuality
24 I-Premise HighQuality
meses I-Premise HighQuality
. I-Premise HighQuality

Esta B-Claim HighQuality
intervención I-Claim HighQuality
grupal I-Claim HighQuality
de I-Claim HighQuality
2 I-Claim HighQuality
semanas I-Claim HighQuality
pareció I-Claim HighQuality
influir I-Claim HighQuality
de I-Claim HighQuality
forma I-Claim HighQuality
duradera I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
CdV I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
tratadas I-Claim HighQuality
con I-Claim HighQuality
quimioterapia I-Claim HighQuality
. I-Claim HighQuality

Las B-Claim HighQuality
diferencias, I-Claim HighQuality
más I-Claim HighQuality
pequeñas I-Claim HighQuality
a I-Claim HighQuality
los I-Claim HighQuality
12 I-Claim HighQuality
meses I-Claim HighQuality
que I-Claim HighQuality
a I-Claim HighQuality
los I-Claim HighQuality
seis, I-Claim HighQuality
sugieren I-Claim HighQuality
que I-Claim HighQuality
una I-Claim HighQuality
segunda I-Claim HighQuality
intervención, I-Claim HighQuality
pero I-Claim HighQuality
más I-Claim HighQuality
corta, I-Claim HighQuality
podría I-Claim HighQuality
ayudar I-Claim HighQuality
a I-Claim HighQuality
mantener I-Claim HighQuality
los I-Claim HighQuality
beneficios I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
6 I-Claim HighQuality
meses. I-Claim HighQuality

Evaluar O -
las O -
toxicidades, O -
los O -
resultados O -
funcionales O -
y O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
asociados O -
a O -
la O -
quimiorradioterapia O -
( O -
CRT O -
) O -
concurrente O -
en O -
pacientes O -
con O -
cáncer O -
de O -
cabeza O -
y O -
cuello O -
. O -

Estudio O -
de O -
resultados O -
prospectivo O -
y O -
retrospectivo O -
. O -

Institución O -
de O -
atención O -
terciaria O -
. O -

Participantes O -
en O -
el O -
Proyecto O -
de O -
Evaluación O -
de O -
Resultados O -
longitudinales O -
cuyo O -
cáncer O -
de O -
cabeza O -
y O -
cuello O -
fue O -
tratado O -
con O -
TRC O -
entre O -
el O -
1 O -
de O -
febrero O -
de O -
2000 O -
y O -
el O -
1 O -
de O -
marzo O -
de O -
2007 O -
( O -
n O -
= O -
104 O -
) O -
. O -

Los O -
pacientes O -
proporcionaron O -
de O -
forma O -
prospectiva O -
información O -
sobre O -
la O -
calidad O -
de O -
vida O -
funcional O -
y O -
relacionada O -
con O -
la O -
salud O -
, O -
incluidos O -
los O -
datos O -
de O -
las O -
visitas O -
de O -
seguimiento O -
de O -
un O -
año O -
y O -
de O -
las O -
más O -
recientes. O -

Se O -
revisaron O -
las O -
historias O -
clínicas O -
para O -
determinar O -
la O -
toxicidad O -
y O -
las O -
tasas O -
de O -
supervivencia. O -

Toxicidades O -
agudas O -
y O -
tardías O -
bien O -
definidas O -
; O -
resultados O -
funcionales O -
( O -
dieta O -
, O -
dentición O -
, O -
traqueostomías O -
) O -
; O -
resultados O -
específicos O -
del O -
cáncer O -
de O -
cabeza O -
y O -
cuello O -
, O -
salud O -
general O -
y O -
depresión O -
; O -
y O -
tasas O -
de O -
supervivencia O -
. O -

La O -
mayoría O -
de O -
los O -
pacientes O -
tenían O -
tumores O -
orofaríngeos O -
o O -
laríngeos O -
( O -
87,5 O -
% O -
) O -
y O -
enfermedad O -
en O -
estado O -
avanzado O -
( O -
75,0 O -
% O -
) O -
. O -

Aproximadamente B-Premise HighQuality
la I-Premise HighQuality
mitad I-Premise HighQuality
tuvo I-Premise HighQuality
toxicidades I-Premise HighQuality
hematológicas I-Premise HighQuality
y I-Premise HighQuality
retrasos I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
relacionados I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
toxicidad. I-Premise HighQuality

Aproximadamente B-Premise HighQuality
una I-Premise HighQuality
cuarta I-Premise HighQuality
parte I-Premise HighQuality
tuvo I-Premise HighQuality
neurotoxicidades I-Premise HighQuality
y/o I-Premise HighQuality
ototoxicidades I-Premise HighQuality
, I-Premise HighQuality
descamación I-Premise HighQuality
húmeda I-Premise HighQuality
, I-Premise HighQuality
neumonía I-Premise HighQuality
, I-Premise HighQuality
náuseas I-Premise HighQuality
y I-Premise HighQuality
vómitos I-Premise HighQuality
que I-Premise HighQuality
requirieron I-Premise HighQuality
hospitalización I-Premise HighQuality
o I-Premise HighQuality
líquidos I-Premise HighQuality
intravenosos I-Premise HighQuality
, I-Premise HighQuality
deshidratación I-Premise HighQuality
o I-Premise HighQuality
desnutrición I-Premise HighQuality
que I-Premise HighQuality
requirieron I-Premise HighQuality
hospitalización I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
fiebre I-Premise HighQuality
leve I-Premise HighQuality
o I-Premise HighQuality
moderada I-Premise HighQuality
. I-Premise HighQuality

Aunque B-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
el I-Premise HighQuality
protocolo I-Premise HighQuality
actual I-Premise HighQuality
de I-Premise HighQuality
radioterapia I-Premise HighQuality
de I-Premise HighQuality
intensidad I-Premise HighQuality
modulada I-Premise HighQuality
( I-Premise HighQuality
IMRT I-Premise HighQuality
) I-Premise HighQuality
utilizando I-Premise HighQuality
el I-Premise HighQuality
sistema I-Premise HighQuality
de I-Premise HighQuality
planificación I-Premise HighQuality
Pinnacle I-Premise HighQuality
( I-Premise HighQuality
3 I-Premise HighQuality
) I-Premise HighQuality
tuvieron I-Premise HighQuality
más I-Premise HighQuality
retrasos I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
relacionados I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
toxicidad I-Premise HighQuality
, I-Premise HighQuality
tuvieron B-Premise HighQuality
menos I-Premise HighQuality
toxicidades I-Premise HighQuality
y I-Premise HighQuality
mejores I-Premise HighQuality
resultados I-Premise HighQuality
funcionales I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
relacionados I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
salud I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
radiación I-Premise HighQuality
lateral I-Premise HighQuality
convencional I-Premise HighQuality
de I-Premise HighQuality
campo I-Premise HighQuality
opuesto I-Premise HighQuality
o I-Premise HighQuality
el I-Premise HighQuality
protocolo I-Premise HighQuality
inicial I-Premise HighQuality
de I-Premise HighQuality
IMRT I-Premise HighQuality
utilizando I-Premise HighQuality
el I-Premise HighQuality
sistema I-Premise HighQuality
de I-Premise HighQuality
planificación I-Premise HighQuality
Best I-Premise HighQuality
nomos I-Premise HighQuality
PEACOCK I-Premise HighQuality
. I-Premise HighQuality

Los B-Claim HighQuality
pacientes I-Claim HighQuality
que I-Claim HighQuality
reciben I-Claim HighQuality
TRC I-Claim HighQuality
experimentan I-Claim HighQuality
un I-Claim HighQuality
número I-Claim HighQuality
considerable I-Claim HighQuality
de I-Claim HighQuality
acontecimientos I-Claim HighQuality
adversos I-Claim HighQuality
relacionados I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
tratamiento, I-Claim HighQuality
que I-Claim HighQuality
afectan I-Claim HighQuality
principalmente I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
función I-Claim HighQuality
orofaríngea I-Claim HighQuality
y I-Claim HighQuality
laríngea, I-Claim HighQuality
y I-Claim HighQuality
se I-Claim HighQuality
ha I-Claim HighQuality
observado I-Claim HighQuality
una I-Claim HighQuality
mejora I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
protocolo I-Claim HighQuality
actual I-Claim HighQuality
de I-Claim HighQuality
RIM. I-Claim HighQuality

Mejorar O -
la O -
rehabilitación O -
protésica O -
dental O -
e O -
incluir O -
evaluaciones O -
con O -
patólogos O -
del O -
habla O -
y O -
la O -
deglución O -
antes O -
y O -
durante O -
el O -
tratamiento O -
puede O -
mejorar O -
los O -
resultados O -
de O -
los O -
pacientes O -
. O -

Evaluar O -
la O -
combinación O -
del O -
antagonista O -
de O -
la O -
gastrina O -
Z-360 O -
y O -
la O -
gemcitabina O -
para O -
el O -
cáncer O -
de O -
páncreas O -
avanzado. O -

Los O -
pacientes O -
con O -
CP O -
no O -
tratados O -
previamente O -
fueron O -
asignados O -
aleatoriamente O -
a O -
Z-360 O -
120 O -
mg O -
, O -
240 O -
mg O -
o O -
placebo O -
. O -

Se O -
administró O -
Z-360/placebo O -
el O -
día O -
-3 O -
y O -
se O -
comenzó O -
con O -
gemcitabina O -
1000 O -
mg/m O -
( O -
2 O -
) O -
el O -
día O -
1 O -
seguido O -
de O -
Z-360 O -
el O -
día O -
2 O -
. O -

A O -
partir O -
de O -
entonces, O -
Z-360/placebo O -
se O -
administró O -
dos O -
veces O -
al O -
día O -
junto O -
con O -
la O -
dosis O -
estándar O -
de O -
gemcitabina. O -

Se O -
midió O -
la O -
farmacocinética O -
de O -
ambos O -
fármacos O -
solos O -
y O -
en O -
combinación. O -

También O -
se O -
registraron O -
la O -
toxicidad, O -
la O -
respuesta O -
y O -
la O -
calidad O -
de O -
vida. O -

Se O -
asignaron O -
al O -
azar O -
33 O -
pacientes O -
con O -
una O -
edad O -
media O -
de O -
62 O -
años, O -
de O -
los O -
cuales O -
6 O -
tenían O -
enfermedad O -
localmente O -
avanzada O -
y O -
26 O -
tenían O -
enfermedad O -
metastásica. O -

El O -
análisis O -
del O -
área O -
bajo O -
la O -
curva O -
de O -
concentración O -
plasmática O -
en O -
función O -
del O -
tiempo O -
( O -
AUC O -
) O -
, O -
la O -
concentración O -
máxima O -
observada O -
( O -
Cmáx O -
( O -
obs O -
) O -
) O -
y O -
el O -
tiempo O -
de O -
la O -
concentración O -
máxima O -
observada O -
( O -
Tmáx O -
( O -
obs O -
) O -
) O -
para O -
Z-360 O -
, O -
gemcitabina O -
y O -
2,2-difluorodeoxiuridina O -
( O -
dFdU O -
) O -
, O -
no O -
pudo O -
excluir O -
un O -
efecto O -
sobre O -
la O -
exposición O -
sistémica O -
a O -
Z-360 O -
, O -
gemcitabina O -
y O -
dFdU O -
cuando O -
se O -
comparó O -
la O -
administración O -
conjunta O -
de O -
Z-360 O -
y O -
gemcitabina O -
con O -
la O -
administración O -
de O -
un O -
solo O -
agente O -
. O -

Los B-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
fueron I-Premise HighQuality
náuseas, I-Premise HighQuality
dolor I-Premise HighQuality
abdominal, I-Premise HighQuality
vómitos I-Premise HighQuality
y I-Premise HighQuality
fatiga. I-Premise HighQuality

Al B-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
estudio, I-Premise HighQuality
el I-Premise HighQuality
62,5 I-Premise HighQuality
%, I-Premise HighQuality
el I-Premise HighQuality
25 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
60 I-Premise HighQuality
% I-Premise HighQuality
tenían I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
estable I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
120 I-Premise HighQuality
mg, I-Premise HighQuality
240 I-Premise HighQuality
mg I-Premise HighQuality
y I-Premise HighQuality
placebo, I-Premise HighQuality
respectivamente. I-Premise HighQuality

Una B-Premise HighQuality
mayor I-Premise HighQuality
proporción I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
Z-360 I-Premise HighQuality
informó I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
mejora I-Premise HighQuality
del I-Premise HighQuality
dolor I-Premise HighQuality
. I-Premise HighQuality

Z-360 B-Claim HighQuality
es I-Claim HighQuality
seguro I-Claim HighQuality
y I-Claim HighQuality
bien I-Claim HighQuality
tolerado I-Claim HighQuality
cuando I-Claim HighQuality
se I-Claim HighQuality
combina I-Claim HighQuality
con I-Claim HighQuality
gemcitabina I-Claim HighQuality
. I-Claim HighQuality

Se O -
necesita O -
un O -
ensayo O -
de O -
fase O -
III O -
para O -
determinar O -
si O -
la O -
combinación O -
de O -
Z-360 O -
y O -
gemcitabina O -
es O -
superior O -
a O -
la O -
gemcitabina O -
sola O -
en O -
el O -
CP O -
avanzado. O -

El O -
etopósido O -
oral O -
es O -
un O -
agente O -
único O -
activo O -
en O -
el O -
cáncer O -
de O -
pulmón O -
de O -
células O -
pequeñas O -
( O -
SCLC O -
) O -
y O -
se O -
prescribe O -
ampliamente O -
como O -
tratamiento O -
de O -
primera O -
línea O -
como O -
alternativa O -
a O -
la O -
quimioterapia O -
combinada O -
intravenosa O -
en O -
pacientes O -
con O -
enfermedad O -
extensa O -
. O -

La O -
intención O -
de O -
este O -
estudio O -
era O -
determinar O -
si O -
los O -
efectos O -
del O -
tratamiento O -
con O -
etopósido O -
oral O -
sobre O -
la O -
supervivencia O -
y O -
la O -
calidad O -
de O -
vida O -
son O -
equivalentes O -
a O -
los O -
de O -
la O -
quimioterapia O -
intravenosa O -
. O -

En O -
un O -
ensayo O -
aleatorio O -
de O -
tratamiento O -
paliativo O -
en O -
el O -
CPCP O -
avanzado, O -
se O -
comparó O -
el O -
etopósido O -
oral O -
( O -
100 O -
mg O -
administrados O -
dos O -
veces O -
al O -
día O -
durante O -
5 O -
días O -
) O -
con O -
la O -
quimioterapia O -
intravenosa O -
consistente O -
en O -
ciclos O -
alternados O -
de O -
cisplatino O -
y O -
etopósido O -
( O -
PE O -
) O -
y O -
ciclofosfamida O -
, O -
doxorrubicina O -
y O -
vincristina O -
( O -
CAV O -
) O -
. O -

Se O -
administraron O -
seis O -
ciclos O -
de O -
quimioterapia O -
cada O -
21 O -
días O -
en O -
ambos O -
regímenes. O -

El O -
control O -
de O -
los O -
síntomas O -
y O -
la O -
calidad O -
de O -
vida O -
se O -
midieron O -
con O -
la O -
lista O -
de O -
control O -
de O -
síntomas O -
de O -
Rotterdam O -
y O -
una O -
tarjeta O -
de O -
diario. O -

En O -
enero O -
de O -
1996, O -
después O -
de O -
que O -
se O -
asignaran O -
aleatoriamente O -
155 O -
pacientes O -
de O -
un O -
total O -
previsto O -
de O -
365, O -
un O -
Comité O -
de O -
Seguimiento O -
de O -
Datos O -
independiente O -
examinó O -
los O -
resultados O -
provisionales. O -

La O -
supervivencia O -
se O -
determinó O -
mediante O -
el O -
método O -
de O -
Kaplan-Meier O -
y O -
se O -
utilizó O -
el O -
test O -
de O -
logrank O -
para O -
comparar O -
los O -
tratamientos. O -

Para O -
las O -
comparaciones O -
de O -
la O -
calidad O -
de O -
vida, O -
se O -
calcularon O -
las O -
puntuaciones O -
medias O -
para O -
cada O -
punto O -
temporal. O -

Se O -
utilizó O -
la O -
prueba O -
U O -
de O -
Mann-Whitney O -
para O -
determinar O -
cualquier O -
diferencia O -
global O -
significativa O -
entre O -
los O -
tratamientos. O -

Para O -
la O -
lista O -
de O -
control O -
de O -
síntomas O -
de O -
Rotterdam, O -
se O -
realizaron O -
análisis O -
separados O -
para O -
cada O -
subconjunto O -
( O -
bienestar O -
psicológico, O -
síntomas O -
físicos, O -
síntomas O -
de O -
cáncer O -
de O -
pulmón, O -
síntomas O -
de O -
tratamiento, O -
actividad O -
y O -
calidad O -
de O -
vida O -
) O -
. O -

Las O -
tasas O -
de O -
respuesta O -
y O -
las O -
puntuaciones O -
de O -
toxicidad O -
se O -
compararon O -
mediante O -
chi2 O -
. O -

Todas O -
las O -
pruebas O -
estadísticas O -
fueron O -
de O -
dos O -
caras. O -

La B-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
un I-Premise HighQuality
año I-Premise HighQuality
fue I-Premise HighQuality
inferior I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
etopósido I-Premise HighQuality
oral I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
terapia I-Premise HighQuality
intravenosa I-Premise HighQuality
( I-Premise HighQuality
9,8 I-Premise HighQuality
% I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
oral I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
19,3 I-Premise HighQuality
% I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
intravenoso; I-Premise HighQuality
diferencia I-Premise HighQuality
= I-Premise HighQuality
9,5 I-Premise HighQuality
%; I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
diferencia I-Premise HighQuality
= I-Premise HighQuality
0,3 I-Premise HighQuality
% I-Premise HighQuality
-18,7 I-Premise HighQuality
%; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
hubo I-Premise HighQuality
una I-Premise HighQuality
tendencia I-Premise HighQuality
hacia I-Premise HighQuality
una I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
inferior I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
4,8 I-Premise HighQuality
meses I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
oral I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
5,9 I-Premise HighQuality
meses I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
terapia I-Premise HighQuality
intravenosa I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
supervivencia I-Premise HighQuality
sin I-Premise HighQuality
progresión I-Premise HighQuality
fue I-Premise HighQuality
peor I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
brazo I-Premise HighQuality
de I-Premise HighQuality
etopósido I-Premise HighQuality
oral I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
= I-Premise HighQuality
3,6 I-Premise HighQuality
meses I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5,6 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
así I-Premise HighQuality
como I-Premise HighQuality
la I-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
global I-Premise HighQuality
( I-Premise HighQuality
32,9 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
46,3 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

A B-Premise HighQuality
excepción I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
náuseas I-Premise HighQuality
y I-Premise HighQuality
vómitos I-Premise HighQuality
agudos I-Premise HighQuality
asociados I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
quimioterapia I-Premise HighQuality
intravenosa I-Premise HighQuality
, I-Premise HighQuality
todos B-Premise HighQuality
los I-Premise HighQuality
aspectos I-Premise HighQuality
del I-Premise HighQuality
control I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
fueron I-Premise HighQuality
iguales I-Premise HighQuality
o I-Premise HighQuality
peores I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
etopósido I-Premise HighQuality
oral I-Premise HighQuality
. I-Premise HighQuality

Se O -
recomendó O -
el O -
cierre O -
del O -
estudio. O -

Estos B-Claim HighQuality
resultados I-Claim HighQuality
provisionales I-Claim HighQuality
muestran I-Claim HighQuality
que I-Claim HighQuality
esta I-Claim HighQuality
pauta I-Claim HighQuality
de I-Claim HighQuality
etopósido I-Claim HighQuality
oral I-Claim HighQuality
es I-Claim HighQuality
inferior I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
quimioterapia I-Claim HighQuality
intravenosa I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
del I-Claim HighQuality
CPCP I-Claim HighQuality
avanzado I-Claim HighQuality
y I-Claim HighQuality
no I-Claim HighQuality
debe I-Claim HighQuality
utilizarse I-Claim HighQuality
como I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
primera I-Claim HighQuality
línea I-Claim HighQuality
de I-Claim HighQuality
esta I-Claim HighQuality
enfermedad. I-Claim HighQuality

Evaluar O -
los O -
efectos O -
de O -
la O -
música O -
de O -
cinco O -
elementos O -
de O -
la O -
medicina O -
china O -
( O -
CM O -
) O -
en O -
la O -
calidad O -
de O -
vida O -
de O -
los O -
pacientes O -
de O -
cáncer O -
avanzado, O -
tanto O -
mayores O -
como O -
no O -
mayores O -
. O -

Con O -
un O -
ensayo O -
controlado O -
aleatorio O -
, O -
170 O -
pacientes O -
con O -
cáncer O -
avanzado O -
fueron O -
asignados O -
al O -
azar O -
a O -
tres O -
grupos O -
: O -
el O -
grupo O -
de O -
música O -
de O -
cinco O -
elementos O -
CM O -
( O -
68 O -
pacientes O -
) O -
, O -
el O -
grupo O -
de O -
musicoterapia O -
occidental O -
( O -
68 O -
casos O -
) O -
, O -
y O -
el O -
grupo O -
de O -
no O -
musicoterapia O -
( O -
34 O -
casos O -
) O -
. O -

Todos O -
los O -
pacientes O -
de O -
70 O -
años O -
o O -
más O -
se O -
consideraron O -
mayores O -
y O -
el O -
resto O -
de O -
pacientes O -
menores O -
de O -
70 O -
años O -
se O -
consideraron O -
no O -
mayores. O -

Los O -
pacientes O -
del O -
grupo O -
de O -
música O -
de O -
cinco O -
elementos O -
CM O -
escucharon O -
música O -
de O -
cinco O -
elementos O -
CM O -
, O -
los O -
pacientes O -
del O -
grupo O -
de O -
música O -
occidental O -
escucharon O -
música O -
occidental O -
, O -
y O -
los O -
pacientes O -
del O -
grupo O -
sin O -
música O -
no O -
escucharon O -
música O -
. O -

El O -
curso O -
del O -
tratamiento O -
fue O -
de O -
3 O -
semanas, O -
con O -
30 O -
minutos O -
cada O -
día, O -
5 O -
días O -
a O -
la O -
semana. O -

Se O -
midieron O -
el O -
Índice O -
de O -
Calidad O -
de O -
Vida O -
en O -
Hospicio-Revisado O -
( O -
HQOLI-R O -
) O -
y O -
la O -
puntuación O -
de O -
rendimiento O -
de O -
Karnofsky O -
( O -
KPS O -
) O -
en O -
los O -
tres O -
grupos O -
antes O -
y O -
después O -
del O -
tratamiento O -
. O -

La O -
puntuación O -
del O -
diario O -
de O -
síntomas O -
se O -
midió O -
en O -
los O -
tres O -
grupos O -
cada O -
3 O -
días, O -
7 O -
veces O -
en O -
total. O -

El B-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
música I-Premise HighQuality
de I-Premise HighQuality
cinco I-Premise HighQuality
elementos I-Premise HighQuality
CM I-Premise HighQuality
mostró I-Premise HighQuality
una I-Premise HighQuality
diferencia I-Premise HighQuality
significativa I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
del I-Premise HighQuality
HQOLI-R I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
KPS I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
diario I-Premise HighQuality
de I-Premise HighQuality
síntomas I-Premise HighQuality
con I-Premise HighQuality
otros I-Premise HighQuality
grupos I-Premise HighQuality
( I-Premise HighQuality
todos I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Hubo B-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
del I-Premise HighQuality
HQOLI-R I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
del I-Premise HighQuality
diario I-Premise HighQuality
de I-Premise HighQuality
síntomas I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
KPS I-Premise HighQuality
después I-Premise HighQuality
del I-Premise HighQuality
tratamiento I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
música I-Premise HighQuality
de I-Premise HighQuality
cinco I-Premise HighQuality
elementos I-Premise HighQuality
de I-Premise HighQuality
CM I-Premise HighQuality
y I-Premise HighQuality
otros I-Premise HighQuality
grupos I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
de I-Premise HighQuality
no I-Premise HighQuality
ancianos I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Además, O -
hubo B-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
HQOLI-R I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
KPS I-Premise HighQuality
después I-Premise HighQuality
del I-Premise HighQuality
tratamiento I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
tres I-Premise HighQuality
grupos I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
de I-Premise HighQuality
mayores I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
musicoterapia I-Claim HighQuality
de I-Claim HighQuality
cinco I-Claim HighQuality
elementos I-Claim HighQuality
CM I-Claim HighQuality
podría I-Claim HighQuality
mejorar I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
KPS I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
cáncer I-Claim HighQuality
avanzado I-Claim HighQuality
senior I-Claim HighQuality
y I-Claim HighQuality
no I-Claim HighQuality
senior I-Claim HighQuality
, I-Claim HighQuality
y I-Claim HighQuality
podría I-Claim HighQuality
mejorar I-Claim HighQuality
los I-Claim HighQuality
síntomas I-Claim HighQuality
subjetivos I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
cáncer I-Claim HighQuality
avanzado I-Claim HighQuality
no I-Claim HighQuality
senior I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
bacilo I-Claim HighQuality
de I-Claim HighQuality
Calmette-Guérin I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
quimioterapia I-Claim HighQuality
intravesical I-Claim HighQuality
representan I-Claim HighQuality
opciones I-Claim HighQuality
adyuvantes I-Claim HighQuality
viables I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
vejiga I-Claim HighQuality
no I-Claim HighQuality
músculo-invasivo I-Claim HighQuality
de I-Claim HighQuality
riesgo I-Claim HighQuality
intermedio. I-Claim HighQuality

Aunque O -
el O -
bacilo O -
de O -
Calmette-Guérin O -
se O -
percibe O -
como O -
menos O -
tolerable O -
que O -
la O -
quimioterapia O -
intravesical O -
, O -
hasta O -
donde O -
sabemos, O -
ningún O -
estudio O -
comparativo O -
ha O -
abordado O -
cuestiones O -
de O -
calidad O -
de O -
vida O -
. O -

Se O -
comparó O -
la O -
calidad O -
de O -
vida O -
de O -
los O -
pacientes O -
con O -
cáncer O -
de O -
vejiga O -
no O -
músculo-invasivo O -
que O -
recibieron O -
gemcitabina O -
intravesical O -
adyuvante O -
o O -
1/3 O -
de O -
dosis O -
de O -
bacilo O -
de O -
Calmette-Guérin O -
. O -

Nuestro O -
estudio O -
multicéntrico, O -
prospectivo, O -
aleatorizado O -
y O -
de O -
fase O -
II O -
incluyó O -
a O -
120 O -
pacientes O -
con O -
cáncer O -
de O -
vejiga O -
no O -
músculo-invasivo O -
de O -
riesgo O -
intermedio. O -

De O -
estos O -
pacientes, O -
88 O -
seguían O -
siendo O -
evaluables O -
al O -
año O -
de O -
seguimiento. O -

Sólo O -
se O -
retiró O -
a O -
1 O -
paciente O -
por O -
efectos O -
adversos. O -

En O -
total, O -
61 O -
pacientes O -
recibieron O -
2.000 O -
mg/50 O -
cc O -
de O -
gemcitabina O -
semanalmente O -
durante O -
6 O -
semanas O -
( O -
mantenimiento O -
mensual O -
durante O -
1 O -
año O -
) O -
mientras O -
que O -
59 O -
recibieron O -
1/3 O -
de O -
dosis O -
de O -
bacilo O -
de O -
Calmette-Guérin O -
Connaught O -
semanalmente O -
durante O -
6 O -
semanas O -
( O -
mantenimiento O -
3 O -
instilaciones O -
semanales O -
a O -
los O -
3 O -
, O -
6 O -
y O -
12 O -
meses O -
) O -
. O -

La O -
calidad O -
de O -
vida O -
se O -
midió O -
con O -
los O -
cuestionarios O -
EORTC O -
QLQ-C30 O -
( O -
European O -
Organization O -
for O -
the O -
Research O -
and O -
Treatment O -
of O -
Cancer O -
Quality O -
of O -
Life O -
Questionnaire O -
Core O -
30 O -
version O -
3.0 O -
) O -
y O -
QLQ-BLS24 O -
( O -
Quality O -
of O -
Life O -
Superficial O -
Bladder O -
Cancer-Specific O -
24 O -
) O -
. O -

Las O -
diferencias O -
de O -
grupo O -
se O -
calcularon O -
mediante O -
ANOVA O -
( O -
ANOVA/MANOVA O -
) O -
. O -

El B-Premise HighQuality
tratamiento I-Premise HighQuality
fue I-Premise HighQuality
bien I-Premise HighQuality
tolerado I-Premise HighQuality
en I-Premise HighQuality
ambos I-Premise HighQuality
grupos, I-Premise HighQuality
aunque B-Premise HighQuality
los I-Premise HighQuality
efectos I-Premise HighQuality
secundarios I-Premise HighQuality
locales I-Premise HighQuality
y I-Premise HighQuality
sistémicos I-Premise HighQuality
fueron I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
brazo I-Premise HighQuality
del I-Premise HighQuality
bacilo I-Premise HighQuality
de I-Premise HighQuality
Calmette-Guérin. I-Premise HighQuality

Los B-Premise HighQuality
análisis I-Premise HighQuality
multivariantes I-Premise HighQuality
no I-Premise HighQuality
mostraron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
grupos I-Premise HighQuality
en I-Premise HighQuality
todas I-Premise HighQuality
las I-Premise HighQuality
dimensiones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
detectaron I-Premise HighQuality
cambios I-Premise HighQuality
significativos I-Premise HighQuality
a I-Premise HighQuality
lo I-Premise HighQuality
largo I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
dominios I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
bacilo I-Premise HighQuality
de I-Premise HighQuality
Calmette-Guérin I-Premise HighQuality
y I-Premise HighQuality
gemcitabina, I-Premise HighQuality
excepto I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
funcionamiento I-Premise HighQuality
físico I-Premise HighQuality
, I-Premise HighQuality
que I-Premise HighQuality
disminuyó I-Premise HighQuality
significativamente I-Premise HighQuality
en I-Premise HighQuality
ambos I-Premise HighQuality
grupos I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,002 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
detectaron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
cuanto I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
recidiva I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
2 I-Premise HighQuality
grupos I-Premise HighQuality
a I-Premise HighQuality
1 I-Premise HighQuality
año I-Premise HighQuality
de I-Premise HighQuality
seguimiento. I-Premise HighQuality

Aunque O -
se B-Claim HighQuality
detectó I-Claim HighQuality
una I-Claim HighQuality
mayor I-Claim HighQuality
tasa I-Claim HighQuality
de I-Claim HighQuality
efectos I-Claim HighQuality
secundarios, I-Claim HighQuality
aunque I-Claim HighQuality
de I-Claim HighQuality
leves I-Claim HighQuality
a I-Claim HighQuality
moderados, I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
bacilo I-Claim HighQuality
de I-Claim HighQuality
Calmette-Guérin I-Claim HighQuality
de I-Claim HighQuality
1/3 I-Claim HighQuality
de I-Claim HighQuality
dosis I-Claim HighQuality
en I-Claim HighQuality
comparación I-Claim HighQuality
con I-Claim HighQuality
la I-Claim HighQuality
gemcitabina, I-Claim HighQuality
nuestro B-Claim HighQuality
estudio I-Claim HighQuality
no I-Claim HighQuality
logró I-Claim HighQuality
mostrar I-Claim HighQuality
diferencias I-Claim HighQuality
significativas I-Claim HighQuality
entre I-Claim HighQuality
los I-Claim HighQuality
2 I-Claim HighQuality
fármacos I-Claim HighQuality
en I-Claim HighQuality
términos I-Claim HighQuality
de I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida. I-Claim HighQuality

Evaluar O -
la O -
eficacia O -
y O -
seguridad O -
del O -
trastuzumab O -
de O -
primera O -
línea, O -
como O -
agente O -
único, O -
en O -
mujeres O -
con O -
cáncer O -
de O -
mama O -
metastásico O -
con O -
sobreexpresión O -
de O -
HER2. O -

Ciento O -
catorce O -
mujeres O -
con O -
cáncer O -
de O -
mama O -
metastásico O -
con O -
sobreexpresión O -
de O -
HER2 O -
fueron O -
aleatorizadas O -
para O -
recibir O -
un O -
tratamiento O -
de O -
primera O -
línea O -
con O -
trastuzumab O -
de O -
4 O -
mg/kg O -
de O -
dosis O -
de O -
carga, O -
seguido O -
de O -
2 O -
mg/kg O -
semanales, O -
o O -
una O -
dosis O -
de O -
carga O -
mayor O -
de O -
8 O -
mg/kg, O -
seguida O -
de O -
4 O -
mg/kg O -
semanales. O -

La B-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
objetiva I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
26 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
[ I-Premise HighQuality
CI I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
18,2 I-Premise HighQuality
% I-Premise HighQuality
a I-Premise HighQuality
34,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
con I-Premise HighQuality
siete I-Premise HighQuality
respuestas I-Premise HighQuality
completas I-Premise HighQuality
y I-Premise HighQuality
23 I-Premise HighQuality
parciales I-Premise HighQuality
. I-Premise HighQuality

Las B-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
en I-Premise HighQuality
111 I-Premise HighQuality
pacientes I-Premise HighQuality
evaluables I-Premise HighQuality
con I-Premise HighQuality
sobreexpresión I-Premise HighQuality
3+ I-Premise HighQuality
y I-Premise HighQuality
2+ I-Premise HighQuality
de I-Premise HighQuality
HER2 I-Premise HighQuality
por I-Premise HighQuality
inmunohistoquímica I-Premise HighQuality
( I-Premise HighQuality
IHC I-Premise HighQuality
) I-Premise HighQuality
fueron I-Premise HighQuality
del I-Premise HighQuality
35 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
24,4 I-Premise HighQuality
% I-Premise HighQuality
a I-Premise HighQuality
44,7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
ninguna I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
0 I-Premise HighQuality
% I-Premise HighQuality
a I-Premise HighQuality
15,5 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

Las B-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
beneficio I-Premise HighQuality
clínico I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
evaluables I-Premise HighQuality
con I-Premise HighQuality
sobreexpresión I-Premise HighQuality
3+ I-Premise HighQuality
y I-Premise HighQuality
2+ I-Premise HighQuality
de I-Premise HighQuality
HER2 I-Premise HighQuality
fueron I-Premise HighQuality
del I-Premise HighQuality
48 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
7 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
respectivamente. I-Premise HighQuality

Las B-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
en I-Premise HighQuality
108 I-Premise HighQuality
pacientes I-Premise HighQuality
evaluables I-Premise HighQuality
con I-Premise HighQuality
y I-Premise HighQuality
sin I-Premise HighQuality
amplificación I-Premise HighQuality
del I-Premise HighQuality
gen I-Premise HighQuality
HER2 I-Premise HighQuality
mediante I-Premise HighQuality
análisis I-Premise HighQuality
de I-Premise HighQuality
hibridación I-Premise HighQuality
fluorescente I-Premise HighQuality
in I-Premise HighQuality
situ I-Premise HighQuality
( I-Premise HighQuality
FISH I-Premise HighQuality
) I-Premise HighQuality
fueron I-Premise HighQuality
del I-Premise HighQuality
34 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
23,9 I-Premise HighQuality
% I-Premise HighQuality
a I-Premise HighQuality
45,7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
del I-Premise HighQuality
7 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
0,8 I-Premise HighQuality
% I-Premise HighQuality
a I-Premise HighQuality
22,8 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente. I-Premise HighQuality

Diecisiete B-Premise HighQuality
( I-Premise HighQuality
57 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
30 I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
respuesta I-Premise HighQuality
objetiva I-Premise HighQuality
y I-Premise HighQuality
22 I-Premise HighQuality
( I-Premise HighQuality
51 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
43 I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
beneficio I-Premise HighQuality
clínico I-Premise HighQuality
no I-Premise HighQuality
habían I-Premise HighQuality
experimentado I-Premise HighQuality
progresión I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
seguimiento I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
12 I-Premise HighQuality
meses I-Premise HighQuality
o I-Premise HighQuality
más I-Premise HighQuality
tarde I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
relacionados I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
fueron I-Premise HighQuality
escalofríos I-Premise HighQuality
( I-Premise HighQuality
25 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
astenia I-Premise HighQuality
( I-Premise HighQuality
23 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
fiebre I-Premise HighQuality
( I-Premise HighQuality
22 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
dolor I-Premise HighQuality
( I-Premise HighQuality
18 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
náuseas I-Premise HighQuality
( I-Premise HighQuality
14 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
produjo I-Premise HighQuality
una I-Premise HighQuality
disfunción I-Premise HighQuality
cardíaca I-Premise HighQuality
en I-Premise HighQuality
dos I-Premise HighQuality
pacientes I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
; I-Premise HighQuality
ambos I-Premise HighQuality
tenían I-Premise HighQuality
antecedentes I-Premise HighQuality
de I-Premise HighQuality
enfermedad I-Premise HighQuality
cardíaca I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
requirieron I-Premise HighQuality
una I-Premise HighQuality
intervención I-Premise HighQuality
adicional I-Premise HighQuality
tras I-Premise HighQuality
la I-Premise HighQuality
interrupción I-Premise HighQuality
del I-Premise HighQuality
trastuzumab I-Premise HighQuality
. I-Premise HighQuality

No B-Claim HighQuality
hubo I-Claim HighQuality
pruebas I-Claim HighQuality
claras I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
relación I-Claim HighQuality
dosis-respuesta I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
respuesta, I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
o I-Claim HighQuality
los I-Claim HighQuality
acontecimientos I-Claim HighQuality
adversos. I-Claim HighQuality

El B-Claim HighQuality
trastuzumab I-Claim HighQuality
como I-Claim HighQuality
agente I-Claim HighQuality
único I-Claim HighQuality
es I-Claim HighQuality
activo I-Claim HighQuality
y I-Claim HighQuality
bien I-Claim HighQuality
tolerado I-Claim HighQuality
como I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
primera I-Claim HighQuality
línea I-Claim HighQuality
en I-Claim HighQuality
mujeres I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
metastásico I-Claim HighQuality
con I-Claim HighQuality
sobreexpresión I-Claim HighQuality
de I-Claim HighQuality
HER2 I-Claim HighQuality
3+ I-Claim HighQuality
por I-Claim HighQuality
IHC I-Claim HighQuality
o I-Claim HighQuality
amplificación I-Claim HighQuality
del I-Claim HighQuality
gen I-Claim HighQuality
por I-Claim HighQuality
FISH I-Claim HighQuality
. I-Claim HighQuality

Se O -
investigó O -
la O -
influencia O -
de O -
la O -
preservación O -
del O -
cuello O -
de O -
la O -
vejiga O -
en O -
la O -
continencia O -
urinaria, O -
la O -
calidad O -
de O -
vida O -
y O -
los O -
márgenes O -
quirúrgicos O -
tras O -
la O -
prostatectomía O -
radical. O -

Un O -
total O -
de O -
208 O -
hombres O -
que O -
se O -
presentaron O -
para O -
una O -
prostatectomía O -
radical O -
fueron O -
asignados O -
al O -
azar O -
a O -
la O -
preservación O -
completa O -
del O -
cuello O -
de O -
la O -
vejiga O -
con O -
anastomosis O -
uretro-uretral O -
posterior O -
o O -
a O -
la O -
no O -
preservación O -
como O -
controles O -
. O -

No O -
se O -
incluyeron O -
en O -
el O -
estudio O -
los O -
pacientes O -
con O -
preservación O -
fallida O -
del O -
cuello O -
de O -
la O -
vejiga. O -

Se O -
documentó O -
la O -
continencia O -
objetiva O -
mediante O -
la O -
prueba O -
de O -
la O -
compresa O -
de O -
24 O -
horas, O -
la O -
continencia O -
social O -
mediante O -
el O -
número O -
de O -
compresas O -
al O -
día O -
y O -
los O -
resultados O -
de O -
la O -
calidad O -
de O -
vida O -
mediante O -
el O -
cuestionario O -
validado O -
de O -
calidad O -
de O -
vida O -
de O -
la O -
incontinencia O -
en O -
un O -
entorno O -
de O -
ciego O -
único. O -

La O -
resección O -
del O -
cáncer O -
se O -
evaluó O -
por O -
el O -
estado O -
del O -
margen O -
quirúrgico O -
. O -

A B-Premise HighQuality
los I-Premise HighQuality
0, I-Premise HighQuality
3, I-Premise HighQuality
6 I-Premise HighQuality
y I-Premise HighQuality
12 I-Premise HighQuality
meses, I-Premise HighQuality
la I-Premise HighQuality
pérdida I-Premise HighQuality
media I-Premise HighQuality
de I-Premise HighQuality
orina I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
de I-Premise HighQuality
preservación I-Premise HighQuality
del I-Premise HighQuality
cuello I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
vejiga I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
713,3 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
237,0, I-Premise HighQuality
49,6 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
15,6, I-Premise HighQuality
44,4 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5,5 I-Premise HighQuality
y I-Premise HighQuality
25,4 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
3,1 I-Premise HighQuality
gm, I-Premise HighQuality
respectivamente I-Premise HighQuality
( I-Premise HighQuality
cada I-Premise HighQuality
uno I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

A B-Premise HighQuality
los I-Premise HighQuality
3, I-Premise HighQuality
6 I-Premise HighQuality
y I-Premise HighQuality
12 I-Premise HighQuality
meses, I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
de I-Premise HighQuality
preservación, I-Premise HighQuality
la I-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
continencia I-Premise HighQuality
social I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
55,3% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
84,2% I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
del I-Premise HighQuality
74,8% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
89,5% I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
del I-Premise HighQuality
81,4% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
94,7% I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,027 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
80,4 I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
90,3 I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
del I-Premise HighQuality
85,4 I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
91,7 I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,016 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
del I-Premise HighQuality
86,0 I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
93,8 I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

Observamos B-Premise HighQuality
una I-Premise HighQuality
pérdida I-Premise HighQuality
de I-Premise HighQuality
orina I-Premise HighQuality
significativamente I-Premise HighQuality
menor, I-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
continencia I-Premise HighQuality
objetiva I-Premise HighQuality
y I-Premise HighQuality
social I-Premise HighQuality
más I-Premise HighQuality
altas I-Premise HighQuality
y I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
más I-Premise HighQuality
altas I-Premise HighQuality
tras I-Premise HighQuality
la I-Premise HighQuality
preservación I-Premise HighQuality
completa I-Premise HighQuality
del I-Premise HighQuality
cuello I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
vejiga I-Premise HighQuality
en I-Premise HighQuality
todos I-Premise HighQuality
los I-Premise HighQuality
puntos I-Premise HighQuality
de I-Premise HighQuality
seguimiento. I-Premise HighQuality

En O -
el O -
análisis O -
de O -
regresión O -
logística O -
múltiple, O -
la O -
preservación O -
completa O -
del O -
cuello O -
de O -
la O -
vejiga O -
fue O -
un O -
predictor O -
positivo O -
independiente O -
de O -
la O -
continencia. O -

No B-Premise HighQuality
se I-Premise HighQuality
encontraron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
estado I-Premise HighQuality
del I-Premise HighQuality
margen I-Premise HighQuality
quirúrgico I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
preservación I-Premise HighQuality
del I-Premise HighQuality
cuello I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
vejiga I-Premise HighQuality
( I-Premise HighQuality
12,5 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
14,7 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,65 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

En B-Claim HighQuality
lo I-Claim HighQuality
que I-Claim HighQuality
es, I-Claim HighQuality
hasta I-Claim HighQuality
donde I-Claim HighQuality
sabemos, I-Claim HighQuality
el I-Claim HighQuality
primer I-Claim HighQuality
ensayo I-Claim HighQuality
prospectivo, I-Claim HighQuality
aleatorizado, I-Claim HighQuality
controlado I-Claim HighQuality
y I-Claim HighQuality
a I-Claim HighQuality
ciegas, I-Claim HighQuality
la I-Claim HighQuality
preservación I-Claim HighQuality
completa I-Claim HighQuality
del I-Claim HighQuality
cuello I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
vejiga I-Claim HighQuality
durante I-Claim HighQuality
la I-Claim HighQuality
prostatectomía I-Claim HighQuality
radical I-Claim HighQuality
se I-Claim HighQuality
asoció I-Claim HighQuality
a I-Claim HighQuality
una I-Claim HighQuality
tasa I-Claim HighQuality
de I-Claim HighQuality
continencia I-Claim HighQuality
urinaria I-Claim HighQuality
significativamente I-Claim HighQuality
mayor I-Claim HighQuality
y I-Claim HighQuality
a I-Claim HighQuality
un I-Claim HighQuality
aumento I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
satisfacción I-Claim HighQuality
del I-Claim HighQuality
paciente I-Claim HighQuality
sin I-Claim HighQuality
comprometer I-Claim HighQuality
los I-Claim HighQuality
márgenes I-Claim HighQuality
de I-Claim HighQuality
resección. I-Claim HighQuality

Docetaxel O -
administrado O -
cada O -
3 O -
semanas O -
es O -
un O -
tratamiento O -
estándar O -
para O -
el O -
cáncer O -
de O -
próstata O -
avanzado O -
resistente O -
a O -
la O -
castración O -
. O -

Se O -
planteó O -
la O -
hipótesis O -
de O -
que O -
la O -
administración O -
de O -
docetaxel O -
cada O -
dos O -
semanas O -
sería O -
mejor O -
tolerada O -
que O -
la O -
de O -
tres O -
semanas O -
en O -
pacientes O -
con O -
cáncer O -
de O -
próstata O -
avanzado O -
resistente O -
a O -
la O -
castración, O -
y O -
se O -
realizó O -
un O -
estudio O -
prospectivo, O -
multicéntrico, O -
aleatorizado O -
y O -
de O -
fase O -
3 O -
para O -
comparar O -
la O -
eficacia O -
y O -
la O -
seguridad. O -

Los O -
pacientes O -
elegibles O -
tenían O -
cáncer O -
de O -
próstata O -
avanzado O -
( O -
metástasis O -
, O -
un O -
resultado O -
de O -
la O -
prueba O -
del O -
antígeno O -
específico O -
de O -
la O -
próstata O -
de O -
más O -
de O -
10-0 O -
ng/mL O -
y O -
una O -
puntuación O -
del O -
estado O -
de O -
rendimiento O -
de O -
la O -
OMS O -
de O -
0-2 O -
) O -
no O -
habían O -
recibido O -
quimioterapia O -
(excepto O -
con O -
estramustina), O -
se O -
habían O -
sometido O -
a O -
una O -
castración O -
quirúrgica O -
o O -
química O -
y O -
habían O -
sido O -
remitidos O -
a O -
un O -
centro O -
de O -
tratamiento O -
en O -
Finlandia, O -
Irlanda O -
o O -
Suecia. O -

La O -
inscripción O -
y O -
el O -
tratamiento O -
se O -
realizaron O -
entre O -
el O -
1 O -
de O -
marzo O -
de O -
2004 O -
y O -
el O -
31 O -
de O -
mayo O -
de O -
2009. O -

La O -
aleatorización O -
se O -
realizó O -
de O -
forma O -
centralizada O -
y O -
se O -
estratificó O -
por O -
centro O -
y O -
por O -
la O -
puntuación O -
del O -
estado O -
funcional O -
de O -
la O -
OMS O -
de O -
0-1 O -
frente O -
a O -
2 O -
. O -

A O -
los O -
pacientes O -
se O -
les O -
asignó O -
75 O -
mg/m O -
( O -
2 O -
) O -
de O -
docetaxel O -
por O -
vía O -
intravenosa O -
el O -
día O -
1 O -
de O -
un O -
ciclo O -
de O -
3 O -
semanas O -
, O -
o O -
50 O -
mg/m O -
( O -
2 O -
) O -
de O -
docetaxel O -
por O -
vía O -
intravenosa O -
los O -
días O -
1 O -
y O -
15 O -
de O -
un O -
ciclo O -
de O -
4 O -
semanas O -
. O -

Se O -
administraron O -
10 O -
mg O -
de O -
prednisolona O -
oral O -
diariamente O -
a O -
todos O -
los O -
pacientes. O -

El O -
criterio O -
de O -
valoración O -
principal O -
fue O -
el O -
tiempo O -
hasta O -
el O -
fracaso O -
del O -
tratamiento O -
( O -
TTTF O -
) O -
. O -

Se O -
evaluaron O -
los O -
datos O -
de O -
la O -
población O -
por O -
protocolo. O -

177 O -
pacientes O -
fueron O -
asignados O -
aleatoriamente O -
al O -
grupo O -
de O -
docetaxel O -
de O -
2 O -
semanas O -
y O -
184 O -
al O -
grupo O -
de O -
3 O -
semanas. O -

Se O -
incluyeron O -
en O -
el O -
análisis O -
170 O -
pacientes O -
en O -
el O -
grupo O -
de O -
2 O -
semanas O -
y O -
176 O -
en O -
el O -
de O -
3 O -
semanas. O -

La B-Premise HighQuality
administración I-Premise HighQuality
bisemanal I-Premise HighQuality
se I-Premise HighQuality
asoció I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
TTTF I-Premise HighQuality
significativamente I-Premise HighQuality
más I-Premise HighQuality
larga I-Premise HighQuality
que I-Premise HighQuality
la I-Premise HighQuality
administración I-Premise HighQuality
bisemanal I-Premise HighQuality
( I-Premise HighQuality
5-6 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
5-0-6-2 I-Premise HighQuality
vs I-Premise HighQuality
4-9 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
4-5-5-4 I-Premise HighQuality
; I-Premise HighQuality
hazard I-Premise HighQuality
ratio I-Premise HighQuality
1-3 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
1-1-1-6 I-Premise HighQuality
, I-Premise HighQuality
p=0-014 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
acontecimientos I-Premise HighQuality
adversos I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3-4 I-Premise HighQuality
se I-Premise HighQuality
produjeron I-Premise HighQuality
con I-Premise HighQuality
mayor I-Premise HighQuality
frecuencia I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
administración I-Premise HighQuality
de I-Premise HighQuality
3 I-Premise HighQuality
semanas I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
de I-Premise HighQuality
2 I-Premise HighQuality
semanas, I-Premise HighQuality
incluyendo I-Premise HighQuality
neutropenia I-Premise HighQuality
( I-Premise HighQuality
93 I-Premise HighQuality
[ I-Premise HighQuality
53 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
61 I-Premise HighQuality
[ I-Premise HighQuality
36 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
leucopenia I-Premise HighQuality
( I-Premise HighQuality
51 I-Premise HighQuality
[ I-Premise HighQuality
29 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
22 I-Premise HighQuality
[ I-Premise HighQuality
13 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
neutropenia I-Premise HighQuality
febril I-Premise HighQuality
( I-Premise HighQuality
25 I-Premise HighQuality
[ I-Premise HighQuality
14 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
seis I-Premise HighQuality
[ I-Premise HighQuality
4 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
notificaron I-Premise HighQuality
infecciones I-Premise HighQuality
neutropénicas I-Premise HighQuality
con I-Premise HighQuality
mayor I-Premise HighQuality
frecuencia I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
docetaxel I-Premise HighQuality
cada I-Premise HighQuality
3 I-Premise HighQuality
semanas I-Premise HighQuality
( I-Premise HighQuality
43 I-Premise HighQuality
[ I-Premise HighQuality
24 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
11 I-Premise HighQuality
[ I-Premise HighQuality
6 I-Premise HighQuality
% I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
p=0-002 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
administración I-Claim HighQuality
de I-Claim HighQuality
docetaxel I-Claim HighQuality
cada I-Claim HighQuality
2 I-Claim HighQuality
semanas I-Claim HighQuality
parece I-Claim HighQuality
ser I-Claim HighQuality
bien I-Claim HighQuality
tolerada I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
próstata I-Claim HighQuality
avanzado I-Claim HighQuality
resistente I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
castración I-Claim HighQuality
y I-Claim HighQuality
podría I-Claim HighQuality
ser I-Claim HighQuality
una I-Claim HighQuality
opción I-Claim HighQuality
útil I-Claim HighQuality
cuando I-Claim HighQuality
es I-Claim HighQuality
poco I-Claim HighQuality
probable I-Claim HighQuality
que I-Claim HighQuality
se I-Claim HighQuality
tolere I-Claim HighQuality
la I-Claim HighQuality
administración I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
dosis I-Claim HighQuality
única I-Claim HighQuality
cada I-Claim HighQuality
3 I-Claim HighQuality
semanas I-Claim HighQuality
. I-Claim HighQuality

Para B-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
gástrico I-Claim HighQuality
o I-Claim HighQuality
gastroesofágico I-Claim HighQuality
avanzado I-Claim HighQuality
( I-Claim HighQuality
AGGEC I-Claim HighQuality
) I-Claim HighQuality
proporcionar I-Claim HighQuality
un I-Claim HighQuality
beneficio I-Claim HighQuality
clínico I-Claim HighQuality
con I-Claim HighQuality
una I-Claim HighQuality
mejor I-Claim HighQuality
paliación I-Claim HighQuality
es I-Claim HighQuality
altamente I-Claim HighQuality
deseable I-Claim HighQuality
. I-Claim HighQuality

Sin O -
embargo, O -
nunca O -
antes O -
se O -
había O -
informado O -
de O -
una O -
evaluación O -
prospectiva O -
del O -
beneficio O -
clínico O -
en O -
pacientes O -
con O -
AGGEC O -
en O -
un O -
entorno O -
de O -
fase O -
III. O -

En O -
un O -
ensayo O -
multinacional O -
( O -
V325 O -
) O -
, O -
445 O -
pacientes O -
fueron O -
asignados O -
al O -
azar O -
y O -
tratados O -
con O -
docetaxel O -
más O -
cisplatino O -
y O -
fluorouracilo O -
( O -
DCF O -
) O -
o O -
cisplatino O -
y O -
fluorouracilo O -
( O -
CF O -
) O -
. O -

El O -
beneficio O -
clínico O -
se O -
evaluó O -
prospectivamente O -
en O -
este O -
ensayo O -
como O -
punto O -
final O -
secundario O -
. O -

La O -
medida O -
principal O -
para O -
el O -
análisis O -
del O -
beneficio O -
clínico O -
fue O -
el O -
tiempo O -
hasta O -
el O -
empeoramiento O -
definitivo O -
en O -
una O -
o O -
más O -
categorías O -
del O -
estado O -
de O -
rendimiento O -
de O -
Karnofsky O -
( O -
KPS O -
) O -
. O -

Los O -
puntos O -
finales O -
de O -
beneficio O -
clínico O -
secundarios O -
incluyeron O -
el O -
tiempo O -
hasta O -
la O -
pérdida O -
de O -
peso O -
definitiva O -
del O -
5 O -
% O -
, O -
el O -
tiempo O -
hasta O -
el O -
empeoramiento O -
definitivo O -
del O -
apetito O -
en O -
un O -
grado O -
, O -
la O -
supervivencia O -
sin O -
dolor O -
( O -
definida O -
como O -
el O -
tiempo O -
hasta O -
la O -
primera O -
aparición O -
del O -
dolor O -
) O -
y O -
el O -
tiempo O -
hasta O -
la O -
primera O -
ingesta O -
de O -
opioides O -
relacionados O -
con O -
el O -
dolor O -
del O -
cáncer O -
. O -

Las O -
evaluaciones O -
de O -
los O -
beneficios O -
clínicos O -
se O -
registraron O -
en O -
cada O -
visita O -
clínica O -
. O -

Las O -
evaluaciones O -
del O -
beneficio O -
clínico O -
se O -
realizaron O -
en O -
más O -
del O -
75 O -
% O -
de O -
los O -
pacientes O -
a O -
lo O -
largo O -
de O -
V325 O -
. O -

El B-Premise HighQuality
DCF I-Premise HighQuality
prolongó I-Premise HighQuality
significativamente I-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
empeoramiento I-Premise HighQuality
definitivo I-Premise HighQuality
del I-Premise HighQuality
KPS I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
FC I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
, I-Premise HighQuality
6,1 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,8 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
hazard I-Premise HighQuality
ratio I-Premise HighQuality
, I-Premise HighQuality
1,38 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
1,08 I-Premise HighQuality
a I-Premise HighQuality
1,76 I-Premise HighQuality
; I-Premise HighQuality
log-rank I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
.009 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Aunque B-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
pérdida I-Premise HighQuality
de I-Premise HighQuality
peso I-Premise HighQuality
definitiva I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
empeoramiento I-Premise HighQuality
definitivo I-Premise HighQuality
del I-Premise HighQuality
apetito I-Premise HighQuality
favorecieron I-Premise HighQuality
al I-Premise HighQuality
DCF I-Premise HighQuality
, I-Premise HighQuality
los B-Premise HighQuality
resultados I-Premise HighQuality
no I-Premise HighQuality
fueron I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativos. I-Premise HighQuality

La B-Premise HighQuality
supervivencia I-Premise HighQuality
sin I-Premise HighQuality
dolor I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
primera I-Premise HighQuality
toma I-Premise HighQuality
de I-Premise HighQuality
opioides I-Premise HighQuality
relacionada I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
dolor I-Premise HighQuality
del I-Premise HighQuality
cáncer I-Premise HighQuality
fueron I-Premise HighQuality
comparables I-Premise HighQuality
. I-Premise HighQuality

Hasta O -
donde O -
sabemos, O -
el O -
V325 O -
es O -
el O -
primer O -
ensayo O -
de O -
fase O -
III O -
que O -
informa O -
de O -
un O -
beneficio O -
clínico O -
en O -
pacientes O -
con O -
AGGEC. O -

El O -
beneficio O -
clínico O -
se O -
evaluó O -
más O -
allá O -
de O -
la O -
quimioterapia O -
específica O -
del O -
protocolo O -
. O -

La B-Claim HighQuality
adición I-Claim HighQuality
de I-Claim HighQuality
D I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
CF I-Claim HighQuality
no I-Claim HighQuality
sólo I-Claim HighQuality
mejoró I-Claim HighQuality
significativamente I-Claim HighQuality
el I-Claim HighQuality
beneficio I-Claim HighQuality
clínico I-Claim HighQuality
sino I-Claim HighQuality
que I-Claim HighQuality
también I-Claim HighQuality
mejoró I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
, I-Claim HighQuality
el I-Claim HighQuality
tiempo I-Claim HighQuality
hasta I-Claim HighQuality
la I-Claim HighQuality
progresión I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
global I-Claim HighQuality
en I-Claim HighQuality
comparación I-Claim HighQuality
con I-Claim HighQuality
la I-Claim HighQuality
CF I-Claim HighQuality
. I-Claim HighQuality

La O -
adición O -
del O -
inhibidor O -
de O -
mTOR O -
everolimus O -
( O -
EVE O -
) O -
al O -
exemestano O -
( O -
EXE O -
) O -
se O -
evaluó O -
en O -
un O -
estudio O -
internacional O -
de O -
fase O -
3 O -
( O -
BOLERO-2 O -
) O -
en O -
pacientes O -
con O -
cáncer O -
de O -
mama O -
con O -
receptores O -
hormonales O -
positivos O -
( O -
HR O -
( O -
+ O -
) O -
) O -
refractario O -
a O -
letrozol O -
o O -
anastrozol O -
. O -

La O -
seguridad O -
y O -
la O -
eficacia O -
de O -
los O -
tratamientos O -
contra O -
el O -
cáncer O -
pueden O -
verse O -
influidas O -
por O -
el O -
origen O -
étnico O -
( O -
Sekine O -
et O -
al O -
. O -

En O -
Br O -
J O -
Cancer O -
99:1757-62 O -
, O -
2008 O -
). O -

Se O -
presentan O -
los O -
resultados O -
de O -
seguridad O -
y O -
eficacia O -
de O -
los O -
pacientes O -
asiáticos O -
frente O -
a O -
los O -
no O -
asiáticos O -
en O -
BOLERO-2. O -

Los O -
pacientes O -
fueron O -
aleatorizados O -
( O -
2:1 O -
) O -
a O -
10 O -
mg/día O -
de O -
EVE O -
+ O -
EXE O -
o O -
a O -
placebo O -
( O -
PBO O -
) O -
+ O -
EXE O -
. O -

El O -
criterio O -
de O -
valoración O -
primario O -
fue O -
la O -
supervivencia O -
sin O -
progresión O -
( O -
PFS O -
) O -
. O -

Los O -
criterios O -
de O -
valoración O -
secundarios O -
fueron O -
la O -
supervivencia O -
global, O -
la O -
tasa O -
de O -
respuesta, O -
la O -
tasa O -
de O -
beneficio O -
clínico O -
y O -
la O -
seguridad. O -

De O -
los O -
143 O -
pacientes O -
asiáticos, O -
98 O -
recibieron O -
EVE O -
+ O -
EXE O -
y O -
45 O -
recibieron O -
PBO O -
+ O -
EXE. O -

El B-Premise HighQuality
tratamiento I-Premise HighQuality
con I-Premise HighQuality
EVE I-Premise HighQuality
+ I-Premise HighQuality
EXE I-Premise HighQuality
mejoró I-Premise HighQuality
significativamente I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SLP I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
PBO I-Premise HighQuality
+ I-Premise HighQuality
EXE I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asiáticos I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
38 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
= I-Premise HighQuality
0,62 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,41-0,94 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SLP I-Premise HighQuality
también I-Premise HighQuality
mejoró I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
no I-Premise HighQuality
asiáticos I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
59% I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
= I-Premise HighQuality
0,41 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,33-0,50 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
duración I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SLP I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asiáticos I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
EVE I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
8,48 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,14 I-Premise HighQuality
meses I-Premise HighQuality
para I-Premise HighQuality
PBO I-Premise HighQuality
+ I-Premise HighQuality
EXE I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
7,33 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
2,83 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
no I-Premise HighQuality
asiáticos I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3/4 I-Premise HighQuality
más I-Premise HighQuality
comunes I-Premise HighQuality
( I-Premise HighQuality
estomatitis I-Premise HighQuality
, I-Premise HighQuality
anemia I-Premise HighQuality
, I-Premise HighQuality
elevación I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
enzimas I-Premise HighQuality
hepáticas I-Premise HighQuality
, I-Premise HighQuality
hiperglucemia I-Premise HighQuality
y I-Premise HighQuality
disnea I-Premise HighQuality
) I-Premise HighQuality
se I-Premise HighQuality
produjeron I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
frecuencia I-Premise HighQuality
similar I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asiáticos I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
asiáticos I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
enfermedad I-Premise HighQuality
pulmonar I-Premise HighQuality
intersticial I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
1/2 I-Premise HighQuality
fue I-Premise HighQuality
más I-Premise HighQuality
frecuente I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asiáticos. I-Premise HighQuality

La B-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
fue I-Premise HighQuality
similar I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
brazos I-Premise HighQuality
de I-Premise HighQuality
tratamiento I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asiáticos I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
adición I-Claim HighQuality
de I-Claim HighQuality
EVE I-Claim HighQuality
a I-Claim HighQuality
EXE I-Claim HighQuality
proporcionó I-Claim HighQuality
un I-Claim HighQuality
beneficio I-Claim HighQuality
clínico I-Claim HighQuality
sustancial I-Claim HighQuality
tanto I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
asiáticos I-Claim HighQuality
como I-Claim HighQuality
no I-Claim HighQuality
asiáticos I-Claim HighQuality
con I-Claim HighQuality
perfiles I-Claim HighQuality
de I-Claim HighQuality
seguridad I-Claim HighQuality
similares I-Claim HighQuality
. I-Claim HighQuality

Esta B-Claim HighQuality
combinación I-Claim HighQuality
representa I-Claim HighQuality
una I-Claim HighQuality
mejora I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
mujeres I-Claim HighQuality
posmenopáusicas I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
avanzado I-Claim HighQuality
HR I-Claim HighQuality
( I-Claim HighQuality
+ I-Claim HighQuality
) I-Claim HighQuality
/HER2 I-Claim HighQuality
( I-Claim HighQuality
- I-Claim HighQuality
) I-Claim HighQuality
que I-Claim HighQuality
progresan I-Claim HighQuality
con I-Claim HighQuality
inhibidores I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
aromatasa I-Claim HighQuality
no I-Claim HighQuality
esteroideos, I-Claim HighQuality
independientemente I-Claim HighQuality
de I-Claim HighQuality
su I-Claim HighQuality
origen I-Claim HighQuality
étnico. I-Claim HighQuality

Los B-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
edad I-Claim HighQuality
avanzada, I-Claim HighQuality
aunque I-Claim HighQuality
estén I-Claim HighQuality
en I-Claim HighQuality
forma, I-Claim HighQuality
suelen I-Claim HighQuality
considerarse I-Claim HighQuality
incapaces I-Claim HighQuality
de I-Claim HighQuality
tolerar I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
sistémico I-Claim HighQuality
con I-Claim HighQuality
platino. I-Claim HighQuality

Se O -
realizó O -
un O -
análisis O -
retrospectivo O -
del O -
Eastern O -
Cooperative O -
Oncology O -
Group O -
( O -
ECOG O -
) O -
5592 O -
, O -
un O -
ensayo O -
aleatorio O -
de O -
fase O -
III O -
de O -
regímenes O -
de O -
quimioterapia O -
basados O -
en O -
platino O -
para O -
el O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
( O -
CPNM O -
) O -
, O -
y O -
se O -
compararon O -
los O -
resultados O -
en O -
los O -
inscritos O -
de O -
70 O -
años O -
o O -
más O -
con O -
los O -
de O -
los O -
pacientes O -
más O -
jóvenes O -
. O -

El O -
ECOG O -
llevó O -
a O -
cabo O -
un O -
ensayo O -
aleatorio O -
de O -
fase O -
III O -
de O -
cisplatino O -
más O -
etopósido O -
o O -
paclitaxel O -
en O -
pacientes O -
de O -
CPNM O -
no O -
tratados O -
con O -
quimioterapia O -
y O -
con O -
enfermedad O -
en O -
estadios O -
III O -
( O -
B O -
) O -
o O -
IV O -
. O -

Se O -
compararon O -
los O -
efectos O -
tóxicos, O -
las O -
tasas O -
de O -
respuesta O -
y O -
las O -
tasas O -
de O -
supervivencia O -
entre O -
los O -
grupos O -
de O -
edad. O -

Todos O -
los O -
valores O -
P O -
fueron O -
de O -
dos O -
caras. O -

Un O -
total O -
de O -
574 O -
pacientes O -
inscritos O -
desde O -
agosto O -
de O -
1993 O -
hasta O -
diciembre O -
de O -
1994 O -
fueron O -
evaluables O -
. O -

Ochenta O -
y O -
seis O -
( O -
15 O -
% O -
) O -
tenían O -
70 O -
años O -
o O -
más. O -

Los B-Premise HighQuality
pacientes I-Premise HighQuality
de I-Premise HighQuality
mayor I-Premise HighQuality
edad I-Premise HighQuality
tenían I-Premise HighQuality
una I-Premise HighQuality
mayor I-Premise HighQuality
incidencia I-Premise HighQuality
de I-Premise HighQuality
comorbilidades I-Premise HighQuality
cardiovasculares I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,009 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
respiratorias I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,04 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
uso I-Premise HighQuality
de I-Premise HighQuality
medicación I-Premise HighQuality
no I-Premise HighQuality
analgésica I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,02 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
leucopenia I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
toxicidad I-Premise HighQuality
neuropsiquiátrica I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,002 I-Premise HighQuality
) I-Premise HighQuality
fueron I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
hombres I-Premise HighQuality
de I-Premise HighQuality
edad I-Premise HighQuality
avanzada I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
más I-Premise HighQuality
jóvenes. I-Premise HighQuality

Las B-Premise HighQuality
mujeres I-Premise HighQuality
mayores I-Premise HighQuality
perdieron I-Premise HighQuality
más I-Premise HighQuality
peso I-Premise HighQuality
que I-Premise HighQuality
las I-Premise HighQuality
más I-Premise HighQuality
jóvenes I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,006 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Otros B-Premise HighQuality
efectos I-Premise HighQuality
tóxicos I-Premise HighQuality
fueron I-Premise HighQuality
similares I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
de I-Premise HighQuality
mayor I-Premise HighQuality
y I-Premise HighQuality
menor I-Premise HighQuality
edad. I-Premise HighQuality

Las B-Premise HighQuality
proporciones I-Premise HighQuality
con I-Premise HighQuality
respuesta I-Premise HighQuality
clínica I-Premise HighQuality
parcial I-Premise HighQuality
o I-Premise HighQuality
completa I-Premise HighQuality
( I-Premise HighQuality
21,5 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
23,3 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
prueba I-Premise HighQuality
exacta I-Premise HighQuality
de I-Premise HighQuality
Fisher I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,66 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
( I-Premise HighQuality
4,37 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,30 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
rango I-Premise HighQuality
logarítmico I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,29 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
distribución I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
( I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
rango I-Premise HighQuality
logarítmico I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,29 I-Premise HighQuality
; I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
, I-Premise HighQuality
9,05 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
8,53 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
un I-Premise HighQuality
año I-Premise HighQuality
, I-Premise HighQuality
38 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
29 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
y I-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
dos I-Premise HighQuality
años I-Premise HighQuality
, I-Premise HighQuality
14 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
12 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
fueron I-Premise HighQuality
similares I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
menores I-Premise HighQuality
de I-Premise HighQuality
70 I-Premise HighQuality
años I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
de I-Premise HighQuality
70 I-Premise HighQuality
años I-Premise HighQuality
o I-Premise HighQuality
más I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
índices I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
resultados I-Premise HighQuality
del I-Premise HighQuality
tratamiento I-Premise HighQuality
fueron I-Premise HighQuality
similares. I-Premise HighQuality

En B-Premise HighQuality
ambos I-Premise HighQuality
grupos I-Premise HighQuality
se I-Premise HighQuality
produjeron I-Premise HighQuality
descensos I-Premise HighQuality
equivalentes I-Premise HighQuality
a I-Premise HighQuality
lo I-Premise HighQuality
largo I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
bienestar I-Premise HighQuality
funcional. I-Premise HighQuality

La B-Claim HighQuality
tasa I-Claim HighQuality
de I-Claim HighQuality
respuesta, I-Claim HighQuality
la I-Claim HighQuality
toxicidad I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
edad I-Claim HighQuality
avanzada I-Claim HighQuality
con I-Claim HighQuality
CPNM I-Claim HighQuality
en I-Claim HighQuality
buen I-Claim HighQuality
estado I-Claim HighQuality
físico I-Claim HighQuality
que I-Claim HighQuality
reciben I-Claim HighQuality
tratamiento I-Claim HighQuality
a I-Claim HighQuality
base I-Claim HighQuality
de I-Claim HighQuality
platino I-Claim HighQuality
parecen I-Claim HighQuality
ser I-Claim HighQuality
similares I-Claim HighQuality
a I-Claim HighQuality
las I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
más I-Claim HighQuality
jóvenes, I-Claim HighQuality
aunque B-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
70 I-Claim HighQuality
años I-Claim HighQuality
o I-Claim HighQuality
más I-Claim HighQuality
tienen I-Claim HighQuality
más I-Claim HighQuality
comorbilidades I-Claim HighQuality
y I-Claim HighQuality
pueden I-Claim HighQuality
esperar I-Claim HighQuality
más I-Claim HighQuality
leucopenia I-Claim HighQuality
y I-Claim HighQuality
toxicidad I-Claim HighQuality
neuropsiquiátrica. I-Claim HighQuality

La B-Claim HighQuality
edad I-Claim HighQuality
avanzada I-Claim HighQuality
por I-Claim HighQuality
sí I-Claim HighQuality
sola I-Claim HighQuality
no I-Claim HighQuality
debe I-Claim HighQuality
impedir I-Claim HighQuality
un I-Claim HighQuality
tratamiento I-Claim HighQuality
adecuado I-Claim HighQuality
del I-Claim HighQuality
CPNM. I-Claim HighQuality

Investigar O -
el O -
efecto O -
de O -
dos O -
dosis O -
de O -
acetato O -
de O -
megestrol O -
( O -
MA O -
) O -
en O -
comparación O -
con O -
el O -
placebo O -
sobre O -
la O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
y O -
el O -
estado O -
nutricional O -
( O -
NS O -
) O -
en O -
pacientes O -
con O -
cáncer O -
avanzado O -
insensible O -
a O -
la O -
endocrina O -
. O -

Doscientos O -
cuarenta O -
pacientes O -
fueron O -
asignados O -
aleatoriamente O -
a O -
MA O -
480 O -
mg/día, O -
MA O -
160 O -
mg/día O -
o O -
placebo O -
equivalente O -
durante O -
12 O -
semanas. O -

El O -
estado O -
nutricional O -
(incluyendo O -
el O -
peso, O -
el O -
grosor O -
de O -
los O -
pliegues O -
de O -
la O -
piel O -
y O -
la O -
circunferencia O -
del O -
brazo) O -
y O -
la O -
calidad O -
de O -
vida O -
(utilizando O -
6 O -
escalas O -
de O -
autoevaluación O -
analógica O -
lineal O -
(LASA)) O -
se O -
evaluaron O -
en O -
el O -
momento O -
de O -
la O -
aleatorización O -
y O -
después O -
de O -
cuatro, O -
ocho O -
y O -
12 O -
semanas. O -

También O -
se O -
utilizó O -
una O -
clasificación O -
de O -
la O -
calidad O -
de O -
vida O -
que O -
incorporaba O -
la O -
calidad O -
de O -
vida O -
y O -
la O -
muerte O -
y O -
que O -
iba O -
de O -
1 O -
= O -
muerto O -
a O -
5 O -
= O -
calidad O -
de O -
vida O -
mucho O -
mejor. O -

Ciento O -
setenta O -
y O -
cuatro O -
pacientes O -
fueron O -
evaluables O -
en O -
la O -
cuarta O -
semana O -
, O -
136 O -
en O -
la O -
octava O -
semana O -
y O -
103 O -
pacientes O -
en O -
la O -
semana O -
12 O -
. O -

Los B-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
AM I-Premise HighQuality
informaron I-Premise HighQuality
de I-Premise HighQuality
una I-Premise HighQuality
mejora I-Premise HighQuality
sustancial I-Premise HighQuality
del I-Premise HighQuality
apetito I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
del I-Premise HighQuality
estado I-Premise HighQuality
de I-Premise HighQuality
ánimo I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
general I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
posiblemente I-Premise HighQuality
de I-Premise HighQuality
menos I-Premise HighQuality
náuseas I-Premise HighQuality
y I-Premise HighQuality
vómitos I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,08 I-Premise HighQuality
) I-Premise HighQuality
que I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
placebo I-Premise HighQuality
, I-Premise HighQuality
según I-Premise HighQuality
una I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
tendencia I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observó I-Premise HighQuality
un I-Premise HighQuality
mayor I-Premise HighQuality
beneficio I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
dosis I-Premise HighQuality
más I-Premise HighQuality
alta, I-Premise HighQuality
que I-Premise HighQuality
(a I-Premise HighQuality
diferencia I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
dosis I-Premise HighQuality
más I-Premise HighQuality
baja) I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
mejor I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
comparaciones I-Premise HighQuality
por I-Premise HighQuality
pares I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
placebo I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
apetito, I-Premise HighQuality
el I-Premise HighQuality
estado I-Premise HighQuality
de I-Premise HighQuality
ánimo I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
general I-Premise HighQuality
(cada I-Premise HighQuality
una I-Premise HighQuality
de I-Premise HighQuality
ellas I-Premise HighQuality
con I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
o I-Premise HighQuality
= I-Premise HighQuality
0,001). I-Premise HighQuality

A B-Premise HighQuality
pesar I-Premise HighQuality
de I-Premise HighQuality
que I-Premise HighQuality
faltaban I-Premise HighQuality
algunos I-Premise HighQuality
datos I-Premise HighQuality
sobre I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida, I-Premise HighQuality
se I-Premise HighQuality
disponía I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
clasificación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
227 I-Premise HighQuality
( I-Premise HighQuality
95% I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes, I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
clasificación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
significativamente I-Premise HighQuality
mayor I-Premise HighQuality
asociada I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
AM I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,002 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Las B-Premise HighQuality
mejoras I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
se I-Premise HighQuality
produjeron I-Premise HighQuality
pronto, I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
plazo I-Premise HighQuality
de I-Premise HighQuality
cuatro I-Premise HighQuality
semanas, I-Premise HighQuality
y I-Premise HighQuality
se I-Premise HighQuality
mantuvieron. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
mediciones I-Premise HighQuality
del I-Premise HighQuality
NS I-Premise HighQuality
, I-Premise HighQuality
incluido I-Premise HighQuality
el I-Premise HighQuality
peso I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,29 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
efectos I-Premise HighQuality
secundarios I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
terapia I-Premise HighQuality
fueron I-Premise HighQuality
menores I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
difirieron I-Premise HighQuality
significativamente I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
tratamientos. I-Premise HighQuality

El B-Claim HighQuality
acetato I-Claim HighQuality
de I-Claim HighQuality
megestrol I-Claim HighQuality
administrado I-Claim HighQuality
a I-Claim HighQuality
480 I-Claim HighQuality
mg/día I-Claim HighQuality
es I-Claim HighQuality
un I-Claim HighQuality
paliativo I-Claim HighQuality
útil I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
avanzado I-Claim HighQuality
insensible I-Claim HighQuality
a I-Claim HighQuality
los I-Claim HighQuality
fármacos I-Claim HighQuality
endocrinos. I-Claim HighQuality

Mejora B-Claim HighQuality
el I-Claim HighQuality
apetito, I-Claim HighQuality
el I-Claim HighQuality
estado I-Claim HighQuality
de I-Claim HighQuality
ánimo I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
en I-Claim HighQuality
general I-Claim HighQuality
de I-Claim HighQuality
estos I-Claim HighQuality
pacientes, I-Claim HighQuality
aunque B-Claim HighQuality
no I-Claim HighQuality
a I-Claim HighQuality
través I-Claim HighQuality
de I-Claim HighQuality
un I-Claim HighQuality
efecto I-Claim HighQuality
directo I-Claim HighQuality
sobre I-Claim HighQuality
el I-Claim HighQuality
estado I-Claim HighQuality
nutricional. I-Claim HighQuality

La B-Claim HighQuality
suramina I-Claim HighQuality
es I-Claim HighQuality
un I-Claim HighQuality
agente I-Claim HighQuality
novedoso I-Claim HighQuality
que I-Claim HighQuality
ha I-Claim HighQuality
demostrado I-Claim HighQuality
pruebas I-Claim HighQuality
preliminares I-Claim HighQuality
de I-Claim HighQuality
actividad I-Claim HighQuality
antitumoral I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
próstata I-Claim HighQuality
refractario I-Claim HighQuality
a I-Claim HighQuality
las I-Claim HighQuality
hormonas I-Claim HighQuality
( I-Claim HighQuality
HRPC I-Claim HighQuality
) I-Claim HighQuality
. I-Claim HighQuality

Se O -
diseñó O -
un O -
ensayo O -
clínico O -
prospectivo O -
y O -
aleatorio O -
para O -
evaluar O -
el O -
dolor O -
y O -
la O -
ingesta O -
de O -
analgésicos O -
opiáceos O -
como O -
sustitutos O -
de O -
la O -
respuesta O -
antitumoral O -
en O -
pacientes O -
con O -
CPDH O -
con O -
dolor O -
significativo O -
dependiente O -
de O -
analgésicos O -
opiáceos. O -

Un O -
ensayo O -
doble O -
ciego, O -
controlado O -
con O -
placebo, O -
aleatorizó O -
a O -
los O -
pacientes O -
para O -
que O -
recibieran O -
un O -
régimen O -
ambulatorio O -
de O -
78 O -
días O -
de O -
suramina O -
más O -
hidrocortisona O -
( O -
HC O -
, O -
40 O -
mg/d O -
) O -
o O -
placebo O -
más O -
HC O -
. O -

La O -
asignación O -
del O -
tratamiento O -
se O -
desenmascaró O -
cuando O -
se O -
produjo O -
la O -
progresión O -
de O -
la O -
enfermedad O -
o O -
la O -
toxicidad O -
limitante O -
de O -
la O -
dosis; O -
a O -
los O -
pacientes O -
con O -
placebo O -
se O -
les O -
permitió O -
cruzar O -
a O -
suramina O -
más O -
HC O -
de O -
etiqueta O -
abierta. O -

Además O -
del O -
dolor O -
y O -
la O -
ingesta O -
de O -
analgésicos O -
opiáceos, O -
se O -
comparó O -
la O -
respuesta O -
del O -
antígeno O -
específico O -
de O -
la O -
próstata O -
(PSA), O -
el O -
tiempo O -
hasta O -
la O -
progresión O -
de O -
la O -
enfermedad, O -
la O -
calidad O -
de O -
vida, O -
el O -
estado O -
de O -
rendimiento O -
y O -
la O -
supervivencia. O -

Las B-Premise HighQuality
reducciones I-Premise HighQuality
medias I-Premise HighQuality
globales I-Premise HighQuality
del I-Premise HighQuality
dolor I-Premise HighQuality
combinado I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
ingesta I-Premise HighQuality
de I-Premise HighQuality
analgésicos I-Premise HighQuality
opiáceos I-Premise HighQuality
fueron I-Premise HighQuality
mayores I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
caso I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
suramina I-Premise HighQuality
más I-Premise HighQuality
HC I-Premise HighQuality
( I-Premise HighQuality
suma I-Premise HighQuality
de I-Premise HighQuality
rangos I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,0001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
respuesta I-Premise HighQuality
al I-Premise HighQuality
dolor I-Premise HighQuality
se I-Premise HighQuality
logró I-Premise HighQuality
en I-Premise HighQuality
una I-Premise HighQuality
proporción I-Premise HighQuality
mayor I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
suramina I-Premise HighQuality
que I-Premise HighQuality
placebo I-Premise HighQuality
( I-Premise HighQuality
43% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
28% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
=.001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y O -
la B-Premise HighQuality
duración I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
respuesta I-Premise HighQuality
fue I-Premise HighQuality
más I-Premise HighQuality
larga I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
respondieron I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
suramina I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
, I-Premise HighQuality
240 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
69 I-Premise HighQuality
días I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
=.0027 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
fue I-Premise HighQuality
más I-Premise HighQuality
largo I-Premise HighQuality
( I-Premise HighQuality
riesgo I-Premise HighQuality
relativo I-Premise HighQuality
= I-Premise HighQuality
1,5 I-Premise HighQuality
; I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
1,2 I-Premise HighQuality
a I-Premise HighQuality
1,9 I-Premise HighQuality
) I-Premise HighQuality
y O -
la B-Premise HighQuality
proporción I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
un I-Premise HighQuality
descenso I-Premise HighQuality
del I-Premise HighQuality
PSA I-Premise HighQuality
superior I-Premise HighQuality
al I-Premise HighQuality
50 I-Premise HighQuality
% I-Premise HighQuality
fue I-Premise HighQuality
mayor I-Premise HighQuality
( I-Premise HighQuality
33 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
16 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
suramina I-Premise HighQuality
. I-Premise HighQuality

Ni B-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
ni I-Premise HighQuality
el I-Premise HighQuality
estado I-Premise HighQuality
funcional I-Premise HighQuality
disminuyeron I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
con I-Premise HighQuality
suramina, I-Premise HighQuality
y O -
la B-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
similar. I-Premise HighQuality

La B-Premise HighQuality
mayoría I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
fueron I-Premise HighQuality
de I-Premise HighQuality
intensidad I-Premise HighQuality
leve I-Premise HighQuality
o I-Premise HighQuality
moderada I-Premise HighQuality
y I-Premise HighQuality
se I-Premise HighQuality
trataron I-Premise HighQuality
fácilmente I-Premise HighQuality
con I-Premise HighQuality
medicamentos. I-Premise HighQuality

El B-Claim HighQuality
tratamiento I-Claim HighQuality
ambulatorio I-Claim HighQuality
con I-Claim HighQuality
suramina I-Claim HighQuality
más I-Claim HighQuality
HC I-Claim HighQuality
es I-Claim HighQuality
bien I-Claim HighQuality
tolerado I-Claim HighQuality
y I-Claim HighQuality
proporciona I-Claim HighQuality
un I-Claim HighQuality
beneficio I-Claim HighQuality
paliativo I-Claim HighQuality
moderado I-Claim HighQuality
y I-Claim HighQuality
un I-Claim HighQuality
retraso I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
progresión I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
enfermedad I-Claim HighQuality
para I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
CPDH I-Claim HighQuality
sintomático I-Claim HighQuality
. I-Claim HighQuality

Comparar O -
la O -
vinflunina O -
( O -
VFL O -
) O -
con O -
el O -
docetaxel O -
en O -
pacientes O -
con O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
( O -
CPNM O -
) O -
en O -
estadio O -
IIIB/IV O -
que O -
han O -
experimentado O -
el O -
fracaso O -
del O -
tratamiento O -
con O -
quimioterapia O -
de O -
primera O -
línea O -
basada O -
en O -
platino O -
. O -

Estudio O -
aleatorio, O -
multicéntrico, O -
de O -
fase O -
III, O -
551 O -
pacientes O -
recibieron O -
vinflunina O -
320 O -
mg/m O -
( O -
2 O -
) O -
o O -
docetaxel O -
75 O -
mg/m O -
( O -
2 O -
) O -
cada O -
21 O -
días O -
hasta O -
la O -
progresión O -
de O -
la O -
enfermedad O -
o O -
toxicidad O -
grave. O -

El O -
criterio O -
de O -
valoración O -
primario O -
fue O -
la O -
supervivencia O -
sin O -
progresión O -
( O -
PFS O -
) O -
. O -

El O -
análisis O -
de O -
no O -
inferioridad O -
se O -
basó O -
en O -
una O -
diferencia O -
del O -
10 O -
% O -
( O -
tasas O -
de O -
error O -
de O -
los O -
tipos O -
I/II O -
: O -
5 O -
% O -
/20 O -
% O -
) O -
. O -

Los O -
criterios O -
de O -
valoración O -
secundarios O -
fueron O -
la O -
tasa O -
de O -
respuesta O -
( O -
ORR O -
) O -
, O -
la O -
duración O -
de O -
la O -
respuesta O -
, O -
la O -
supervivencia O -
global O -
( O -
OS O -
) O -
, O -
el O -
beneficio O -
clínico O -
, O -
la O -
calidad O -
de O -
vida O -
( O -
QOL O -
) O -
y O -
la O -
seguridad O -
. O -

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SLP I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
2,3 I-Premise HighQuality
meses I-Premise HighQuality
para I-Premise HighQuality
cada I-Premise HighQuality
brazo I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
1,004 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,841 I-Premise HighQuality
a I-Premise HighQuality
1,199 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
ORR I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
estable I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SG I-Premise HighQuality
, I-Premise HighQuality
fueron I-Premise HighQuality
del I-Premise HighQuality
4,4 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
5,5 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
del I-Premise HighQuality
36,0 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
39,6 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
del I-Premise HighQuality
6,7 I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
7,2 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
0,973 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,805 I-Premise HighQuality
a I-Premise HighQuality
1,176 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
hay I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
beneficio I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
( I-Premise HighQuality
Functional I-Premise HighQuality
Assessment I-Premise HighQuality
of I-Premise HighQuality
Cancer I-Premise HighQuality
Therapy-Lung I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
inesperados. I-Premise HighQuality

Grado B-Premise HighQuality
superior I-Premise HighQuality
a I-Premise HighQuality
0 I-Premise HighQuality
( I-Premise HighQuality
vinflunina I-Premise HighQuality
v I-Premise HighQuality
docetaxel I-Premise HighQuality
) I-Premise HighQuality
anemia I-Premise HighQuality
( I-Premise HighQuality
82,1 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
79,8 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
neutropenia I-Premise HighQuality
( I-Premise HighQuality
49,3 I-Premise HighQuality
v I-Premise HighQuality
39,02 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
trombocitopenia I-Premise HighQuality
( I-Premise HighQuality
30,6 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
14,3 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
neutropenia I-Premise HighQuality
febril I-Premise HighQuality
( I-Premise HighQuality
3.3 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
4.7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
estreñimiento I-Premise HighQuality
( I-Premise HighQuality
39.2 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
11.7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
fatiga I-Premise HighQuality
( I-Premise HighQuality
36.6 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
33.9 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
reacción I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
lugar I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
inyección I-Premise HighQuality
( I-Premise HighQuality
31.9 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
0.7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
náuseas I-Premise HighQuality
( I-Premise HighQuality
26.7 I-Premise HighQuality
% I-Premise HighQuality
v I-Premise HighQuality
23.7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
vómitos I-Premise HighQuality
( I-Premise HighQuality
23.8 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
14,2 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
alopecia I-Premise HighQuality
( I-Premise HighQuality
19,8 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
35,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
estomatitis I-Premise HighQuality
( I-Premise HighQuality
19,4 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
12,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
dolor I-Premise HighQuality
abdominal I-Premise HighQuality
( I-Premise HighQuality
20,1 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
3,6 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
mialgia I-Premise HighQuality
( I-Premise HighQuality
14,7 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6,6 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
neuropatía I-Premise HighQuality
periférica I-Premise HighQuality
( I-Premise HighQuality
10.7 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
15,0 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
artralgia I-Premise HighQuality
( I-Premise HighQuality
7,0 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
7,7 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
diarrea I-Premise HighQuality
( I-Premise HighQuality
6,2 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
12,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
edema I-Premise HighQuality
( I-Premise HighQuality
1,5 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
trastornos I-Premise HighQuality
ungueales I-Premise HighQuality
( I-Premise HighQuality
1,1 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5 I-Premise HighQuality
; I-Premise HighQuality
1 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Este B-Claim HighQuality
estudio I-Claim HighQuality
de I-Claim HighQuality
fase I-Claim HighQuality
III I-Claim HighQuality
de I-Claim HighQuality
no I-Claim HighQuality
inferioridad I-Claim HighQuality
mostró I-Claim HighQuality
puntos I-Claim HighQuality
finales I-Claim HighQuality
de I-Claim HighQuality
eficacia I-Claim HighQuality
similares I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
vinflunina I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
docetaxel I-Claim HighQuality
. I-Claim HighQuality

A B-Claim HighQuality
pesar I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
mayores I-Claim HighQuality
tasas I-Claim HighQuality
de I-Claim HighQuality
algunos I-Claim HighQuality
efectos I-Claim HighQuality
adversos I-Claim HighQuality
( I-Claim HighQuality
anemia I-Claim HighQuality
, I-Claim HighQuality
dolor I-Claim HighQuality
abdominal I-Claim HighQuality
, I-Claim HighQuality
estreñimiento I-Claim HighQuality
, I-Claim HighQuality
fatiga I-Claim HighQuality
) I-Claim HighQuality
el B-Claim HighQuality
perfil I-Claim HighQuality
de I-Claim HighQuality
toxicidad I-Claim HighQuality
general I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
vinflunina I-Claim HighQuality
fue I-Claim HighQuality
manejable I-Claim HighQuality
. I-Claim HighQuality

Por O -
lo O -
tanto, O -
el B-Claim HighQuality
VFL I-Claim HighQuality
puede I-Claim HighQuality
ser I-Claim HighQuality
otra I-Claim HighQuality
opción I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
segunda I-Claim HighQuality
línea I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
CPNM I-Claim HighQuality
avanzado. I-Claim HighQuality

Este O -
ensayo O -
aleatorio, O -
controlado O -
con O -
placebo O -
y O -
a O -
ciegas, O -
investigó O -
la O -
seguridad O -
y O -
la O -
eficacia O -
de O -
SAMITAL® O -
, O -
una O -
formulación O -
de O -
extractos O -
botánicos O -
altamente O -
estandarizados, O -
en O -
el O -
tratamiento O -
de O -
la O -
mucositis O -
oral O -
( O -
OM O -
) O -
inducida O -
por O -
la O -
quimio/radioterapia O -
en O -
pacientes O -
con O -
cáncer O -
de O -
cabeza O -
y O -
cuello O -
. O -

Los O -
pacientes O -
recibieron O -
SAMITAL® O -
o O -
placebo O -
cuatro O -
veces O -
al O -
día O -
durante O -
un O -
máximo O -
de O -
50 O -
días O -
durante O -
la O -
quimio/radioterapia O -
programada. O -

La O -
gravedad O -
de O -
la O -
OM O -
se O -
controló O -
según O -
una O -
escala O -
de O -
gravedad O -
modificada O -
de O -
la O -
OMS O -
, O -
y O -
las O -
evaluaciones O -
del O -
dolor O -
y O -
la O -
calidad O -
de O -
vida O -
se O -
basaron O -
en O -
el O -
efecto O -
de O -
los O -
síntomas O -
de O -
la O -
OM O -
sobre O -
las O -
actividades O -
diarias O -
relevantes O -
, O -
según O -
una O -
escala O -
visual O -
analógica O -
. O -

Las B-Premise HighQuality
puntuaciones I-Premise HighQuality
medias I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
gravedad I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
OM I-Premise HighQuality
se I-Premise HighQuality
redujeron I-Premise HighQuality
significativamente I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
línea I-Premise HighQuality
de I-Premise HighQuality
base I-Premise HighQuality
) I-Premise HighQuality
desde I-Premise HighQuality
el I-Premise HighQuality
día I-Premise HighQuality
31 I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
tratamiento I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
SAMITAL® I-Premise HighQuality
( I-Premise HighQuality
n I-Premise HighQuality
= I-Premise HighQuality
20 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observó I-Premise HighQuality
ninguna I-Premise HighQuality
mejora I-Premise HighQuality
significativa I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
placebo I-Premise HighQuality
( I-Premise HighQuality
n I-Premise HighQuality
= I-Premise HighQuality
10 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
reducción I-Premise HighQuality
del I-Premise HighQuality
dolor I-Premise HighQuality
fue I-Premise HighQuality
significativa I-Premise HighQuality
desde I-Premise HighQuality
el I-Premise HighQuality
día I-Premise HighQuality
4 I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
tratamiento I-Premise HighQuality
con I-Premise HighQuality
SAMITAL® I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
días I-Premise HighQuality
7 I-Premise HighQuality
a I-Premise HighQuality
21 I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
placebo I-Premise HighQuality
. I-Premise HighQuality

SAMITAL® B-Premise HighQuality
también I-Premise HighQuality
mejoró I-Premise HighQuality
significativamente I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida, I-Premise HighQuality
como I-Premise HighQuality
demuestran I-Premise HighQuality
las I-Premise HighQuality
mejoras I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
actividades I-Premise HighQuality
diarias I-Premise HighQuality
relevantes, I-Premise HighQuality
como I-Premise HighQuality
comer, I-Premise HighQuality
beber I-Premise HighQuality
y I-Premise HighQuality
dormir. I-Premise HighQuality

Todos O -
los O -
pacientes O -
de O -
SAMITAL® O -
completaron O -
el O -
periodo O -
de O -
tratamiento, O -
pero O -
ningún O -
receptor O -
de O -
placebo O -
completó O -
el O -
tratamiento. O -

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
efectos I-Premise HighQuality
adversos I-Premise HighQuality
graves I-Premise HighQuality
con I-Premise HighQuality
SAMITAL® I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
absorción I-Premise HighQuality
sistémica I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
principios I-Premise HighQuality
activos I-Premise HighQuality
relevantes I-Premise HighQuality
fue I-Premise HighQuality
indetectable. I-Premise HighQuality

SAMITAL® B-Claim HighQuality
disminuyó I-Claim HighQuality
significativamente I-Claim HighQuality
la I-Claim HighQuality
gravedad I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
OM I-Claim HighQuality
inducida I-Claim HighQuality
por I-Claim HighQuality
la I-Claim HighQuality
quimio/radioterapia I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
cabeza I-Claim HighQuality
y I-Claim HighQuality
cuello, I-Claim HighQuality
sin I-Claim HighQuality
que I-Claim HighQuality
se I-Claim HighQuality
produjeran I-Claim HighQuality
efectos I-Claim HighQuality
adversos I-Claim HighQuality
relacionados I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
tratamiento. I-Claim HighQuality

El B-Claim HighQuality
alivio I-Claim HighQuality
del I-Claim HighQuality
dolor I-Claim HighQuality
duró I-Claim HighQuality
todo I-Claim HighQuality
el I-Claim HighQuality
periodo I-Claim HighQuality
de I-Claim HighQuality
tratamiento, I-Claim HighQuality
y I-Claim HighQuality
las I-Claim HighQuality
mejoras I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
se I-Claim HighQuality
reflejaron I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
beneficios I-Claim HighQuality
significativos I-Claim HighQuality
de I-Claim HighQuality
SAMITAL® I-Claim HighQuality
en I-Claim HighQuality
actividades I-Claim HighQuality
como I-Claim HighQuality
beber, I-Claim HighQuality
comer I-Claim HighQuality
y I-Claim HighQuality
hablar. I-Claim HighQuality

Los O -
pacientes O -
que O -
desarrollan O -
un O -
cáncer O -
de O -
próstata O -
resistente O -
a O -
la O -
castración O -
( O -
CRPCa O -
) O -
suelen O -
continuar O -
con O -
la O -
terapia O -
de O -
privación O -
de O -
andrógenos O -
( O -
ADT O -
) O -
. O -

No O -
se O -
ha O -
estudiado O -
bien O -
si O -
estos O -
pacientes O -
deben O -
seguir O -
recibiendo O -
TDA. O -

Se O -
llevó O -
a O -
cabo O -
un O -
ensayo O -
aleatorio O -
multicéntrico O -
para O -
comparar O -
un O -
enfoque O -
intermitente O -
frente O -
a O -
uno O -
continuo O -
de O -
ADT O -
en O -
pacientes O -
con O -
CPRC. O -

La O -
supervivencia O -
global, O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
(QOL) O -
y O -
el O -
coste O -
fueron O -
los O -
principales O -
criterios O -
de O -
valoración. O -

Los O -
pacientes O -
con O -
CPRC O -
fueron O -
aleatorizados O -
2:1 O -
a O -
agonistas O -
de O -
la O -
hormona O -
liberadora O -
de O -
hormona O -
luteinizante O -
( O -
LHRHa O -
) O -
intermitentes O -
o O -
continuos. O -

Se O -
realizó O -
un O -
seguimiento O -
de O -
los O -
pacientes O -
con O -
evaluaciones O -
clínicas, O -
análisis O -
de O -
laboratorio O -
y O -
cuestionarios O -
de O -
calidad O -
de O -
vida O -
( O -
EORTC O -
QLQ-C30 O -
o O -
PROSQOLI O -
) O -
cada O -
dos O -
meses. O -

Si O -
la O -
testosterona O -
sérica O -
se O -
elevaba O -
por O -
encima O -
de O -
los O -
niveles O -
de O -
castrado O -
( O -
1,75 O -
nmol/L O -
) O -
, O -
se O -
reiniciaba O -
la O -
LHRHa O -
. O -

El O -
estudio O -
se O -
diseñó O -
para O -
cerrarse O -
si O -
> O -
50 O -
% O -
de O -
los O -
pacientes O -
necesitaban O -
reiniciar O -
la O -
ADT O -
en O -
el O -
brazo O -
intermitente O -
. O -

Se O -
siguió O -
a O -
31 O -
pacientes O -
con O -
una O -
mediana O -
de O -
seguimiento O -
de O -
26,8 O -
meses, O -
18 O -
en O -
el O -
brazo O -
intermitente O -
y O -
13 O -
en O -
el O -
continuo. O -

Doce O -
de O -
los O -
18 O -
pacientes O -
del O -
brazo O -
intermitente O -
fueron O -
reiniciados O -
con O -
LHRHa O -
en O -
una O -
mediana O -
de O -
tiempo O -
de O -
17,9 O -
meses O -
. O -

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
o I-Premise HighQuality
específica I-Premise HighQuality
del I-Premise HighQuality
cáncer I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
brazos. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
brazos I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
0 I-Premise HighQuality
y I-Premise HighQuality
12 I-Premise HighQuality
meses. I-Premise HighQuality

Los B-Premise HighQuality
costes I-Premise HighQuality
medios I-Premise HighQuality
totales I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
24 I-Premise HighQuality
meses I-Premise HighQuality
fueron I-Premise HighQuality
significativamente I-Premise HighQuality
menores I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
brazo I-Premise HighQuality
intermitente I-Premise HighQuality
( I-Premise HighQuality
3135 I-Premise HighQuality
$ I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
8253 I-Premise HighQuality
$ I-Premise HighQuality
canadienses I-Premise HighQuality
, I-Premise HighQuality
P=0,0167 I-Premise HighQuality
) I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
continuo I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
principal I-Premise HighQuality
limitación I-Premise HighQuality
de I-Premise HighQuality
este I-Premise HighQuality
estudio I-Premise HighQuality
es I-Premise HighQuality
el I-Premise HighQuality
reducido I-Premise HighQuality
tamaño I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
muestra. I-Premise HighQuality

Hemos B-Claim HighQuality
observado I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
TDA I-Claim HighQuality
intermitente I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
CPRC, I-Claim HighQuality
utilizando I-Claim HighQuality
una I-Claim HighQuality
testosterona I-Claim HighQuality
de I-Claim HighQuality
> I-Claim HighQuality
1,75 I-Claim HighQuality
ngmol/L I-Claim HighQuality
como I-Claim HighQuality
desencadenante I-Claim HighQuality
para I-Claim HighQuality
reiniciar I-Claim HighQuality
la I-Claim HighQuality
LHRHa, I-Claim HighQuality
supone I-Claim HighQuality
un I-Claim HighQuality
ahorro I-Claim HighQuality
sustancial I-Claim HighQuality
de I-Claim HighQuality
costes I-Claim HighQuality
sin I-Claim HighQuality
impacto I-Claim HighQuality
negativo I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
resultados I-Claim HighQuality
oncológicos I-Claim HighQuality
y I-Claim HighQuality
de I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida. I-Claim HighQuality

La O -
terapia O -
hormonal O -
para O -
la O -
menopausia O -
se O -
sigue O -
utilizando O -
en O -
la O -
clínica, O -
pero O -
siguen O -
existiendo O -
dudas O -
sobre O -
sus O -
riesgos O -
y O -
beneficios O -
para O -
la O -
prevención O -
de O -
enfermedades O -
crónicas. O -

Informar O -
de O -
una O -
visión O -
global O -
e O -
integrada O -
de O -
los O -
resultados O -
de O -
los O -
2 O -
ensayos O -
de O -
terapia O -
hormonal O -
de O -
la O -
Iniciativa O -
de O -
Salud O -
de O -
la O -
Mujer O -
(WHI) O -
con O -
un O -
seguimiento O -
extendido O -
después O -
de O -
la O -
intervención. O -

Un O -
total O -
de O -
27.347 O -
mujeres O -
posmenopáusicas O -
de O -
entre O -
50 O -
y O -
79 O -
años O -
se O -
inscribieron O -
en O -
40 O -
centros O -
estadounidenses O -
. O -

Las O -
mujeres O -
con O -
el O -
útero O -
intacto O -
recibieron O -
estrógenos O -
equinos O -
conjugados O -
( O -
CEE O -
; O -
0,625 O -
mg/d O -
) O -
más O -
acetato O -
de O -
medroxiprogesterona O -
( O -
MPA O -
; O -
2,5 O -
mg/d O -
) O -
( O -
n O -
= O -
8506 O -
) O -
o O -
placebo O -
( O -
n O -
= O -
8102 O -
) O -
. O -

Las O -
mujeres O -
con O -
histerectomía O -
previa O -
recibieron O -
CEE O -
solo O -
( O -
0,625 O -
mg/d O -
) O -
( O -
n O -
= O -
5310 O -
) O -
o O -
placebo O -
( O -
n O -
= O -
5429 O -
) O -
. O -

La O -
intervención O -
duró O -
una O -
mediana O -
de O -
5,6 O -
años O -
en O -
el O -
ensayo O -
de O -
CEE O -
más O -
MPA O -
y O -
7,2 O -
años O -
en O -
el O -
ensayo O -
de O -
CEE O -
solo, O -
con O -
13 O -
años O -
de O -
seguimiento O -
acumulado O -
hasta O -
el O -
30 O -
de O -
septiembre O -
de O -
2010. O -

Los O -
resultados O -
primarios O -
de O -
eficacia O -
y O -
seguridad O -
fueron O -
la O -
enfermedad O -
coronaria O -
(EC) O -
y O -
el O -
cáncer O -
de O -
mama O -
invasivo, O -
respectivamente. O -

Un O -
índice O -
global O -
incluía O -
también O -
el O -
ictus, O -
la O -
embolia O -
pulmonar, O -
el O -
cáncer O -
colorrectal, O -
el O -
cáncer O -
de O -
endometrio, O -
la O -
fractura O -
de O -
cadera O -
y O -
la O -
muerte. O -

Durante B-Premise HighQuality
la I-Premise HighQuality
fase I-Premise HighQuality
de I-Premise HighQuality
intervención I-Premise HighQuality
de I-Premise HighQuality
CEE I-Premise HighQuality
más I-Premise HighQuality
MPA I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
número I-Premise HighQuality
de I-Premise HighQuality
casos I-Premise HighQuality
de I-Premise HighQuality
cardiopatía I-Premise HighQuality
coronaria I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
196 I-Premise HighQuality
para I-Premise HighQuality
CEE I-Premise HighQuality
más I-Premise HighQuality
MPA I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
159 I-Premise HighQuality
para I-Premise HighQuality
placebo I-Premise HighQuality
( I-Premise HighQuality
hazard I-Premise HighQuality
ratio I-Premise HighQuality
[ I-Premise HighQuality
HR I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
1,18 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,95-1,45 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
206 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
155 I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
, I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
cáncer I-Premise HighQuality
de I-Premise HighQuality
mama I-Premise HighQuality
invasivo I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
1,24 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
1,01-1,53 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Otros B-Premise HighQuality
riesgos I-Premise HighQuality
fueron I-Premise HighQuality
el I-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
accidentes I-Premise HighQuality
cerebrovasculares, I-Premise HighQuality
la I-Premise HighQuality
embolia I-Premise HighQuality
pulmonar, I-Premise HighQuality
la I-Premise HighQuality
demencia I-Premise HighQuality
(en I-Premise HighQuality
mujeres I-Premise HighQuality
de I-Premise HighQuality
edad I-Premise HighQuality
≥65 I-Premise HighQuality
años), I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
vesícula I-Premise HighQuality
biliar I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
incontinencia I-Premise HighQuality
urinaria; I-Premise HighQuality
los I-Premise HighQuality
beneficios I-Premise HighQuality
fueron I-Premise HighQuality
la I-Premise HighQuality
disminución I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
fracturas I-Premise HighQuality
de I-Premise HighQuality
cadera, I-Premise HighQuality
la I-Premise HighQuality
diabetes I-Premise HighQuality
y I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
vasomotores. I-Premise HighQuality

La B-Premise HighQuality
mayoría I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
riesgos I-Premise HighQuality
y I-Premise HighQuality
beneficios I-Premise HighQuality
se I-Premise HighQuality
disiparon I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
intervención, I-Premise HighQuality
aunque B-Premise HighQuality
persistió I-Premise HighQuality
un I-Premise HighQuality
cierto I-Premise HighQuality
aumento I-Premise HighQuality
del I-Premise HighQuality
riesgo I-Premise HighQuality
de I-Premise HighQuality
cáncer I-Premise HighQuality
de I-Premise HighQuality
mama I-Premise HighQuality
durante I-Premise HighQuality
el I-Premise HighQuality
seguimiento I-Premise HighQuality
acumulado I-Premise HighQuality
( I-Premise HighQuality
434 I-Premise HighQuality
casos I-Premise HighQuality
para I-Premise HighQuality
CEE I-Premise HighQuality
más I-Premise HighQuality
MPA I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
323 I-Premise HighQuality
para I-Premise HighQuality
placebo; I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
1,28 I-Premise HighQuality
[ I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
1,11-1,48 I-Premise HighQuality
] I-Premise HighQuality
) I-Premise HighQuality
. O -

Los B-Premise HighQuality
riesgos I-Premise HighQuality
y I-Premise HighQuality
beneficios I-Premise HighQuality
estuvieron I-Premise HighQuality
más I-Premise HighQuality
equilibrados I-Premise HighQuality
durante I-Premise HighQuality
la I-Premise HighQuality
intervención I-Premise HighQuality
de I-Premise HighQuality
CEE I-Premise HighQuality
solo, I-Premise HighQuality
con I-Premise HighQuality
204 I-Premise HighQuality
casos I-Premise HighQuality
de I-Premise HighQuality
cardiopatía I-Premise HighQuality
coronaria I-Premise HighQuality
para I-Premise HighQuality
CEE I-Premise HighQuality
solo I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
222 I-Premise HighQuality
casos I-Premise HighQuality
para I-Premise HighQuality
placebo I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
0,94 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,78-1,14 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
104 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
135 I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
, I-Premise HighQuality
para I-Premise HighQuality
el I-Premise HighQuality
cáncer I-Premise HighQuality
de I-Premise HighQuality
mama I-Premise HighQuality
invasivo I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
0,79 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,61-1,02 I-Premise HighQuality
) I-Premise HighQuality
; I-Premise HighQuality
acumulativamente I-Premise HighQuality
, I-Premise HighQuality
hubo I-Premise HighQuality
168 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
216 I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
, I-Premise HighQuality
casos I-Premise HighQuality
de I-Premise HighQuality
cáncer I-Premise HighQuality
de I-Premise HighQuality
mama I-Premise HighQuality
diagnosticados I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
, I-Premise HighQuality
0,79 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,65-0,97 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los O -
resultados O -
de O -
otros O -
resultados O -
fueron O -
similares O -
a O -
los O -
de O -
CEE O -
más O -
MPA O -
. O -

Ninguno O -
de O -
los O -
dos O -
regímenes O -
afectó O -
a O -
la O -
mortalidad O -
por O -
todas O -
las O -
causas. O -

En B-Premise HighQuality
el I-Premise HighQuality
caso I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CEE I-Premise HighQuality
sola, I-Premise HighQuality
las I-Premise HighQuality
mujeres I-Premise HighQuality
más I-Premise HighQuality
jóvenes I-Premise HighQuality
( I-Premise HighQuality
de I-Premise HighQuality
50 I-Premise HighQuality
a I-Premise HighQuality
59 I-Premise HighQuality
años I-Premise HighQuality
) I-Premise HighQuality
tuvieron I-Premise HighQuality
resultados I-Premise HighQuality
más I-Premise HighQuality
favorables I-Premise HighQuality
en I-Premise HighQuality
cuanto I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
mortalidad I-Premise HighQuality
por I-Premise HighQuality
todas I-Premise HighQuality
las I-Premise HighQuality
causas, I-Premise HighQuality
el I-Premise HighQuality
infarto I-Premise HighQuality
de I-Premise HighQuality
miocardio I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
índice I-Premise HighQuality
global I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
nominal I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
tendencia I-Premise HighQuality
por I-Premise HighQuality
edad I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
riesgos I-Premise HighQuality
absolutos I-Premise HighQuality
de I-Premise HighQuality
acontecimientos I-Premise HighQuality
adversos I-Premise HighQuality
( I-Premise HighQuality
medidos I-Premise HighQuality
por I-Premise HighQuality
el I-Premise HighQuality
índice I-Premise HighQuality
global I-Premise HighQuality
) I-Premise HighQuality
por I-Premise HighQuality
cada I-Premise HighQuality
10.000 I-Premise HighQuality
mujeres I-Premise HighQuality
que I-Premise HighQuality
tomaron I-Premise HighQuality
anualmente I-Premise HighQuality
CEE I-Premise HighQuality
más I-Premise HighQuality
AMP I-Premise HighQuality
oscilaron I-Premise HighQuality
entre I-Premise HighQuality
12 I-Premise HighQuality
casos I-Premise HighQuality
de I-Premise HighQuality
exceso I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
edades I-Premise HighQuality
de I-Premise HighQuality
50-59 I-Premise HighQuality
años I-Premise HighQuality
y I-Premise HighQuality
38 I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
edades I-Premise HighQuality
de I-Premise HighQuality
70-79 I-Premise HighQuality
años I-Premise HighQuality
; I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
mujeres I-Premise HighQuality
que I-Premise HighQuality
tomaron I-Premise HighQuality
CEE I-Premise HighQuality
solo I-Premise HighQuality
, I-Premise HighQuality
entre I-Premise HighQuality
19 I-Premise HighQuality
casos I-Premise HighQuality
menos I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
edades I-Premise HighQuality
de I-Premise HighQuality
50-59 I-Premise HighQuality
años I-Premise HighQuality
y I-Premise HighQuality
51 I-Premise HighQuality
casos I-Premise HighQuality
de I-Premise HighQuality
exceso I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
edades I-Premise HighQuality
de I-Premise HighQuality
70-79 I-Premise HighQuality
años I-Premise HighQuality
. I-Premise HighQuality

Los O -
resultados O -
de O -
calidad O -
de O -
vida O -
tuvieron O -
resultados O -
mixtos O -
en O -
ambos O -
ensayos. O -

La B-Claim HighQuality
terapia I-Claim HighQuality
hormonal I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
menopausia I-Claim HighQuality
tiene I-Claim HighQuality
un I-Claim HighQuality
complejo I-Claim HighQuality
patrón I-Claim HighQuality
de I-Claim HighQuality
riesgos I-Claim HighQuality
y I-Claim HighQuality
beneficios I-Claim HighQuality
. I-Claim HighQuality

Los B-Claim HighQuality
resultados I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
intervención I-Claim HighQuality
y I-Claim HighQuality
del I-Claim HighQuality
seguimiento I-Claim HighQuality
posterior I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
intervención I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
2 I-Claim HighQuality
ensayos I-Claim HighQuality
de I-Claim HighQuality
terapia I-Claim HighQuality
hormonal I-Claim HighQuality
del I-Claim HighQuality
WHI I-Claim HighQuality
no I-Claim HighQuality
apoyan I-Claim HighQuality
el I-Claim HighQuality
uso I-Claim HighQuality
de I-Claim HighQuality
esta I-Claim HighQuality
terapia I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
prevención I-Claim HighQuality
de I-Claim HighQuality
enfermedades I-Claim HighQuality
crónicas, I-Claim HighQuality
aunque B-Claim HighQuality
es I-Claim HighQuality
adecuada I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
síntomas I-Claim HighQuality
en I-Claim HighQuality
algunas I-Claim HighQuality
mujeres. I-Claim HighQuality

Los O -
supervivientes O -
de O -
cáncer O -
colorrectal O -
corren O -
el O -
riesgo O -
de O -
tener O -
malos O -
resultados O -
en O -
materia O -
de O -
salud O -
debido O -
a O -
estilos O -
de O -
vida O -
poco O -
saludables, O -
pero O -
son O -
pocos O -
los O -
estudios O -
que O -
han O -
desarrollado O -
intervenciones O -
traducibles O -
de O -
cambio O -
de O -
comportamiento O -
en O -
materia O -
de O -
salud. O -

Este O -
estudio O -
tiene O -
como O -
objetivo O -
determinar O -
los O -
efectos O -
de O -
una O -
intervención O -
de O -
cambio O -
de O -
comportamiento O -
de O -
salud O -
múltiple O -
administrada O -
por O -
teléfono O -
( O -
CanChange O -
) O -
en O -
los O -
resultados O -
de O -
salud O -
y O -
comportamiento O -
entre O -
los O -
sobrevivientes O -
de O -
cáncer O -
colorrectal O -
. O -

En O -
este O -
ensayo O -
controlado O -
aleatorio O -
de O -
dos O -
grupos, O -
410 O -
supervivientes O -
de O -
cáncer O -
colorrectal O -
fueron O -
asignados O -
de O -
forma O -
aleatoria O -
a O -
la O -
intervención O -
de O -
entrenamiento O -
de O -
salud O -
( O -
11 O -
sesiones O -
de O -
entrenamiento O -
de O -
salud O -
basadas O -
en O -
la O -
teoría O -
y O -
realizadas O -
por O -
teléfono O -
durante O -
6 O -
meses O -
y O -
centradas O -
en O -
la O -
actividad O -
física, O -
el O -
control O -
del O -
peso, O -
los O -
hábitos O -
dietéticos, O -
el O -
alcohol O -
y O -
el O -
tabaquismo O -
) O -
o O -
a O -
la O -
atención O -
habitual. O -

La O -
evaluación O -
de O -
los O -
resultados O -
primarios O -
( O -
es O -
decir, O -
la O -
actividad O -
física O -
[ O -
Índice O -
de O -
Tiempo O -
Libre O -
de O -
Godin O -
] O -
, O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
[ O -
HRQoL O -
; O -
Short O -
Form-36 O -
] O -
, O -
y O -
la O -
fatiga O -
relacionada O -
con O -
el O -
cáncer O -
[ O -
Functional O -
Assessment O -
of O -
Chronic O -
Illness O -
Therapy O -
Fatigue O -
Scale O -
] O -
) O -
y O -
secundarios O -
( O -
es O -
decir, O -
el O -
índice O -
de O -
masa O -
corporal O -
[ O -
kg/m O -
( O -
2 O -
) O -
] O -
, O -
la O -
dieta O -
y O -
la O -
ingesta O -
de O -
alcohol O -
[ O -
Food O -
Frequency O -
Questionnaire O -
] O -
, O -
y O -
el O -
tabaquismo O -
) O -
se O -
llevaron O -
a O -
cabo O -
al O -
inicio O -
y O -
a O -
los O -
6 O -
y O -
12 O -
meses O -
. O -

A B-Premise HighQuality
los I-Premise HighQuality
12 I-Premise HighQuality
meses, I-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
efectos I-Premise HighQuality
significativos I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
intervención I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
actividad I-Premise HighQuality
física I-Premise HighQuality
moderada I-Premise HighQuality
( I-Premise HighQuality
28,5 I-Premise HighQuality
minutos I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,003 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
índice I-Premise HighQuality
de I-Premise HighQuality
masa I-Premise HighQuality
corporal I-Premise HighQuality
( I-Premise HighQuality
-0,9 I-Premise HighQuality
kg/m I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
) I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
energía I-Premise HighQuality
procedente I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
grasa I-Premise HighQuality
total I-Premise HighQuality
( I-Premise HighQuality
-7,0 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,006 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
energía I-Premise HighQuality
procedente I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
grasa I-Premise HighQuality
saturada I-Premise HighQuality
( I-Premise HighQuality
-2,8 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,016 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observó I-Premise HighQuality
un I-Premise HighQuality
efecto I-Premise HighQuality
significativo I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
intervención I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
ingesta I-Premise HighQuality
de I-Premise HighQuality
verduras I-Premise HighQuality
( I-Premise HighQuality
0,4 I-Premise HighQuality
raciones I-Premise HighQuality
al I-Premise HighQuality
día; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
meses. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
encontraron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
o I-Premise HighQuality
12 I-Premise HighQuality
meses I-Premise HighQuality
en I-Premise HighQuality
cuanto I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
CVRS, I-Premise HighQuality
la I-Premise HighQuality
fatiga I-Premise HighQuality
relacionada I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
cáncer, I-Premise HighQuality
la I-Premise HighQuality
ingesta I-Premise HighQuality
de I-Premise HighQuality
fruta, I-Premise HighQuality
fibra I-Premise HighQuality
o I-Premise HighQuality
alcohol, I-Premise HighQuality
o I-Premise HighQuality
el I-Premise HighQuality
tabaquismo. I-Premise HighQuality

La B-Claim HighQuality
intervención I-Claim HighQuality
CanChange I-Claim HighQuality
fue I-Claim HighQuality
eficaz I-Claim HighQuality
para I-Claim HighQuality
mejorar I-Claim HighQuality
la I-Claim HighQuality
actividad I-Claim HighQuality
física, I-Claim HighQuality
los I-Claim HighQuality
hábitos I-Claim HighQuality
dietéticos I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
índice I-Claim HighQuality
de I-Claim HighQuality
masa I-Claim HighQuality
corporal I-Claim HighQuality
en I-Claim HighQuality
supervivientes I-Claim HighQuality
de I-Claim HighQuality
cáncer I-Claim HighQuality
colorrectal. I-Claim HighQuality

La O -
intervención O -
es O -
traducible O -
a O -
través O -
de O -
los O -
servicios O -
telefónicos O -
de O -
apoyo O -
e O -
información O -
sobre O -
el O -
cáncer O -
existentes O -
en O -
Australia O -
y O -
otros O -
países. O -

La O -
evaluación O -
de O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
( O -
HRQoL O -
) O -
y O -
la O -
mejora O -
de O -
los O -
síntomas O -
fueron O -
objetivos O -
secundarios O -
planificados O -
de O -
antemano O -
para O -
la O -
población O -
general O -
y O -
los O -
análisis O -
posthoc O -
para O -
los O -
subgrupos O -
con O -
mutación O -
positiva/negativa O -
del O -
receptor O -
del O -
factor O -
de O -
crecimiento O -
epidérmico O -
( O -
EGFR O -
) O -
en O -
IPASS O -
. O -

La O -
CVRS O -
se O -
evaluó O -
mediante O -
la O -
Evaluación O -
Funcional O -
del O -
Tratamiento O -
del O -
Cáncer O -
de O -
Pulmón O -
( O -
FACT-L O -
) O -
y O -
el O -
Índice O -
de O -
Resultados O -
del O -
Ensayo O -
( O -
TOI O -
) O -
; O -
la O -
mejora O -
de O -
los O -
síntomas O -
mediante O -
la O -
Subescala O -
de O -
Cáncer O -
de O -
Pulmón O -
( O -
LCS O -
) O -
. O -

Las O -
mejoras O -
se O -
definen O -
como O -
: O -
6 O -
o O -
más O -
( O -
FACT-L O -
; O -
TOI O -
) O -
, O -
2 O -
o O -
más O -
( O -
LCS O -
) O -
aumento O -
de O -
puntos O -
mantenido O -
durante O -
21 O -
o O -
más O -
días O -
. O -

En O -
general O -
( O -
n O -
= O -
1151/1217 O -
evaluables O -
) O -
, O -
las O -
tasas O -
de O -
mejora O -
de O -
la O -
CVRS O -
fueron O -
significativamente O -
mayores O -
con O -
gefitinib O -
frente O -
a O -
carboplatino/paclitaxel O -
; O -
las O -
tasas O -
de O -
mejora O -
de O -
los O -
síntomas O -
fueron O -
similares O -
para O -
ambos O -
tratamientos O -
. O -

Un B-Premise HighQuality
número I-Premise HighQuality
significativamente I-Premise HighQuality
mayor I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
registró I-Premise HighQuality
mejoras I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
CVRS I-Premise HighQuality
y I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
con I-Premise HighQuality
gefitinib I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
con I-Premise HighQuality
mutación I-Premise HighQuality
EGFR I-Premise HighQuality
positiva I-Premise HighQuality
( I-Premise HighQuality
n I-Premise HighQuality
= I-Premise HighQuality
259 I-Premise HighQuality
; I-Premise HighQuality
FACT-L I-Premise HighQuality
70,2 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
44,5 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
odds I-Premise HighQuality
ratio I-Premise HighQuality
, I-Premise HighQuality
3,01 I-Premise HighQuality
[ I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
1,79-5,07 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
; I-Premise HighQuality
TOI I-Premise HighQuality
70,2 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
38,3 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
3,96 I-Premise HighQuality
[ I-Premise HighQuality
2,33-6,71 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
; I-Premise HighQuality
LCS I-Premise HighQuality
75,6 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
53.9 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
2,70 I-Premise HighQuality
[ I-Premise HighQuality
1,58-4,62 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
con I-Premise HighQuality
carboplatino/paclitaxel I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
con I-Premise HighQuality
mutación I-Premise HighQuality
EGFR I-Premise HighQuality
negativa I-Premise HighQuality
( I-Premise HighQuality
n I-Premise HighQuality
= I-Premise HighQuality
169 I-Premise HighQuality
; I-Premise HighQuality
FACT-L I-Premise HighQuality
14,6 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
36,3 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
odds I-Premise HighQuality
ratio I-Premise HighQuality
, I-Premise HighQuality
0.31 I-Premise HighQuality
[ I-Premise HighQuality
0,15-0,65 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,002 I-Premise HighQuality
; I-Premise HighQuality
TOI I-Premise HighQuality
12,4 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
28,8 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
0,35 I-Premise HighQuality
[ I-Premise HighQuality
0,16-0,79 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,011 I-Premise HighQuality
; I-Premise HighQuality
LCS I-Premise HighQuality
20,2 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
47,5 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
0,28 I-Premise HighQuality
[ I-Premise HighQuality
0,14-0,55 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
empeoramiento I-Premise HighQuality
( I-Premise HighQuality
meses I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
FACT-L I-Premise HighQuality
fue I-Premise HighQuality
más I-Premise HighQuality
larga I-Premise HighQuality
con I-Premise HighQuality
gefitinib I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
carboplatino/paclitaxel I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
población I-Premise HighQuality
global I-Premise HighQuality
( I-Premise HighQuality
8,3 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
2,5 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
con I-Premise HighQuality
mutación I-Premise HighQuality
EGFR I-Premise HighQuality
positiva I-Premise HighQuality
( I-Premise HighQuality
15,6 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
3,0 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
similar I-Premise HighQuality
para I-Premise HighQuality
ambos I-Premise HighQuality
tratamientos I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subgrupo I-Premise HighQuality
con I-Premise HighQuality
mutación I-Premise HighQuality
EGFR I-Premise HighQuality
negativa I-Premise HighQuality
( I-Premise HighQuality
1,4 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
1,4 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
de I-Premise HighQuality
mejora I-Premise HighQuality
con I-Premise HighQuality
gefitinib I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
8 I-Premise HighQuality
días I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
tumores I-Premise HighQuality
con I-Premise HighQuality
mutación I-Premise HighQuality
EGFR I-Premise HighQuality
positiva I-Premise HighQuality
que I-Premise HighQuality
mejoraron I-Premise HighQuality
. I-Premise HighQuality

Los B-Claim HighQuality
criterios I-Claim HighQuality
de I-Claim HighQuality
valoración I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
CVRS I-Claim HighQuality
y I-Claim HighQuality
los I-Claim HighQuality
síntomas I-Claim HighQuality
fueron I-Claim HighQuality
coherentes I-Claim HighQuality
con I-Claim HighQuality
los I-Claim HighQuality
resultados I-Claim HighQuality
de I-Claim HighQuality
eficacia I-Claim HighQuality
del I-Claim HighQuality
IPASS I-Claim HighQuality
y I-Claim HighQuality
favorecieron I-Claim HighQuality
a I-Claim HighQuality
gefitinib I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
tumores I-Claim HighQuality
con I-Claim HighQuality
mutación I-Claim HighQuality
EGFR I-Claim HighQuality
positiva I-Claim HighQuality
y I-Claim HighQuality
a I-Claim HighQuality
carboplatino/paclitaxel I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
tumores I-Claim HighQuality
con I-Claim HighQuality
mutación I-Claim HighQuality
EGFR I-Claim HighQuality
negativa. I-Claim HighQuality

En B-Claim HighQuality
un I-Claim HighQuality
ensayo I-Claim HighQuality
clínico I-Claim HighQuality
aleatorizado I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
pulmón I-Claim HighQuality
no I-Claim HighQuality
microcítico I-Claim HighQuality
avanzado I-Claim HighQuality
( I-Claim HighQuality
NSCLC I-Claim HighQuality
) I-Claim HighQuality
, I-Claim HighQuality
la I-Claim HighQuality
infusión I-Claim HighQuality
con I-Claim HighQuality
adenosina I-Claim HighQuality
5'-trifosfato I-Claim HighQuality
( I-Claim HighQuality
ATP I-Claim HighQuality
) I-Claim HighQuality
inhibió I-Claim HighQuality
la I-Claim HighQuality
pérdida I-Claim HighQuality
de I-Claim HighQuality
peso I-Claim HighQuality
corporal I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
. I-Claim HighQuality

En O -
el O -
presente O -
artículo, O -
se O -
informa O -
de O -
los O -
efectos O -
del O -
ATP O -
en O -
la O -
composición O -
corporal, O -
la O -
ingesta O -
de O -
energía O -
y O -
el O -
gasto O -
energético O -
como O -
medidas O -
de O -
resultado O -
secundarias O -
en O -
los O -
mismos O -
pacientes. O -

Los O -
pacientes O -
con O -
CPNM O -
, O -
estadio O -
IIIB O -
o O -
IV O -
, O -
fueron O -
asignados O -
al O -
azar O -
para O -
recibir O -
10 O -
infusiones O -
intravenosas O -
de O -
30 O -
horas O -
de O -
ATP O -
cada O -
2 O -
a O -
4 O -
semanas O -
o O -
sin O -
ATP O -
. O -

Se O -
evaluaron O -
la O -
masa O -
grasa O -
( O -
FM O -
) O -
, O -
la O -
masa O -
libre O -
de O -
grasa O -
( O -
FFM O -
) O -
y O -
el O -
área O -
muscular O -
del O -
brazo O -
a O -
intervalos O -
de O -
4 O -
semanas O -
durante O -
28 O -
semanas O -
. O -

Se O -
evaluaron O -
la O -
ingesta O -
de O -
alimentos, O -
la O -
masa O -
celular O -
corporal O -
(MCC) O -
y O -
el O -
gasto O -
energético O -
en O -
reposo O -
(GEC) O -
a O -
intervalos O -
de O -
8 O -
semanas O -
durante O -
16 O -
semanas. O -

Se O -
comprobó O -
la O -
significación O -
estadística O -
de O -
las O -
diferencias O -
entre O -
grupos O -
mediante O -
un O -
análisis O -
de O -
covarianza O -
de O -
medidas O -
repetidas. O -

Se O -
asignaron O -
al O -
azar O -
58 O -
pacientes O -
( O -
28 O -
ATP O -
, O -
30 O -
control O -
) O -
. O -

No B-Premise HighQuality
se I-Premise HighQuality
encontró I-Premise HighQuality
ningún I-Premise HighQuality
cambio I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
composición I-Premise HighQuality
corporal I-Premise HighQuality
durante I-Premise HighQuality
el I-Premise HighQuality
período I-Premise HighQuality
de I-Premise HighQuality
seguimiento I-Premise HighQuality
de I-Premise HighQuality
28 I-Premise HighQuality
semanas I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
ATP I-Premise HighQuality
, I-Premise HighQuality
mientras I-Premise HighQuality
que I-Premise HighQuality
, I-Premise HighQuality
por I-Premise HighQuality
4 I-Premise HighQuality
semanas I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
perdió I-Premise HighQuality
0,6 I-Premise HighQuality
kg I-Premise HighQuality
de I-Premise HighQuality
FM I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,004 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
0,5 I-Premise HighQuality
kg I-Premise HighQuality
de I-Premise HighQuality
FFM I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,02 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
1,8 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
área I-Premise HighQuality
muscular I-Premise HighQuality
del I-Premise HighQuality
brazo I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,02 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
0,6 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
BCM I-Premise HighQuality
/ I-Premise HighQuality
kg I-Premise HighQuality
de I-Premise HighQuality
peso I-Premise HighQuality
corporal I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,054 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
disminuyó I-Premise HighQuality
568 I-Premise HighQuality
KJ I-Premise HighQuality
/ I-Premise HighQuality
d I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
ingesta I-Premise HighQuality
de I-Premise HighQuality
energía I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,0001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Premise HighQuality
apetito I-Premise HighQuality
también I-Premise HighQuality
se I-Premise HighQuality
mantuvo I-Premise HighQuality
estable I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
ATP, I-Premise HighQuality
pero I-Premise HighQuality
disminuyó I-Premise HighQuality
significativamente I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,0004 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
REE I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
ATP I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
control. I-Premise HighQuality

La B-Claim HighQuality
inhibición I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
pérdida I-Claim HighQuality
de I-Claim HighQuality
peso I-Claim HighQuality
mediante I-Claim HighQuality
infusiones I-Claim HighQuality
de I-Claim HighQuality
ATP I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
CPNM I-Claim HighQuality
avanzado I-Claim HighQuality
se I-Claim HighQuality
atribuye I-Claim HighQuality
a I-Claim HighQuality
que I-Claim HighQuality
se I-Claim HighQuality
contrarresta I-Claim HighQuality
la I-Claim HighQuality
pérdida I-Claim HighQuality
de I-Claim HighQuality
tejidos I-Claim HighQuality
metabólicamente I-Claim HighQuality
activos I-Claim HighQuality
e I-Claim HighQuality
inactivos I-Claim HighQuality
. I-Claim HighQuality

Estos B-Premise HighQuality
efectos I-Premise HighQuality
se I-Premise HighQuality
atribuyen I-Premise HighQuality
en I-Premise HighQuality
parte I-Premise HighQuality
al I-Premise HighQuality
mantenimiento I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
ingesta I-Premise HighQuality
de I-Premise HighQuality
energía. I-Premise HighQuality

Evaluar O -
si O -
el O -
tratamiento O -
con O -
docetaxel O -
como O -
agente O -
único O -
daría O -
lugar O -
a O -
una O -
mayor O -
supervivencia O -
que O -
el O -
mejor O -
tratamiento O -
de O -
apoyo O -
en O -
pacientes O -
con O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
que O -
habían O -
sido O -
tratados O -
previamente O -
con O -
quimioterapia O -
basada O -
en O -
platino. O -

Los O -
puntos O -
finales O -
secundarios O -
incluyeron O -
la O -
evaluación O -
de O -
la O -
respuesta O -
(sólo O -
en O -
el O -
brazo O -
de O -
docetaxel), O -
la O -
toxicidad O -
y O -
la O -
calidad O -
de O -
vida. O -

Los O -
pacientes O -
con O -
estados O -
de O -
rendimiento O -
de O -
0 O -
a O -
2 O -
y O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
en O -
estadio O -
IIIB/IV O -
con O -
lesiones O -
medibles O -
o O -
evaluables O -
fueron O -
elegibles O -
para O -
entrar O -
en O -
el O -
estudio O -
si O -
habían O -
sido O -
sometidos O -
a O -
uno O -
o O -
más O -
regímenes O -
de O -
quimioterapia O -
con O -
platino O -
y O -
si O -
tenían O -
parámetros O -
hematológicos O -
y O -
bioquímicos O -
adecuados O -
. O -

Se O -
excluyeron O -
si O -
tenían O -
metástasis O -
cerebrales O -
sintomáticas O -
o O -
si O -
habían O -
sido O -
tratados O -
previamente O -
con O -
paclitaxel O -
. O -

Los O -
pacientes O -
fueron O -
estratificados O -
por O -
el O -
estado O -
de O -
rendimiento O -
y O -
la O -
mejor O -
respuesta O -
a O -
la O -
quimioterapia O -
con O -
cisplatino O -
y O -
luego O -
fueron O -
asignados O -
al O -
azar O -
al O -
tratamiento O -
con O -
docetaxel O -
100 O -
mg/m O -
( O -
2 O -
) O -
( O -
49 O -
pacientes O -
) O -
o O -
75 O -
mg/m O -
( O -
2 O -
) O -
( O -
55 O -
pacientes O -
) O -
o O -
al O -
mejor O -
cuidado O -
de O -
apoyo O -
. O -

Los O -
pacientes O -
de O -
ambos O -
brazos O -
fueron O -
evaluados O -
cada O -
3 O -
semanas. O -

Ciento O -
cuatro O -
pacientes O -
( O -
103 O -
de O -
los O -
cuales O -
eran O -
elegibles O -
para O -
entrar O -
en O -
el O -
estudio O -
) O -
estaban O -
bien O -
equilibrados O -
para O -
los O -
factores O -
de O -
pronóstico O -
. O -

De O -
los O -
84 O -
pacientes O -
con O -
lesiones O -
medibles, O -
seis O -
( O -
7 O -
. O -

1 O -
% O -
) O -
lograron O -
respuestas O -
parciales O -
( O -
tres O -
pacientes O -
en O -
cada O -
nivel O -
de O -
dosis O -
) O -
. O -

El B-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
fue I-Premise HighQuality
mayor I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
docetaxel I-Premise HighQuality
que I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
mejor I-Premise HighQuality
tratamiento I-Premise HighQuality
de I-Premise HighQuality
apoyo I-Premise HighQuality
( I-Premise HighQuality
10,6 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6,7 I-Premise HighQuality
semanas I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
<0,001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
al I-Premise HighQuality
igual I-Premise HighQuality
que I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
( I-Premise HighQuality
7,0 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,6 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
rango I-Premise HighQuality
logarítmico I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,047 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
diferencia I-Premise HighQuality
fue I-Premise HighQuality
más I-Premise HighQuality
significativa I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
docetaxel I-Premise HighQuality
75 I-Premise HighQuality
mg/m I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
correspondientes I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
mejor I-Premise HighQuality
tratamiento I-Premise HighQuality
de I-Premise HighQuality
apoyo I-Premise HighQuality
( I-Premise HighQuality
7,5 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,6 I-Premise HighQuality
meses I-Premise HighQuality
; I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
rango I-Premise HighQuality
logarítmico I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,010 I-Premise HighQuality
; I-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
un I-Premise HighQuality
año I-Premise HighQuality
, I-Premise HighQuality
37 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
11 I-Premise HighQuality
% I-Premise HighQuality
; I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
chi I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
=0,003 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
produjo I-Premise HighQuality
neutropenia I-Premise HighQuality
febril I-Premise HighQuality
en I-Premise HighQuality
11 I-Premise HighQuality
pacientes I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
docetaxel I-Premise HighQuality
100 I-Premise HighQuality
mg/m I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
tres I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
cuales I-Premise HighQuality
murieron, I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
paciente I-Premise HighQuality
tratado I-Premise HighQuality
con I-Premise HighQuality
docetaxel I-Premise HighQuality
75 I-Premise HighQuality
mg/m I-Premise HighQuality
( I-Premise HighQuality
2 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
toxicidad I-Premise HighQuality
no I-Premise HighQuality
hematológica I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3 I-Premise HighQuality
ó I-Premise HighQuality
4, I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
excepción I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
diarrea, I-Premise HighQuality
se I-Premise HighQuality
produjo I-Premise HighQuality
en I-Premise HighQuality
una I-Premise HighQuality
proporción I-Premise HighQuality
similar I-Premise HighQuality
tanto I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
docetaxel I-Premise HighQuality
como I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
de I-Premise HighQuality
mejor I-Premise HighQuality
tratamiento I-Premise HighQuality
de I-Premise HighQuality
apoyo. I-Premise HighQuality

El B-Claim HighQuality
tratamiento I-Claim HighQuality
con I-Claim HighQuality
docetaxel I-Claim HighQuality
se I-Claim HighQuality
asocia I-Claim HighQuality
a I-Claim HighQuality
una I-Claim HighQuality
prolongación I-Claim HighQuality
significativa I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
supervivencia, I-Claim HighQuality
y O -
a B-Claim HighQuality
una I-Claim HighQuality
dosis I-Claim HighQuality
de I-Claim HighQuality
75 I-Claim HighQuality
mg/m I-Claim HighQuality
( I-Claim HighQuality
2 I-Claim HighQuality
), I-Claim HighQuality
los I-Claim HighQuality
beneficios I-Claim HighQuality
del I-Claim HighQuality
tratamiento I-Claim HighQuality
con I-Claim HighQuality
docetaxel I-Claim HighQuality
superan I-Claim HighQuality
los I-Claim HighQuality
riesgos. I-Claim HighQuality

Se O -
ha O -
demostrado O -
que O -
los O -
programas O -
de O -
recuperación O -
mejorada O -
( O -
ERP O -
) O -
reducen O -
la O -
duración O -
de O -
la O -
estancia O -
hospitalaria O -
( O -
LOS O -
) O -
y O -
las O -
complicaciones O -
en O -
la O -
cirugía O -
colorrectal O -
. O -

No O -
está O -
claro O -
si O -
los O -
ERP O -
tienen O -
los O -
mismos O -
beneficios O -
en O -
la O -
cirugía O -
de O -
resección O -
hepática O -
abierta, O -
y O -
se O -
carece O -
de O -
ensayos O -
clínicos O -
aleatorios. O -

Los O -
pacientes O -
consecutivos O -
programados O -
para O -
una O -
resección O -
hepática O -
abierta O -
fueron O -
asignados O -
aleatoriamente O -
a O -
un O -
grupo O -
de O -
ERP O -
o O -
a O -
la O -
atención O -
estándar O -
. O -

Los O -
criterios O -
de O -
valoración O -
primarios O -
fueron O -
el O -
tiempo O -
hasta O -
el O -
alta O -
médica O -
("MFD") O -
y O -
la O -
estancia O -
en O -
el O -
hospital. O -

Los O -
criterios O -
de O -
valoración O -
secundarios O -
fueron O -
la O -
morbilidad O -
postoperatoria, O -
las O -
puntuaciones O -
de O -
dolor, O -
la O -
tasa O -
de O -
reingreso, O -
la O -
mortalidad, O -
la O -
calidad O -
de O -
vida O -
(QoL) O -
y O -
la O -
satisfacción O -
del O -
paciente. O -

Los O -
elementos O -
de O -
la O -
ERP O -
incluían O -
una O -
mayor O -
educación O -
preoperatoria, O -
carga O -
preoperatoria O -
de O -
carbohidratos O -
por O -
vía O -
oral, O -
fluidoterapia O -
postoperatoria O -
dirigida O -
a O -
objetivos, O -
movilización O -
temprana O -
y O -
fisioterapia. O -

Ambos O -
grupos O -
recibieron O -
anestesia O -
normalizada O -
con O -
analgesia O -
epidural. O -

El O -
análisis O -
incluyó O -
a O -
46 O -
pacientes O -
en O -
el O -
grupo O -
de O -
ERP O -
y O -
a O -
45 O -
en O -
el O -
grupo O -
de O -
atención O -
estándar. O -

La B-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
de I-Premise HighQuality
MFD I-Premise HighQuality
se I-Premise HighQuality
redujo I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
ERP I-Premise HighQuality
( I-Premise HighQuality
3 I-Premise HighQuality
días I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6 I-Premise HighQuality
días I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
atención I-Premise HighQuality
estándar I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0-001 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
al I-Premise HighQuality
igual I-Premise HighQuality
que I-Premise HighQuality
la I-Premise HighQuality
LOS I-Premise HighQuality
( I-Premise HighQuality
4 I-Premise HighQuality
días I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
7 I-Premise HighQuality
días I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0-001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
ERP I-Premise HighQuality
redujo I-Premise HighQuality
significativamente I-Premise HighQuality
la I-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
complicaciones I-Premise HighQuality
médicas I-Premise HighQuality
( I-Premise HighQuality
7 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
27% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0-020 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
pero B-Premise HighQuality
no I-Premise HighQuality
las I-Premise HighQuality
complicaciones I-Premise HighQuality
quirúrgicas I-Premise HighQuality
( I-Premise HighQuality
15 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
11% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0-612 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
los I-Premise HighQuality
reingresos I-Premise HighQuality
( I-Premise HighQuality
4 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
0% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0-153 I-Premise HighQuality
) I-Premise HighQuality
o I-Premise HighQuality
la I-Premise HighQuality
mortalidad I-Premise HighQuality
( I-Premise HighQuality
ambos I-Premise HighQuality
2% I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0-987 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
a I-Premise HighQuality
lo I-Premise HighQuality
largo I-Premise HighQuality
de I-Premise HighQuality
28 I-Premise HighQuality
días I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
mejor I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
ERP I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0-002 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
satisfacción I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes. I-Premise HighQuality

Los B-Claim HighQuality
ERP I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
cirugía I-Claim HighQuality
de I-Claim HighQuality
resección I-Claim HighQuality
hepática I-Claim HighQuality
abierta I-Claim HighQuality
son I-Claim HighQuality
seguros I-Claim HighQuality
y I-Claim HighQuality
eficaces I-Claim HighQuality
. I-Claim HighQuality

Los B-Claim HighQuality
pacientes I-Claim HighQuality
tratados I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
ERP I-Claim HighQuality
se I-Claim HighQuality
recuperaron I-Claim HighQuality
más I-Claim HighQuality
rápido, I-Claim HighQuality
fueron I-Claim HighQuality
dados I-Claim HighQuality
de I-Claim HighQuality
alta I-Claim HighQuality
antes I-Claim HighQuality
y I-Claim HighQuality
tuvieron I-Claim HighQuality
menos I-Claim HighQuality
complicaciones I-Claim HighQuality
médicas I-Claim HighQuality
y I-Claim HighQuality
una I-Claim HighQuality
mejor I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida. I-Claim HighQuality

Aunque O -
el O -
deterioro O -
cognitivo O -
inducido O -
por O -
la O -
quimioterapia O -
es O -
común O -
entre O -
las O -
pacientes O -
con O -
cáncer O -
de O -
mama, O -
las O -
pruebas O -
de O -
intervenciones O -
eficaces O -
para O -
abordar O -
los O -
déficits O -
cognitivos O -
son O -
limitadas. O -

Este O -
ensayo O -
controlado O -
aleatorio O -
examinó O -
la O -
viabilidad O -
y O -
la O -
eficacia O -
preliminar O -
de O -
un O -
programa O -
de O -
Meditación O -
con O -
Sonido O -
Tibetano O -
( O -
TSM O -
) O -
para O -
mejorar O -
la O -
función O -
cognitiva O -
y O -
la O -
calidad O -
de O -
vida O -
en O -
pacientes O -
con O -
cáncer O -
de O -
mama O -
. O -

Se O -
reclutaron O -
47 O -
pacientes O -
con O -
cáncer O -
de O -
mama O -
( O -
edad O -
media O -
de O -
56,3 O -
años O -
) O -
, O -
que O -
estaban O -
en O -
el O -
estadio O -
I-III O -
en O -
el O -
momento O -
del O -
diagnóstico O -
, O -
entre O -
6 O -
y O -
60 O -
meses O -
después O -
de O -
la O -
quimioterapia O -
, O -
y O -
que O -
informaron O -
de O -
un O -
deterioro O -
cognitivo O -
al O -
inicio O -
del O -
estudio O -
. O -

Los O -
participantes O -
fueron O -
asignados O -
al O -
azar O -
a O -
dos O -
sesiones O -
semanales O -
de O -
TSM O -
durante O -
6 O -
semanas O -
o O -
a O -
un O -
grupo O -
de O -
control O -
en O -
lista O -
de O -
espera. O -

Las O -
evaluaciones O -
neuropsicológicas O -
se O -
completaron O -
al O -
inicio O -
y O -
un O -
mes O -
después O -
del O -
tratamiento. O -

Medidas O -
de O -
autoinforme O -
de O -
la O -
función O -
cognitiva O -
( O -
Evaluación O -
Funcional O -
de O -
la O -
Terapia O -
del O -
Cáncer O -
( O -
FACT O -
) O -
-Cog O -
) O -
, O -
la O -
calidad O -
de O -
vida O -
( O -
SF-36 O -
) O -
, O -
los O -
síntomas O -
depresivos O -
( O -
Escala O -
de O -
Depresión O -
del O -
Centro O -
de O -
Estudios O -
Epidemiológicos O -
) O -
, O -
las O -
alteraciones O -
del O -
sueño O -
( O -
Índice O -
de O -
Calidad O -
del O -
Sueño O -
de O -
Pittsburgh O -
) O -
, O -
la O -
fatiga O -
( O -
Inventario O -
Breve O -
de O -
Fatiga O -
) O -
y O -
la O -
espiritualidad O -
( O -
FACT-Sp O -
) O -
se O -
completaron O -
al O -
inicio O -
, O -
al O -
final O -
del O -
tratamiento O -
y O -
1 O -
mes O -
después O -
. O -

En B-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control, I-Premise HighQuality
las I-Premise HighQuality
mujeres I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
TSM I-Premise HighQuality
obtuvieron I-Premise HighQuality
mejores I-Premise HighQuality
resultados I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
prueba I-Premise HighQuality
de I-Premise HighQuality
memoria I-Premise HighQuality
verbal I-Premise HighQuality
( I-Premise HighQuality
Prueba I-Premise HighQuality
de I-Premise HighQuality
Aprendizaje I-Premise HighQuality
Verbal I-Premise HighQuality
Auditivo I-Premise HighQuality
Rey I-Premise HighQuality
ensayo I-Premise HighQuality
1 I-Premise HighQuality
) I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,06 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
tarea I-Premise HighQuality
de I-Premise HighQuality
memoria I-Premise HighQuality
a I-Premise HighQuality
corto I-Premise HighQuality
plazo I-Premise HighQuality
y I-Premise HighQuality
velocidad I-Premise HighQuality
de I-Premise HighQuality
procesamiento I-Premise HighQuality
( I-Premise HighQuality
Símbolo I-Premise HighQuality
de I-Premise HighQuality
Dígitos I-Premise HighQuality
) I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,09 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
manifestaron I-Premise HighQuality
una I-Premise HighQuality
mejora I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
función I-Premise HighQuality
cognitiva I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,06 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
capacidades I-Premise HighQuality
cognitivas I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,08 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
salud I-Premise HighQuality
mental I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,04 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
espiritualidad I-Premise HighQuality
( I-Premise HighQuality
p I-Premise HighQuality
= I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
al I-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
tratamiento, I-Premise HighQuality
pero I-Premise HighQuality
no I-Premise HighQuality
un I-Premise HighQuality
mes I-Premise HighQuality
después I-Premise HighQuality
. I-Premise HighQuality

Este B-Claim HighQuality
ensayo I-Claim HighQuality
controlado I-Claim HighQuality
aleatorio I-Claim HighQuality
reveló I-Claim HighQuality
que I-Claim HighQuality
el I-Claim HighQuality
programa I-Claim HighQuality
TSM I-Claim HighQuality
parece I-Claim HighQuality
ser I-Claim HighQuality
una I-Claim HighQuality
intervención I-Claim HighQuality
factible I-Claim HighQuality
y I-Claim HighQuality
aceptable I-Claim HighQuality
y I-Claim HighQuality
puede I-Claim HighQuality
estar I-Claim HighQuality
asociado I-Claim HighQuality
con I-Claim HighQuality
mejoras I-Claim HighQuality
a I-Claim HighQuality
corto I-Claim HighQuality
plazo I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
función I-Claim HighQuality
cognitiva I-Claim HighQuality
objetiva I-Claim HighQuality
y I-Claim HighQuality
subjetiva, I-Claim HighQuality
así I-Claim HighQuality
como I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
salud I-Claim HighQuality
mental I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
espiritualidad I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
. I-Claim HighQuality

La B-Claim HighQuality
elección I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
reconstrucción I-Claim HighQuality
después I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
gastrectomía I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
importancia I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
función I-Claim HighQuality
del I-Claim HighQuality
reservorio I-Claim HighQuality
restante I-Claim HighQuality
es I-Claim HighQuality
un I-Claim HighQuality
tema I-Claim HighQuality
de I-Claim HighQuality
controversia I-Claim HighQuality
. I-Claim HighQuality

Para O -
ampliar O -
los O -
criterios O -
de O -
elección O -
del O -
tratamiento O -
, O -
realizamos O -
un O -
ensayo O -
clínico O -
prospectivo O -
aleatorio O -
para O -
determinar O -
el O -
impacto O -
de O -
varios O -
procedimientos O -
de O -
gastrectomía O -
en O -
la O -
calidad O -
de O -
vida O -
. O -

Los O -
pacientes O -
consecutivos O -
( O -
n O -
= O -
64 O -
) O -
elegibles O -
para O -
la O -
cirugía O -
curativa O -
del O -
cáncer O -
gástrico O -
fueron O -
aleatorizados O -
para O -
someterse O -
a O -
una O -
gastrectomía O -
total O -
( O -
n O -
= O -
31 O -
) O -
o O -
subtotal O -
( O -
n O -
= O -
13 O -
) O -
o O -
a O -
la O -
implantación O -
de O -
una O -
bolsa O -
yeyunal O -
en O -
forma O -
de O -
S O -
( O -
n O -
= O -
20 O -
) O -
como O -
sustituto O -
gástrico O -
. O -

La O -
evaluación O -
de O -
la O -
calidad O -
de O -
vida O -
se O -
basó O -
en O -
una O -
batería O -
de O -
cuestionarios O -
que O -
abarcaban O -
aspectos O -
generales O -
y O -
específicos O -
de O -
la O -
vida O -
. O -

Los O -
pacientes O -
fueron O -
evaluados O -
por O -
uno O -
de O -
los O -
dos O -
psiquiatras O -
que O -
no O -
conocían O -
la O -
afiliación O -
de O -
los O -
pacientes O -
al O -
grupo. O -

Las O -
evaluaciones O -
se O -
realizaron O -
en O -
tres O -
ocasiones: O -
durante O -
la O -
semana O -
anterior O -
a O -
la O -
cirugía O -
y O -
3 O -
y O -
12 O -
meses O -
después O -
de O -
la O -
intervención O -
quirúrgica O -
. O -

Las B-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
complicaciones I-Premise HighQuality
y I-Premise HighQuality
mortalidad I-Premise HighQuality
postoperatorias I-Premise HighQuality
fueron I-Premise HighQuality
similares I-Premise HighQuality
en I-Premise HighQuality
todos I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
tratamiento, I-Premise HighQuality
con I-Premise HighQuality
pocas I-Premise HighQuality
complicaciones I-Premise HighQuality
graves. I-Premise HighQuality

Independientemente B-Premise HighQuality
del I-Premise HighQuality
tipo I-Premise HighQuality
de I-Premise HighQuality
tratamiento, I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
presentaban I-Premise HighQuality
síntomas I-Premise HighQuality
alimentarios I-Premise HighQuality
y I-Premise HighQuality
limitaciones I-Premise HighQuality
funcionales I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
vida I-Premise HighQuality
cotidiana, I-Premise HighQuality
mientras B-Premise HighQuality
que I-Premise HighQuality
su I-Premise HighQuality
bienestar I-Premise HighQuality
mental I-Premise HighQuality
mejoró I-Premise HighQuality
tras I-Premise HighQuality
la I-Premise HighQuality
cirugía. I-Premise HighQuality

Los B-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
se I-Premise HighQuality
sometieron I-Premise HighQuality
a I-Premise HighQuality
una I-Premise HighQuality
gastrectomía I-Premise HighQuality
subtotal I-Premise HighQuality
obtuvieron I-Premise HighQuality
los I-Premise HighQuality
mejores I-Premise HighQuality
resultados, I-Premise HighQuality
especialmente I-Premise HighQuality
en I-Premise HighQuality
lo I-Premise HighQuality
que I-Premise HighQuality
respecta I-Premise HighQuality
a I-Premise HighQuality
las I-Premise HighQuality
quejas I-Premise HighQuality
de I-Premise HighQuality
diarrea. I-Premise HighQuality

Los B-Premise HighQuality
pacientes I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
se I-Premise HighQuality
les I-Premise HighQuality
administró I-Premise HighQuality
un I-Premise HighQuality
sustituto I-Premise HighQuality
gástrico I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
gastrectomía I-Premise HighQuality
no I-Premise HighQuality
mostraron I-Premise HighQuality
diferencias I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
sólo I-Premise HighQuality
se I-Premise HighQuality
sometieron I-Premise HighQuality
a I-Premise HighQuality
una I-Premise HighQuality
gastrectomía I-Premise HighQuality
total I-Premise HighQuality
. I-Premise HighQuality

Concluimos B-Claim HighQuality
que, I-Claim HighQuality
a I-Claim HighQuality
pesar I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
importantes I-Claim HighQuality
consecuencias I-Claim HighQuality
desfavorables I-Claim HighQuality
que I-Claim HighQuality
siguen I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
gastrectomía, I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
se I-Claim HighQuality
recuperan I-Claim HighQuality
con I-Claim HighQuality
una I-Claim HighQuality
mejora I-Claim HighQuality
del I-Claim HighQuality
estado I-Claim HighQuality
mental. I-Claim HighQuality

Una B-Claim HighQuality
reconstrucción I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
bolsa I-Claim HighQuality
después I-Claim HighQuality
de I-Claim HighQuality
una I-Claim HighQuality
gastrectomía I-Claim HighQuality
total I-Claim HighQuality
no I-Claim HighQuality
mejora I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
, I-Claim HighQuality
pero O -
una B-Claim HighQuality
gastrectomía I-Claim HighQuality
subtotal I-Claim HighQuality
tiene I-Claim HighQuality
ventajas I-Claim HighQuality
que I-Claim HighQuality
deben I-Claim HighQuality
ser I-Claim HighQuality
consideradas I-Claim HighQuality
cuando I-Claim HighQuality
el I-Claim HighQuality
procedimiento I-Claim HighQuality
es I-Claim HighQuality
clínicamente I-Claim HighQuality
factible I-Claim HighQuality
. I-Claim HighQuality

Evaluar O -
el O -
efecto O -
de O -
la O -
epoetina O -
alfa O -
sobre O -
la O -
calidad O -
de O -
vida O -
( O -
QOL O -
) O -
en O -
pacientes O -
con O -
tumores O -
sólidos O -
y O -
anemia O -
leve O -
a O -
moderada O -
que O -
reciben O -
quimioterapia O -
basada O -
en O -
platino O -
en O -
relación O -
con O -
las O -
normas O -
de O -
la O -
población O -
. O -

En O -
el O -
estudio O -
original, O -
los O -
pacientes O -
( O -
n O -
= O -
316 O -
) O -
con O -
niveles O -
de O -
hemoglobina O -
( O -
Hb O -
) O -
< O -
o O -
=12,1 O -
g/dl O -
fueron O -
asignados O -
al O -
azar O -
2:1 O -
para O -
recibir O -
epoetina O -
alfa O -
en O -
una O -
dosis O -
de O -
10.000 O -
U O -
tres O -
veces O -
por O -
semana O -
s.c. O -
o O -
el O -
mejor O -
cuidado O -
de O -
apoyo O -
( O -
BSC O -
) O -
para O -
comparar O -
los O -
efectos O -
sobre O -
el O -
uso O -
de O -
transfusiones O -
, O -
la O -
respuesta O -
hematológica O -
y O -
la O -
CdV O -
( O -
medida O -
por O -
la O -
Evaluación O -
Funcional O -
de O -
la O -
Terapia O -
del O -
Cáncer-Anemia O -
[ O -
FACT-An O -
] O -
y O -
la O -
Escala O -
Analógica O -
Lineal O -
del O -
Cáncer O -
[ O -
CLAS O -
] O -
) O -
. O -

Los O -
datos O -
sobre O -
la O -
calidad O -
de O -
vida O -
de O -
este O -
ensayo, O -
ya O -
publicados, O -
se O -
volvieron O -
a O -
analizar O -
aquí O -
en O -
relación O -
con O -
las O -
normas O -
de O -
la O -
población. O -

Las O -
puntuaciones O -
medias O -
de O -
la O -
calidad O -
de O -
vida O -
inicial O -
fueron O -
similares O -
entre O -
los O -
grupos. O -

Al O -
finalizar O -
el O -
estudio, O -
las O -
puntuaciones O -
medias O -
de O -
la O -
CLAS, O -
la O -
FACT-An, O -
la O -
subescala O -
de O -
anemia O -
de O -
la O -
FACT-An O -
y O -
la O -
subescala O -
de O -
fatiga O -
de O -
la O -
FACT-An O -
fueron O -
significativamente O -
mayores O -
en O -
los O -
pacientes O -
que O -
recibieron O -
epoetina O -
alfa O -
que O -
en O -
los O -
tratados O -
con O -
BSC. O -

En O -
comparación O -
con O -
las O -
normas O -
de O -
la O -
población, O -
ambos O -
grupos O -
presentaban O -
un O -
deterioro O -
de O -
la O -
calidad O -
de O -
vida O -
al O -
inicio O -
del O -
estudio. O -

Las B-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
medias I-Premise HighQuality
de I-Premise HighQuality
cambio I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
desde I-Premise HighQuality
el I-Premise HighQuality
inicio I-Premise HighQuality
hasta I-Premise HighQuality
el I-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
estudio I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
epoetina I-Premise HighQuality
alfa I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
BSC I-Premise HighQuality
fueron I-Premise HighQuality
de I-Premise HighQuality
3,17 I-Premise HighQuality
puntos I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
FACT-Total, I-Premise HighQuality
de I-Premise HighQuality
9,90 I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
subescala I-Premise HighQuality
FACT-An I-Premise HighQuality
de I-Premise HighQuality
Fatiga I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
7,30 I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
subescala I-Premise HighQuality
FACT-An I-Premise HighQuality
de I-Premise HighQuality
Anemia. I-Premise HighQuality

Esto B-Premise HighQuality
fue I-Premise HighQuality
equivalente I-Premise HighQuality
a I-Premise HighQuality
correcciones I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
déficits I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
atribuibles I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
epoetina I-Premise HighQuality
alfa I-Premise HighQuality
del I-Premise HighQuality
97,3% I-Premise HighQuality
, I-Premise HighQuality
el I-Premise HighQuality
40,7% I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
38,0% I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
subescalas I-Premise HighQuality
FACT-General, I-Premise HighQuality
FACT-An I-Premise HighQuality
Fatiga I-Premise HighQuality
y I-Premise HighQuality
FACT-An I-Premise HighQuality
Anemia I-Premise HighQuality
, I-Premise HighQuality
respectivamente, I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
BSC I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observó I-Premise HighQuality
un I-Premise HighQuality
beneficio I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
algo I-Premise HighQuality
mayor I-Premise HighQuality
para I-Premise HighQuality
las I-Premise HighQuality
subescalas I-Premise HighQuality
FACT-An I-Premise HighQuality
Fatiga I-Premise HighQuality
y I-Premise HighQuality
FACT-An I-Premise HighQuality
Anemia I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
subconjunto I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
niveles I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
basales I-Premise HighQuality
> I-Premise HighQuality
10,5 I-Premise HighQuality
g/dl I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
pacientes I-Premise HighQuality
de I-Premise HighQuality
este I-Premise HighQuality
estudio I-Premise HighQuality
presentaban I-Premise HighQuality
un I-Premise HighQuality
deterioro I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
las I-Premise HighQuality
normas I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
población. I-Premise HighQuality

El B-Claim HighQuality
tratamiento I-Claim HighQuality
temprano I-Claim HighQuality
con I-Claim HighQuality
epoetina I-Claim HighQuality
alfa I-Claim HighQuality
para I-Claim HighQuality
corregir I-Claim HighQuality
la I-Claim HighQuality
anemia I-Claim HighQuality
mejoró I-Claim HighQuality
la I-Claim HighQuality
CdV I-Claim HighQuality
de I-Claim HighQuality
forma I-Claim HighQuality
estadísticamente I-Claim HighQuality
significativa I-Claim HighQuality
y I-Claim HighQuality
clínicamente I-Claim HighQuality
significativa I-Claim HighQuality
, I-Claim HighQuality
y I-Claim HighQuality
las I-Claim HighQuality
mejoras I-Claim HighQuality
fueron I-Claim HighQuality
mayores I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
niveles I-Claim HighQuality
basales I-Claim HighQuality
de I-Claim HighQuality
Hb I-Claim HighQuality
> I-Claim HighQuality
10,5 I-Claim HighQuality
g/dl I-Claim HighQuality
. I-Claim HighQuality

Observar O -
el O -
efecto O -
del O -
régimen O -
integral O -
de O -
la O -
medicina O -
china O -
( O -
CM O -
) O -
como O -
terapia O -
de O -
mantenimiento O -
( O -
MT O -
) O -
en O -
el O -
tiempo O -
hasta O -
la O -
progresión O -
( O -
TTP O -
) O -
y O -
la O -
calidad O -
de O -
vida O -
( O -
QOL O -
) O -
de O -
los O -
pacientes O -
con O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
avanzado O -
( O -
NSCLC O -
) O -
. O -

El O -
estudio O -
fue O -
un O -
ensayo O -
clínico O -
prospectivo, O -
aleatorio O -
y O -
controlado. O -

Cincuenta O -
pacientes O -
no O -
progresivos O -
con O -
CPNM O -
avanzado O -
que O -
respondieron O -
a O -
la O -
terapia O -
de O -
primera O -
línea O -
fueron O -
distribuidos O -
aleatoriamente O -
en O -
el O -
grupo O -
de O -
prueba O -
( O -
25 O -
casos O -
, O -
tratados O -
con O -
un O -
régimen O -
integral O -
de O -
CM O -
: O -
goteo O -
intravenoso O -
de O -
la O -
preparación O -
de O -
hierbas O -
chinas O -
, O -
la O -
administración O -
oral O -
de O -
la O -
decocción O -
de O -
hierbas O -
chinas O -
, O -
y O -
la O -
aplicación O -
de O -
puntos O -
) O -
y O -
el O -
grupo O -
de O -
control O -
[ O -
25 O -
casos O -
, O -
tratados O -
con O -
uno O -
de O -
los O -
tres O -
regímenes O -
de O -
quimioterapia O -
de O -
mantenimiento O -
de O -
un O -
solo O -
agente O -
: O -
pemetrexed O -
( O -
500 O -
mg/m2 O -
, O -
día O -
1 O -
) O -
, O -
docetaxel O -
( O -
75 O -
mg/m2 O -
, O -
día O -
1 O -
) O -
, O -
y O -
gemcitabina O -
( O -
1000 O -
mg/mi O -
, O -
día O -
1 O -
y O -
día O -
8 O -
) O -
en O -
la O -
proporción O -
de O -
1:1 O -
] O -
. O -

Cada O -
ciclo O -
constaba O -
de O -
21 O -
días. O -

Los O -
ciclos O -
se O -
repitieron O -
hasta O -
que O -
la O -
enfermedad O -
progresó, O -
o O -
se O -
produjeron O -
reacciones O -
tóxicas O -
o O -
adversas O -
intolerables, O -
o O -
los O -
pacientes O -
se O -
negaron O -
a O -
continuar O -
el O -
tratamiento. O -

El O -
criterio O -
de O -
valoración O -
primario O -
fue O -
el O -
TTP O -
y O -
el O -
secundario, O -
la O -
calidad O -
de O -
vida. O -

La O -
calidad O -
de O -
vida O -
se O -
evaluó O -
mediante O -
el O -
cuestionario O -
de O -
calidad O -
de O -
vida O -
QLQ-LC43 O -
de O -
la O -
Organización O -
Europea O -
para O -
la O -
Investigación O -
y O -
el O -
Tratamiento O -
del O -
Cáncer O -
( O -
EORTC O -
QLQ-LC43 O -
) O -
. O -

Se O -
han O -
analizado O -
estadísticamente O -
el O -
TTP O -
de O -
cincuenta O -
pacientes O -
y O -
la O -
CdV O -
de O -
43 O -
pacientes. O -

( O -
1 O -
) O -
El B-Premise HighQuality
TTP I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
prueba I-Premise HighQuality
se I-Premise HighQuality
prolongó I-Premise HighQuality
durante I-Premise HighQuality
23 I-Premise HighQuality
días I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
, I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
diferencia I-Premise HighQuality
insignificante I-Premise HighQuality
( I-Premise HighQuality
87 I-Premise HighQuality
días I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
64 I-Premise HighQuality
días I-Premise HighQuality
, I-Premise HighQuality
P=0,063 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

( O -
2 O -
) O -
Las B-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
dominios I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
EORTC I-Premise HighQuality
QLQ-LC43 I-Premise HighQuality
fueron I-Premise HighQuality
significativamente I-Premise HighQuality
mejores I-Premise HighQuality
desde I-Premise HighQuality
el I-Premise HighQuality
punto I-Premise HighQuality
de I-Premise HighQuality
vista I-Premise HighQuality
estadístico I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
prueba I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
excepto B-Premise HighQuality
las I-Premise HighQuality
funciones I-Premise HighQuality
cognitivas I-Premise HighQuality
y I-Premise HighQuality
sociales I-Premise HighQuality
, I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
de I-Premise HighQuality
disfagia I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
dolor I-Premise HighQuality
en I-Premise HighQuality
otras I-Premise HighQuality
partes I-Premise HighQuality
. I-Premise HighQuality

( O -
1 O -
) O -
El B-Claim HighQuality
régimen I-Claim HighQuality
integral I-Claim HighQuality
de I-Claim HighQuality
CM I-Claim HighQuality
como I-Claim HighQuality
MT I-Claim HighQuality
tuvo I-Claim HighQuality
una I-Claim HighQuality
eficacia I-Claim HighQuality
equivalente I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
TTP I-Claim HighQuality
cuando I-Claim HighQuality
se I-Claim HighQuality
comparó I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
régimen I-Claim HighQuality
de I-Claim HighQuality
quimioterapia I-Claim HighQuality
de I-Claim HighQuality
mantenimiento I-Claim HighQuality
con I-Claim HighQuality
un I-Claim HighQuality
solo I-Claim HighQuality
agente I-Claim HighQuality
. I-Claim HighQuality

Era B-Claim HighQuality
ventajoso I-Claim HighQuality
respecto I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
mejora I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida. I-Claim HighQuality

( O -
2 O -
) O -
Es B-Claim HighQuality
necesario I-Claim HighQuality
ampliar I-Claim HighQuality
el I-Claim HighQuality
tamaño I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
muestra I-Claim HighQuality
para I-Claim HighQuality
confirmar I-Claim HighQuality
aún I-Claim HighQuality
más I-Claim HighQuality
la I-Claim HighQuality
eficacia I-Claim HighQuality
terapéutica I-Claim HighQuality
del I-Claim HighQuality
régimen I-Claim HighQuality
integral I-Claim HighQuality
de I-Claim HighQuality
CM I-Claim HighQuality
como I-Claim HighQuality
MT I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
CPNM I-Claim HighQuality
avanzado I-Claim HighQuality
. I-Claim HighQuality

La O -
proctocolectomía O -
restauradora O -
con O -
anastomosis O -
ileal O -
( O -
IPAA O -
) O -
es O -
el O -
procedimiento O -
quirúrgico O -
estándar O -
para O -
la O -
colitis O -
ulcerosa O -
( O -
CU O -
) O -
y O -
la O -
poliposis O -
adenomatosa O -
familiar O -
( O -
PAF O -
) O -
. O -

Aunque O -
las O -
técnicas O -
mínimamente O -
invasivas O -
se O -
han O -
aplicado O -
cada O -
vez O -
más, O -
todavía O -
no O -
se O -
dispone O -
de O -
pruebas O -
claras O -
de O -
la O -
superioridad O -
de O -
los O -
procedimientos O -
laparoscópicos O -
de O -
bolsa. O -

El O -
objetivo O -
del O -
ensayo O -
LapConPouch O -
fue O -
comparar O -
la O -
eficacia O -
del O -
procedimiento O -
de O -
bolsa O -
ileoanal O -
laparoscópica O -
( O -
LAP O -
) O -
frente O -
al O -
convencional O -
( O -
CON O -
) O -
en O -
pacientes O -
sometidos O -
a O -
proctocolectomía O -
restauradora O -
electiva O -
. O -

El O -
ensayo O -
se O -
diseñó O -
como O -
un O -
ensayo O -
controlado, O -
aleatorizado O -
y O -
preoperatorio O -
en O -
un O -
solo O -
centro, O -
utilizando O -
un O -
diseño O -
de O -
superioridad O -
paralelo O -
de O -
dos O -
grupos. O -

Los O -
pacientes O -
programados O -
para O -
una O -
proctocolectomía O -
reparadora O -
por O -
PAF O -
o O -
por O -
CU O -
fueron O -
elegibles O -
para O -
participar. O -

Los O -
pacientes O -
y O -
los O -
evaluadores O -
de O -
resultados O -
no O -
conocían O -
la O -
asignación O -
de O -
grupos. O -

El O -
criterio O -
de O -
valoración O -
primario O -
se O -
definió O -
como O -
la O -
cantidad O -
de O -
pérdida O -
de O -
sangre O -
. O -

Los O -
análisis O -
estadísticos O -
fueron O -
exploratorios, O -
ya O -
que O -
el O -
ensayo O -
tuvo O -
que O -
interrumpirse O -
prematuramente. O -

Un O -
total O -
de O -
42 O -
pacientes O -
( O -
21 O -
LAP O -
( O -
50,0 O -
% O -
) O -
; O -
21 O -
CON O -
( O -
50,0 O -
% O -
) O -
) O -
fueron O -
aleatorizados O -
. O -

El B-Premise HighQuality
ensayo I-Premise HighQuality
tuvo I-Premise HighQuality
que I-Premise HighQuality
interrumpirse I-Premise HighQuality
prematuramente I-Premise HighQuality
debido I-Premise HighQuality
a I-Premise HighQuality
que I-Premise HighQuality
el I-Premise HighQuality
reclutamiento I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
fue I-Premise HighQuality
insuficiente. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
cantidad I-Premise HighQuality
de I-Premise HighQuality
pérdida I-Premise HighQuality
de I-Premise HighQuality
sangre I-Premise HighQuality
entre I-Premise HighQuality
ambos I-Premise HighQuality
grupos: I-Premise HighQuality
LAP I-Premise HighQuality
261,5 I-Premise HighQuality
± I-Premise HighQuality
195,4 I-Premise HighQuality
ml I-Premise HighQuality
, I-Premise HighQuality
CON I-Premise HighQuality
228,1 I-Premise HighQuality
± I-Premise HighQuality
119,5 I-Premise HighQuality
ml I-Premise HighQuality
. I-Premise HighQuality

Los O -
criterios O -
de O -
valoración O -
secundarios O -
difieren O -
en O -
ambos O -
grupos. O -

La B-Claim HighQuality
cirugía I-Claim HighQuality
laparoscópica I-Claim HighQuality
fue I-Claim HighQuality
superior I-Claim HighQuality
en I-Claim HighQuality
cuanto I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
longitud I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
incisión I-Claim HighQuality
cutánea; I-Claim HighQuality
en O -
cambio, O -
el B-Claim HighQuality
enfoque I-Claim HighQuality
convencional I-Claim HighQuality
fue I-Claim HighQuality
superior I-Claim HighQuality
en I-Claim HighQuality
cuanto I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
duración I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
operación. I-Claim HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
discrepancias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
duración I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
estancia I-Premise HighQuality
hospitalaria, I-Premise HighQuality
el I-Premise HighQuality
dolor I-Premise HighQuality
postoperatorio, I-Premise HighQuality
la I-Premise HighQuality
función I-Premise HighQuality
intestinal I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
entre I-Premise HighQuality
ambos I-Premise HighQuality
enfoques. I-Premise HighQuality

La O -
tasa O -
de O -
conversión O -
del O -
enfoque O -
LAP O -
al O -
CON O -
fue O -
del O -
23,8%. O -

No B-Claim HighQuality
hubo I-Claim HighQuality
diferencias I-Claim HighQuality
con I-Claim HighQuality
respecto I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
pérdida I-Claim HighQuality
de I-Claim HighQuality
sangre I-Claim HighQuality
entre I-Claim HighQuality
el I-Claim HighQuality
grupo I-Claim HighQuality
LAP I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
grupo I-Claim HighQuality
CON I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
enfoque I-Claim HighQuality
LAP I-Claim HighQuality
es I-Claim HighQuality
factible I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
proctocolectomía I-Claim HighQuality
restauradora I-Claim HighQuality
, I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
IPAA I-Claim HighQuality
parece I-Claim HighQuality
al I-Claim HighQuality
menos I-Claim HighQuality
tan I-Claim HighQuality
segura I-Claim HighQuality
como I-Claim HighQuality
la I-Claim HighQuality
cirugía I-Claim HighQuality
CON I-Claim HighQuality
. I-Claim HighQuality

La O -
ventaja O -
más O -
evidente O -
de O -
la O -
técnica O -
mínimamente O -
invasiva O -
es O -
la O -
mejora O -
de O -
la O -
cosmética. O -

Este O -
análisis O -
de O -
los O -
resultados O -
de O -
un O -
ensayo O -
aleatorio O -
y O -
controlado O -
que O -
evalúa O -
los O -
efectos O -
del O -
tratamiento O -
con O -
epoetina O -
alfa O -
( O -
EPO O -
) O -
sobre O -
las O -
necesidades O -
de O -
transfusión, O -
la O -
hemoglobina O -
( O -
Hb O -
) O -
y O -
la O -
calidad O -
de O -
vida O -
( O -
QOL O -
) O -
en O -
pacientes O -
con O -
cáncer O -
que O -
reciben O -
quimioterapia O -
basada O -
en O -
el O -
platino O -
se O -
realizó O -
para O -
evaluar O -
el O -
efecto O -
del O -
nivel O -
inicial O -
de O -
Hb O -
en O -
los O -
resultados O -
del O -
estudio O -
. O -

Los O -
pacientes O -
con O -
niveles O -
de O -
Hb O -
< O -
o O -
=12,1 O -
g/dl O -
fueron O -
aleatorizados O -
2:1 O -
para O -
recibir O -
EPO O -
, O -
10.000 O -
U O -
tres O -
veces O -
por O -
semana O -
s.c. O -
o O -
el O -
mejor O -
cuidado O -
de O -
apoyo O -
( O -
BSC O -
) O -
hasta O -
4 O -
semanas O -
después O -
de O -
su O -
último O -
ciclo O -
de O -
quimioterapia O -
. O -

Para O -
este O -
análisis, O -
se O -
estratificó O -
a O -
los O -
pacientes O -
según O -
el O -
nivel O -
inicial O -
de O -
Hb O -
( O -
< O -
o O -
=9,7 O -
g/dl O -
, O -
> O -
9,7 O -
g/dl O -
a O -
< O -
o O -
=10,5 O -
g/dl O -
, O -
> O -
10,5 O -
g/dl O -
a O -
< O -
o O -
=11,3 O -
g/dl O -
, O -
y O -
> O -
11,3 O -
g/dl O -
a O -
< O -
o O -
=12,1 O -
g/dl O -
) O -
y O -
se O -
volvieron O -
a O -
analizar O -
los O -
resultados O -
del O -
estudio. O -

Un B-Premise HighQuality
número I-Premise HighQuality
significativamente I-Premise HighQuality
menor I-Premise HighQuality
de I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
EPO I-Premise HighQuality
que I-Premise HighQuality
con I-Premise HighQuality
BSC I-Premise HighQuality
con I-Premise HighQuality
niveles I-Premise HighQuality
iniciales I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
> I-Premise HighQuality
9,7 I-Premise HighQuality
g/dl I-Premise HighQuality
a I-Premise HighQuality
< I-Premise HighQuality
o I-Premise HighQuality
=12,1 I-Premise HighQuality
g/dl I-Premise HighQuality
requirieron I-Premise HighQuality
transfusiones I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
EPO I-Premise HighQuality
mantuvo I-Premise HighQuality
los I-Premise HighQuality
niveles I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
a I-Premise HighQuality
lo I-Premise HighQuality
largo I-Premise HighQuality
del I-Premise HighQuality
estudio I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
niveles I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
> I-Premise HighQuality
11,3 I-Premise HighQuality
g/dl I-Premise HighQuality
a I-Premise HighQuality
< I-Premise HighQuality
o I-Premise HighQuality
=12,1 I-Premise HighQuality
g/dl I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
disminución I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
BSC I-Premise HighQuality
. I-Premise HighQuality

Para B-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
niveles I-Premise HighQuality
basales I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
> I-Premise HighQuality
10,5 I-Premise HighQuality
g/dl I-Premise HighQuality
, I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
se I-Premise HighQuality
midieron I-Premise HighQuality
los I-Premise HighQuality
cambios I-Premise HighQuality
medios I-Premise HighQuality
desde I-Premise HighQuality
el I-Premise HighQuality
punto I-Premise HighQuality
de I-Premise HighQuality
partida I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
última I-Premise HighQuality
evaluación I-Premise HighQuality
mediante I-Premise HighQuality
las I-Premise HighQuality
evaluaciones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
Escala I-Premise HighQuality
Analógica I-Premise HighQuality
Lineal I-Premise HighQuality
del I-Premise HighQuality
Cáncer I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
energía I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
general, I-Premise HighQuality
así I-Premise HighQuality
como I-Premise HighQuality
mediante I-Premise HighQuality
la I-Premise HighQuality
Evaluación I-Premise HighQuality
Funcional I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
Terapia I-Premise HighQuality
del I-Premise HighQuality
Cáncer I-Premise HighQuality
( I-Premise HighQuality
FACT I-Premise HighQuality
) I-Premise HighQuality
-Fatiga I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
subescala I-Premise HighQuality
FACT-Anemia I-Premise HighQuality
, I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
fueron I-Premise HighQuality
significativamente I-Premise HighQuality
mayores I-Premise HighQuality
con I-Premise HighQuality
EPO I-Premise HighQuality
que I-Premise HighQuality
con I-Premise HighQuality
BSC I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
CdV I-Premise HighQuality
disminuyó I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
BSC I-Premise HighQuality
, I-Premise HighQuality
y O -
las B-Premise HighQuality
disminuciones I-Premise HighQuality
medias I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
CdV I-Premise HighQuality
fueron I-Premise HighQuality
mayores I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
de I-Premise HighQuality
BSC I-Premise HighQuality
con I-Premise HighQuality
niveles I-Premise HighQuality
basales I-Premise HighQuality
de I-Premise HighQuality
Hb I-Premise HighQuality
> I-Premise HighQuality
10,5 I-Premise HighQuality
g/dl I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
general I-Premise HighQuality
de I-Premise HighQuality
BSC I-Premise HighQuality
. I-Premise HighQuality

En B-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
que I-Claim HighQuality
reciben I-Claim HighQuality
quimioterapia I-Claim HighQuality
basada I-Claim HighQuality
en I-Claim HighQuality
platino I-Claim HighQuality
y I-Claim HighQuality
con I-Claim HighQuality
niveles I-Claim HighQuality
de I-Claim HighQuality
Hb I-Claim HighQuality
basales I-Claim HighQuality
> I-Claim HighQuality
10,5 I-Claim HighQuality
g/dl I-Claim HighQuality
, I-Claim HighQuality
la I-Claim HighQuality
intervención I-Claim HighQuality
temprana I-Claim HighQuality
con I-Claim HighQuality
EPO I-Claim HighQuality
reduce I-Claim HighQuality
las I-Claim HighQuality
transfusiones I-Claim HighQuality
, I-Claim HighQuality
mantiene I-Claim HighQuality
el I-Claim HighQuality
nivel I-Claim HighQuality
de I-Claim HighQuality
Hb I-Claim HighQuality
, I-Claim HighQuality
y I-Claim HighQuality
mantiene I-Claim HighQuality
o I-Claim HighQuality
mejora I-Claim HighQuality
la I-Claim HighQuality
CdV I-Claim HighQuality
. I-Claim HighQuality

Este B-Claim HighQuality
estudio I-Claim HighQuality
apoya I-Claim HighQuality
los I-Claim HighQuality
efectos I-Claim HighQuality
positivos I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
intervención I-Claim HighQuality
temprana I-Claim HighQuality
cuando I-Claim HighQuality
se I-Claim HighQuality
analiza I-Claim HighQuality
según I-Claim HighQuality
el I-Claim HighQuality
valor I-Claim HighQuality
inicial I-Claim HighQuality
de I-Claim HighQuality
Hb I-Claim HighQuality
. I-Claim HighQuality

Se B-Claim HighQuality
desconoce I-Claim HighQuality
hasta I-Claim HighQuality
qué I-Claim HighQuality
punto I-Claim HighQuality
la I-Claim HighQuality
quimioterapia I-Claim HighQuality
puede I-Claim HighQuality
aliviar I-Claim HighQuality
los I-Claim HighQuality
síntomas I-Claim HighQuality
relacionados I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
tumor, I-Claim HighQuality
mejorar I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
y I-Claim HighQuality
prolongar I-Claim HighQuality
la I-Claim HighQuality
supervivencia I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
gástrico, I-Claim HighQuality
a I-Claim HighQuality
pesar I-Claim HighQuality
del I-Claim HighQuality
amplio I-Claim HighQuality
uso I-Claim HighQuality
de I-Claim HighQuality
esta I-Claim HighQuality
modalidad I-Claim HighQuality
de I-Claim HighQuality
tratamiento. I-Claim HighQuality

El O -
objetivo O -
de O -
este O -
estudio O -
era O -
estimar O -
la O -
ganancia O -
en O -
cantidad O -
y O -
calidad O -
de O -
vida O -
que O -
produce O -
la O -
quimioterapia O -
en O -
estos O -
pacientes O -
. O -

Entre O -
enero O -
de O -
1991 O -
y O -
febrero O -
de O -
1995, O -
61 O -
pacientes O -
con O -
cáncer O -
gástrico O -
fueron O -
asignados O -
aleatoriamente O -
a O -
quimioterapia O -
además O -
de O -
los O -
mejores O -
cuidados O -
de O -
apoyo O -
o O -
a O -
los O -
mejores O -
cuidados O -
de O -
apoyo. O -

En O -
este O -
último O -
grupo O -
se O -
permitió O -
la O -
quimioterapia O -
si O -
las O -
medidas O -
de O -
apoyo O -
no O -
conducían O -
a O -
la O -
paliación O -
. O -

La O -
quimioterapia O -
fue O -
el O -
régimen O -
ELF, O -
consistente O -
en O -
5-fluorouracilo, O -
leucovorina O -
y O -
etopósido, O -
o, O -
en O -
los O -
pacientes O -
de O -
edad O -
avanzada O -
y O -
con O -
bajo O -
rendimiento, O -
un O -
régimen O -
de O -
5-fluorouracilo/leucovorina O -
( O -
FLv O -
) O -
. O -

La O -
calidad O -
de O -
vida O -
se O -
evaluó O -
con O -
el O -
instrumento O -
EORTC-QLQ-C30 O -
. O -

Más B-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
quimioterapia I-Premise HighQuality
( I-Premise HighQuality
45 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
14/31 I-Premise HighQuality
) I-Premise HighQuality
tuvieron I-Premise HighQuality
una I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
mejorada I-Premise HighQuality
o I-Premise HighQuality
prolongada I-Premise HighQuality
durante I-Premise HighQuality
un I-Premise HighQuality
periodo I-Premise HighQuality
mínimo I-Premise HighQuality
de I-Premise HighQuality
4 I-Premise HighQuality
meses I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
mejores I-Premise HighQuality
cuidados I-Premise HighQuality
de I-Premise HighQuality
apoyo I-Premise HighQuality
( I-Premise HighQuality
20 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
6/30 I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,05 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observó I-Premise HighQuality
una I-Premise HighQuality
diferencia I-Premise HighQuality
similar I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
evaluación I-Premise HighQuality
del I-Premise HighQuality
médico I-Premise HighQuality
tratante I-Premise HighQuality
sobre I-Premise HighQuality
si I-Premise HighQuality
el I-Premise HighQuality
paciente I-Premise HighQuality
había I-Premise HighQuality
mejorado I-Premise HighQuality
subjetivamente I-Premise HighQuality
o I-Premise HighQuality
seguía I-Premise HighQuality
estando I-Premise HighQuality
bien I-Premise HighQuality
durante I-Premise HighQuality
al I-Premise HighQuality
menos I-Premise HighQuality
4 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
17/31 I-Premise HighQuality
, I-Premise HighQuality
55 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6/30 I-Premise HighQuality
, I-Premise HighQuality
20 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
mayor I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
quimioterapia I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
8 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5 I-Premise HighQuality
meses I-Premise HighQuality
) I-Premise HighQuality
aunque B-Premise HighQuality
la I-Premise HighQuality
diferencia I-Premise HighQuality
no I-Premise HighQuality
fue I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativa I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,12 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Sin B-Premise HighQuality
embargo, I-Premise HighQuality
tras I-Premise HighQuality
las I-Premise HighQuality
correcciones I-Premise HighQuality
por I-Premise HighQuality
desequilibrios I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
características I-Premise HighQuality
previas I-Premise HighQuality
al I-Premise HighQuality
tratamiento, I-Premise HighQuality
el I-Premise HighQuality
tratamiento I-Premise HighQuality
con I-Premise HighQuality
quimioterapia I-Premise HighQuality
se I-Premise HighQuality
asoció I-Premise HighQuality
con I-Premise HighQuality
un I-Premise HighQuality
beneficio I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,003 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Además, B-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
ajustado I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
fueron I-Premise HighQuality
más I-Premise HighQuality
largos I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asignados I-Premise HighQuality
al I-Premise HighQuality
azar I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
quimioterapia I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
5 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
2 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,03 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los B-Claim HighQuality
resultados I-Claim HighQuality
muestran I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
quimioterapia I-Claim HighQuality
puede I-Claim HighQuality
aumentar I-Claim HighQuality
la I-Claim HighQuality
cantidad I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
en I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
gástrico I-Claim HighQuality
avanzado. I-Claim HighQuality

Sin B-Claim HighQuality
embargo, I-Claim HighQuality
el I-Claim HighQuality
número I-Claim HighQuality
de I-Claim HighQuality
pacientes I-Claim HighQuality
que I-Claim HighQuality
se I-Claim HighQuality
benefician I-Claim HighQuality
del I-Claim HighQuality
tratamiento I-Claim HighQuality
es I-Claim HighQuality
todavía I-Claim HighQuality
bastante I-Claim HighQuality
limitado. I-Claim HighQuality

La B-Claim HighQuality
colectomía I-Claim HighQuality
asistida I-Claim HighQuality
por I-Claim HighQuality
laparoscopia I-Claim HighQuality
( I-Claim HighQuality
LAC I-Claim HighQuality
) I-Claim HighQuality
ha I-Claim HighQuality
surgido I-Claim HighQuality
como I-Claim HighQuality
la I-Claim HighQuality
estrategia I-Claim HighQuality
quirúrgica I-Claim HighQuality
mínimamente I-Claim HighQuality
invasiva I-Claim HighQuality
preferida I-Claim HighQuality
para I-Claim HighQuality
las I-Claim HighQuality
enfermedades I-Claim HighQuality
del I-Claim HighQuality
colon I-Claim HighQuality
. I-Claim HighQuality

Se B-Claim HighQuality
desconocen I-Claim HighQuality
la I-Claim HighQuality
seguridad I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
eficacia I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
CAV I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
colon, I-Claim HighQuality
así O -
como O -
la B-Claim HighQuality
naturaleza I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
magnitud I-Claim HighQuality
de I-Claim HighQuality
cualquier I-Claim HighQuality
beneficio I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
( I-Claim HighQuality
QOL I-Claim HighQuality
) I-Claim HighQuality
resultante I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
CAV I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
colon. I-Claim HighQuality

Comparar O -
los O -
resultados O -
de O -
la O -
calidad O -
de O -
vida O -
a O -
corto O -
plazo O -
después O -
de O -
la O -
LAC O -
frente O -
a O -
la O -
colectomía O -
abierta O -
para O -
el O -
cáncer O -
de O -
colon. O -

Ensayo O -
controlado O -
multicéntrico O -
y O -
aleatorizado O -
( O -
Clinical O -
Outcomes O -
of O -
Surgical O -
Therapy O -
[ O -
COST O -
] O -
) O -
. O -

Entre O -
septiembre O -
de O -
1994 O -
y O -
febrero O -
de O -
1999, O -
37 O -
de O -
48 O -
centros O -
proporcionaron O -
datos O -
para O -
el O -
componente O -
de O -
calidad O -
de O -
vida O -
del O -
ensayo O -
para O -
449 O -
pacientes O -
consecutivos O -
con O -
cáncer O -
de O -
colon O -
clínicamente O -
resecable. O -

Puntuaciones O -
en O -
la O -
Escala O -
de O -
Sintomatología O -
( O -
SDS O -
) O -
, O -
Índice O -
de O -
Calidad O -
de O -
Vida O -
, O -
y O -
una O -
escala O -
de O -
calificación O -
global O -
de O -
un O -
solo O -
ítem O -
a O -
los O -
2 O -
días O -
, O -
2 O -
semanas O -
y O -
2 O -
meses O -
del O -
postoperatorio O -
; O -
duración O -
del O -
uso O -
de O -
analgésicos O -
postoperatorios O -
en O -
el O -
hospital O -
; O -
y O -
duración O -
de O -
la O -
estancia O -
. O -

De O -
449 O -
pacientes, O -
428 O -
proporcionaron O -
datos O -
sobre O -
la O -
calidad O -
de O -
vida. O -

En B-Premise HighQuality
un I-Premise HighQuality
análisis I-Premise HighQuality
por I-Premise HighQuality
intención I-Premise HighQuality
de I-Premise HighQuality
tratar I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
que I-Premise HighQuality
se I-Premise HighQuality
compararon I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
intensidad I-Premise HighQuality
del I-Premise HighQuality
dolor I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SDS, I-Premise HighQuality
el I-Premise HighQuality
resumen I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SDS, I-Premise HighQuality
el I-Premise HighQuality
resumen I-Premise HighQuality
del I-Premise HighQuality
índice I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
escala I-Premise HighQuality
de I-Premise HighQuality
calificación I-Premise HighQuality
global I-Premise HighQuality
en I-Premise HighQuality
cada I-Premise HighQuality
punto I-Premise HighQuality
temporal, I-Premise HighQuality
la I-Premise HighQuality
única I-Premise HighQuality
diferencia I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativa I-Premise HighQuality
observada I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
fue I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
escala I-Premise HighQuality
de I-Premise HighQuality
calificación I-Premise HighQuality
global I-Premise HighQuality
a I-Premise HighQuality
las I-Premise HighQuality
2 I-Premise HighQuality
semanas I-Premise HighQuality
del I-Premise HighQuality
postoperatorio. I-Premise HighQuality

Las B-Premise HighQuality
puntuaciones I-Premise HighQuality
medias I-Premise HighQuality
( I-Premise HighQuality
mediana I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
escala I-Premise HighQuality
de I-Premise HighQuality
valoración I-Premise HighQuality
global I-Premise HighQuality
a I-Premise HighQuality
las I-Premise HighQuality
2 I-Premise HighQuality
semanas I-Premise HighQuality
del I-Premise HighQuality
postoperatorio I-Premise HighQuality
fueron I-Premise HighQuality
de I-Premise HighQuality
76,9 I-Premise HighQuality
( I-Premise HighQuality
80 I-Premise HighQuality
) I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
LAC I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
74,4 I-Premise HighQuality
( I-Premise HighQuality
75 I-Premise HighQuality
) I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
colectomía I-Premise HighQuality
abierta I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,009 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Durante B-Premise HighQuality
su I-Premise HighQuality
estancia I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
hospital, I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asignados I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
CAV I-Premise HighQuality
necesitaron I-Premise HighQuality
menos I-Premise HighQuality
días I-Premise HighQuality
de I-Premise HighQuality
analgésicos I-Premise HighQuality
parenterales I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
asignados I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
colectomía I-Premise HighQuality
abierta I-Premise HighQuality
( I-Premise HighQuality
media I-Premise HighQuality
[ I-Premise HighQuality
mediana I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
3,2 I-Premise HighQuality
[ I-Premise HighQuality
3 I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
4,0 I-Premise HighQuality
[ I-Premise HighQuality
4 I-Premise HighQuality
] I-Premise HighQuality
días I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
< I-Premise HighQuality
0,001 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
analgésicos I-Premise HighQuality
orales I-Premise HighQuality
( I-Premise HighQuality
media I-Premise HighQuality
[ I-Premise HighQuality
mediana I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
1,9 I-Premise HighQuality
[ I-Premise HighQuality
1 I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
2,2 I-Premise HighQuality
[ I-Premise HighQuality
2 I-Premise HighQuality
] I-Premise HighQuality
días I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,03 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Sólo B-Claim HighQuality
se I-Claim HighQuality
encontraron I-Claim HighQuality
beneficios I-Claim HighQuality
mínimos I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
CdV I-Claim HighQuality
a I-Claim HighQuality
corto I-Claim HighQuality
plazo I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
colon I-Claim HighQuality
en I-Claim HighQuality
comparación I-Claim HighQuality
con I-Claim HighQuality
la I-Claim HighQuality
colectomía I-Claim HighQuality
abierta I-Claim HighQuality
estándar. I-Claim HighQuality

Hasta B-Claim HighQuality
que I-Claim HighQuality
los I-Claim HighQuality
ensayos I-Claim HighQuality
en I-Claim HighQuality
curso I-Claim HighQuality
establezcan I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
LAC I-Claim HighQuality
es I-Claim HighQuality
tan I-Claim HighQuality
eficaz I-Claim HighQuality
como I-Claim HighQuality
la I-Claim HighQuality
colectomía I-Claim HighQuality
abierta I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
prevención I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
recurrencia I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
muerte I-Claim HighQuality
por I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
colon I-Claim HighQuality
, I-Claim HighQuality
este I-Claim HighQuality
procedimiento I-Claim HighQuality
no I-Claim HighQuality
debe I-Claim HighQuality
ofrecerse I-Claim HighQuality
a I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
colon I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
impacto I-Claim HighQuality
del I-Claim HighQuality
hipertiroidismo I-Claim HighQuality
subclínico I-Claim HighQuality
prolongado I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
no I-Claim HighQuality
está I-Claim HighQuality
claro. I-Claim HighQuality

Por O -
lo O -
tanto O -
, O -
se O -
evaluó O -
la O -
calidad O -
de O -
vida O -
en O -
pacientes O -
con O -
carcinoma O -
diferenciado O -
de O -
tiroides O -
( O -
DTC O -
) O -
en O -
la O -
terapia O -
de O -
tiroxina O -
supresora O -
de O -
TSH O -
como O -
un O -
modelo O -
para O -
el O -
hipertiroidismo O -
subclínico O -
y O -
se O -
investigó O -
si O -
la O -
restauración O -
al O -
eutiroidismo O -
afecta O -
a O -
la O -
calidad O -
de O -
vida O -
. O -

Se O -
realizó O -
un O -
ensayo O -
prospectivo, O -
a O -
ciegas, O -
controlado O -
con O -
placebo O -
y O -
aleatorizado O -
de O -
6 O -
meses O -
de O -
duración O -
con O -
dos O -
grupos O -
paralelos. O -

Veinticuatro O -
sujetos O -
con O -
antecedentes O -
de O -
carcinoma O -
diferenciado O -
de O -
tiroides O -
con O -
> O -
10 O -
años O -
de O -
tratamiento O -
supresor O -
de O -
la O -
TSH O -
con O -
L-tiroxina O -
completaron O -
el O -
estudio O -
. O -

La O -
dosis O -
de O -
L-tiroxina O -
se O -
sustituyó O -
por O -
la O -
medicación O -
del O -
estudio O -
que O -
contenía O -
L-tiroxina O -
o O -
L-tiroxina O -
más O -
placebo O -
. O -

La O -
medicación O -
se O -
tituló O -
para O -
establecer O -
la O -
continuación O -
de O -
la O -
supresión O -
de O -
la O -
TSH O -
(grupo O -
de O -
baja O -
TSH) O -
y O -
el O -
eutiroidismo O -
(grupo O -
eutiroideo). O -

Ambos O -
grupos O -
estaban O -
formados O -
por O -
12 O -
pacientes. O -

Se O -
evaluó O -
la O -
calidad O -
de O -
vida O -
mediante O -
cinco O -
cuestionarios O -
validados. O -

En O -
la O -
línea O -
de O -
base O -
, O -
el O -
cuestionario O -
de O -
trastornos O -
somáticos O -
( O -
SDQ O -
) O -
indicó O -
más O -
disfunción O -
somática O -
en O -
los O -
pacientes O -
en O -
comparación O -
con O -
los O -
valores O -
de O -
referencia O -
, O -
mientras O -
que O -
la O -
puntuación O -
de O -
la O -
depresión O -
( O -
HADS O -
) O -
reveló O -
una O -
mejor O -
puntuación O -
que O -
el O -
grupo O -
de O -
referencia O -
. O -

Todos O -
los O -
demás O -
parámetros O -
de O -
calidad O -
de O -
vida O -
eran O -
normales. O -

En O -
la O -
línea O -
de O -
base, O -
no O -
se O -
observaron O -
diferencias O -
significativas O -
entre O -
los O -
grupos O -
de O -
bajo O -
TSH O -
y O -
de O -
eutiroidismo. O -

Después B-Premise HighQuality
de I-Premise HighQuality
6 I-Premise HighQuality
meses, I-Premise HighQuality
ninguno I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
parámetros I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
baja I-Premise HighQuality
HTA I-Premise HighQuality
era I-Premise HighQuality
diferente I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
valores I-Premise HighQuality
iniciales. I-Premise HighQuality

En B-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
eutiroideo I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
motivación I-Premise HighQuality
mejoró I-Premise HighQuality
significativamente I-Premise HighQuality
( I-Premise HighQuality
Índice I-Premise HighQuality
de I-Premise HighQuality
Fatiga I-Premise HighQuality
Multidimensional-20 I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,003 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
aunque B-Premise HighQuality
este I-Premise HighQuality
parámetro I-Premise HighQuality
no I-Premise HighQuality
difirió I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
referencia I-Premise HighQuality
al I-Premise HighQuality
inicio I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observó I-Premise HighQuality
un I-Premise HighQuality
probable I-Premise HighQuality
empeoramiento I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
limitaciones I-Premise HighQuality
de I-Premise HighQuality
rol I-Premise HighQuality
como I-Premise HighQuality
consecuencia I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
problemas I-Premise HighQuality
físicos I-Premise HighQuality
( I-Premise HighQuality
Short I-Premise HighQuality
Form-36 I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,050 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observó I-Premise HighQuality
ninguna I-Premise HighQuality
mejora I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
del I-Premise HighQuality
SDQ. I-Premise HighQuality

En B-Claim HighQuality
resumen, I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
DTC I-Claim HighQuality
y I-Claim HighQuality
con I-Claim HighQuality
hipertiroidismo I-Claim HighQuality
subclínico I-Claim HighQuality
de I-Claim HighQuality
larga I-Claim HighQuality
duración I-Claim HighQuality
en I-Claim HighQuality
general I-Claim HighQuality
está I-Claim HighQuality
preservada. I-Claim HighQuality

La B-Claim HighQuality
restauración I-Claim HighQuality
del I-Claim HighQuality
eutiroidismo I-Claim HighQuality
en I-Claim HighQuality
general I-Claim HighQuality
no I-Claim HighQuality
afecta I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
. I-Claim HighQuality

La O -
mayoría O -
de O -
los O -
pacientes O -
con O -
glioblastoma O -
son O -
mayores O -
de O -
60 O -
años, O -
pero O -
las O -
directrices O -
de O -
tratamiento O -
se O -
basan O -
en O -
ensayos O -
realizados O -
en O -
pacientes O -
de O -
hasta O -
70 O -
años. O -

Realizamos O -
un O -
ensayo O -
aleatorio O -
para O -
evaluar O -
el O -
tratamiento O -
paliativo O -
óptimo O -
en O -
pacientes O -
de O -
60 O -
años O -
o O -
más O -
con O -
glioblastoma O -
. O -

Se O -
reclutaron O -
pacientes O -
con O -
glioblastoma O -
recién O -
diagnosticado O -
en O -
Austria, O -
Dinamarca, O -
Francia, O -
Noruega, O -
Suecia, O -
Suiza O -
y O -
Turquía. O -

Fueron O -
asignados O -
mediante O -
un O -
programa O -
de O -
aleatorización O -
generado O -
por O -
ordenador O -
, O -
estratificado O -
por O -
centro O -
, O -
a O -
recibir O -
temozolomida O -
( O -
200 O -
mg/m O -
( O -
2 O -
) O -
en O -
los O -
días O -
1-5 O -
de O -
cada O -
28 O -
días O -
durante O -
un O -
máximo O -
de O -
seis O -
ciclos O -
) O -
, O -
radioterapia O -
hipofraccionada O -
( O -
34-0 O -
Gy O -
administrados O -
en O -
fracciones O -
de O -
3-4 O -
Gy O -
durante O -
2 O -
semanas O -
) O -
, O -
o O -
radioterapia O -
estándar O -
( O -
60-0 O -
Gy O -
administrados O -
en O -
fracciones O -
de O -
2-0 O -
Gy O -
durante O -
6 O -
semanas O -
) O -
. O -

Los O -
pacientes O -
y O -
el O -
personal O -
del O -
estudio O -
conocían O -
la O -
asignación O -
del O -
tratamiento. O -

El O -
criterio O -
de O -
valoración O -
principal O -
fue O -
la O -
supervivencia O -
global. O -

Los O -
análisis O -
se O -
realizaron O -
por O -
intención O -
de O -
tratar. O -

Este O -
ensayo O -
está O -
registrado O -
con O -
el O -
número O -
ISRCTN81470623. O -

Se O -
inscribieron O -
342 O -
pacientes, O -
de O -
los O -
cuales O -
291 O -
fueron O -
aleatorizados O -
en O -
tres O -
grupos O -
de O -
tratamiento O -
( O -
temozolomida O -
n=93 O -
, O -
radioterapia O -
hipofraccionada O -
n=98 O -
, O -
radioterapia O -
estándar O -
n=100 O -
) O -
y O -
51 O -
de O -
ellos O -
fueron O -
aleatorizados O -
en O -
sólo O -
dos O -
grupos O -
( O -
temozolomida O -
n=26 O -
, O -
radioterapia O -
hipofraccionada O -
n=25 O -
) O -
. O -

En B-Premise HighQuality
la I-Premise HighQuality
aleatorización I-Premise HighQuality
de I-Premise HighQuality
tres I-Premise HighQuality
grupos, I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
estándar, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
mayor I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
temozolomida I-Premise HighQuality
( I-Premise HighQuality
8-3 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
7-1-9-5 I-Premise HighQuality
; I-Premise HighQuality
n=93 I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
6-0 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
5-1-6-8 I-Premise HighQuality
; I-Premise HighQuality
n=100 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
hazard I-Premise HighQuality
ratio I-Premise HighQuality
[ I-Premise HighQuality
HR I-Premise HighQuality
] I-Premise HighQuality
0-70 I-Premise HighQuality
; I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
0-52-0-93 I-Premise HighQuality
, I-Premise HighQuality
p=0-01 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
pero I-Premise HighQuality
no I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
hipofraccionada I-Premise HighQuality
( I-Premise HighQuality
7-5 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
6-5-8-6 I-Premise HighQuality
; I-Premise HighQuality
n=98 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
HR I-Premise HighQuality
0-85 I-Premise HighQuality
[ I-Premise HighQuality
0-64-1-12 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
p=0-24 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Para B-Premise HighQuality
todos I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
temozolomida I-Premise HighQuality
o I-Premise HighQuality
radioterapia I-Premise HighQuality
hipofraccionada I-Premise HighQuality
( I-Premise HighQuality
n=242 I-Premise HighQuality
) I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
similar I-Premise HighQuality
( I-Premise HighQuality
8-4 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
7-3-9-4 I-Premise HighQuality
; I-Premise HighQuality
n=119 I-Premise HighQuality
] I-Premise HighQuality
vs I-Premise HighQuality
7-4 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
6-4-8-4 I-Premise HighQuality
; I-Premise HighQuality
n=123 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
HR I-Premise HighQuality
0-82 I-Premise HighQuality
, I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
0-63-1-06 I-Premise HighQuality
; I-Premise HighQuality
p=0-12 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Para B-Premise HighQuality
los I-Premise HighQuality
mayores I-Premise HighQuality
de I-Premise HighQuality
70 I-Premise HighQuality
años, I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
fue I-Premise HighQuality
mejor I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
temozolomida I-Premise HighQuality
y I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
hipofraccionada I-Premise HighQuality
que I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
estándar I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
temozolomida I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
estándar I-Premise HighQuality
0-35 I-Premise HighQuality
[ I-Premise HighQuality
0-21-0-56 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0-0001 I-Premise HighQuality
; I-Premise HighQuality
HR I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
radioterapia I-Premise HighQuality
hipofraccionada I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
estándar I-Premise HighQuality
0-59 I-Premise HighQuality
[ I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
0-37-0-93 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
p=0-02 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
pacientes I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
temozolomida I-Premise HighQuality
que I-Premise HighQuality
tenían I-Premise HighQuality
metilación I-Premise HighQuality
del I-Premise HighQuality
promotor I-Premise HighQuality
de I-Premise HighQuality
MGMT I-Premise HighQuality
del I-Premise HighQuality
tumor I-Premise HighQuality
tuvieron I-Premise HighQuality
una I-Premise HighQuality
supervivencia I-Premise HighQuality
significativamente I-Premise HighQuality
mayor I-Premise HighQuality
que I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
no I-Premise HighQuality
tenían I-Premise HighQuality
metilación I-Premise HighQuality
del I-Premise HighQuality
promotor I-Premise HighQuality
de I-Premise HighQuality
MGMT I-Premise HighQuality
( I-Premise HighQuality
9-7 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
8-0-11-4 I-Premise HighQuality
] I-Premise HighQuality
vs I-Premise HighQuality
6-8 I-Premise HighQuality
meses I-Premise HighQuality
[ I-Premise HighQuality
5-9-7-7 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
HR I-Premise HighQuality
0-56 I-Premise HighQuality
[ I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
0-34-0-93 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
p=0-02 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
pero I-Premise HighQuality
no I-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
tenían I-Premise HighQuality
el I-Premise HighQuality
promotor I-Premise HighQuality
de I-Premise HighQuality
MGMT I-Premise HighQuality
metilado I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
metilado I-Premise HighQuality
tratados I-Premise HighQuality
con I-Premise HighQuality
radioterapia I-Premise HighQuality
( I-Premise HighQuality
HR I-Premise HighQuality
0-97 I-Premise HighQuality
[ I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
0-69-1-38 I-Premise HighQuality
] I-Premise HighQuality
; I-Premise HighQuality
p=0-81 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Como O -
era O -
de O -
esperar, O -
los B-Premise HighQuality
acontecimientos I-Premise HighQuality
adversos I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3-4 I-Premise HighQuality
más I-Premise HighQuality
comunes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
temozolomida I-Premise HighQuality
fueron I-Premise HighQuality
la I-Premise HighQuality
neutropenia I-Premise HighQuality
( I-Premise HighQuality
n=12 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
trombocitopenia I-Premise HighQuality
( I-Premise HighQuality
n=18 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
notificaron I-Premise HighQuality
infecciones I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3-5 I-Premise HighQuality
en I-Premise HighQuality
todos I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
aleatorización I-Premise HighQuality
en I-Premise HighQuality
18 I-Premise HighQuality
pacientes I-Premise HighQuality
. I-Premise HighQuality

Dos B-Premise HighQuality
pacientes I-Premise HighQuality
tuvieron I-Premise HighQuality
infecciones I-Premise HighQuality
mortales I-Premise HighQuality
( I-Premise HighQuality
uno I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
temozolomida I-Premise HighQuality
y I-Premise HighQuality
otro I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
radioterapia I-Premise HighQuality
estándar I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
uno I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
temozolomida I-Premise HighQuality
con I-Premise HighQuality
trombocitopenia I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
2 I-Premise HighQuality
murió I-Premise HighQuality
por I-Premise HighQuality
complicaciones I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
cirugía I-Premise HighQuality
por I-Premise HighQuality
una I-Premise HighQuality
hemorragia I-Premise HighQuality
gastrointestinal I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
radioterapia I-Claim HighQuality
estándar I-Claim HighQuality
se I-Claim HighQuality
asoció I-Claim HighQuality
con I-Claim HighQuality
malos I-Claim HighQuality
resultados, I-Claim HighQuality
especialmente I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
mayores I-Claim HighQuality
de I-Claim HighQuality
70 I-Claim HighQuality
años. I-Claim HighQuality

Tanto B-Claim HighQuality
la I-Claim HighQuality
temozolomida I-Claim HighQuality
como I-Claim HighQuality
la I-Claim HighQuality
radioterapia I-Claim HighQuality
hipofraccionada I-Claim HighQuality
deben I-Claim HighQuality
considerarse I-Claim HighQuality
como I-Claim HighQuality
opciones I-Claim HighQuality
de I-Claim HighQuality
tratamiento I-Claim HighQuality
estándar I-Claim HighQuality
en I-Claim HighQuality
los I-Claim HighQuality
pacientes I-Claim HighQuality
ancianos I-Claim HighQuality
con I-Claim HighQuality
glioblastoma I-Claim HighQuality
. I-Claim HighQuality

El B-Claim HighQuality
estado I-Claim HighQuality
de I-Claim HighQuality
metilación I-Claim HighQuality
del I-Claim HighQuality
promotor I-Claim HighQuality
MGMT I-Claim HighQuality
podría I-Claim HighQuality
ser I-Claim HighQuality
un I-Claim HighQuality
marcador I-Claim HighQuality
predictivo I-Claim HighQuality
útil I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
beneficio I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
temozolomida I-Claim HighQuality
. I-Claim HighQuality

Evaluar O -
la O -
diferencia O -
de O -
eficacia, O -
efectos O -
secundarios O -
y O -
calidad O -
de O -
vida O -
en O -
pacientes O -
con O -
cáncer O -
de O -
pulmón O -
no O -
microcítico O -
avanzado O -
(CPNM) O -
tratados O -
con O -
oxaliplatino O -
más O -
vinorelbina O -
o O -
cisplatino O -
más O -
vinorelbina. O -

Los O -
pacientes O -
elegibles O -
fueron O -
asignados O -
aleatoriamente O -
al O -
grupo O -
NL O -
( O -
oxaliplatino O -
+ O -
vinorelbina O -
) O -
y O -
al O -
grupo O -
NP O -
( O -
cisplatino O -
+ O -
vinorelbina O -
) O -
en O -
una O -
proporción O -
de O -
2:1 O -
. O -

En O -
el O -
grupo O -
NL O -
, O -
70 O -
casos O -
evaluables O -
fueron O -
tratados O -
con O -
oxaliplatino O -
130 O -
mg/m O -
( O -
2 O -
) O -
i.v O -
. O -

el O -
día O -
2 O -
, O -
y O -
vinorelbina O -
25 O -
mg/m O -
( O -
2 O -
) O -
i.v O -
. O -

los O -
días O -
1 O -
y O -
8 O -
en O -
21 O -
días O -
por O -
ciclo O -
. O -

En O -
el O -
grupo O -
NP O -
, O -
32 O -
casos O -
evaluables O -
fueron O -
tratados O -
con O -
cisplatino O -
80 O -
mg/m O -
( O -
2 O -
) O -
i.v O -
. O -

dividido O -
a O -
2 O -
- O -
3 O -
días O -
de O -
dosificación O -
, O -
21 O -
días O -
por O -
ciclo O -
, O -
y O -
vinorelbina O -
administrada O -
por O -
la O -
misma O -
forma O -
que O -
en O -
el O -
grupo O -
NL O -
. O -

Se O -
observó O -
la O -
tasa O -
de O -
respuesta, O -
el O -
tiempo O -
hasta O -
la O -
progresión O -
(TTP), O -
la O -
supervivencia O -
a O -
un O -
año, O -
los O -
efectos O -
secundarios O -
y O -
la O -
calidad O -
de O -
vida. O -

La B-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
respuesta I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
35,7 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
43,8 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,4 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
TTP I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
4,7 I-Premise HighQuality
meses I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
5,5 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,6 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
un I-Premise HighQuality
año I-Premise HighQuality
fue I-Premise HighQuality
del I-Premise HighQuality
38,5 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
al I-Premise HighQuality
58,6 I-Premise HighQuality
% I-Premise HighQuality
( I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,07 I-Premise HighQuality
) I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
NL I-Premise HighQuality
y I-Premise HighQuality
NP I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
toxicidad I-Premise HighQuality
neurosensorial I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
I-II I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
más I-Premise HighQuality
frecuente I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
NL I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
NP I-Premise HighQuality
( I-Premise HighQuality
68,4 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
36,4 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,0017 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Sin B-Premise HighQuality
embargo, I-Premise HighQuality
la I-Premise HighQuality
granulocitopenia I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
I-II I-Premise HighQuality
fue I-Premise HighQuality
significativamente I-Premise HighQuality
menor I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
NL I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
NP I-Premise HighQuality
( I-Premise HighQuality
49,4 I-Premise HighQuality
% I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
70,6 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,037 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
estadísticas I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
grupos I-Premise HighQuality
en I-Premise HighQuality
cuanto I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida. I-Premise HighQuality

Debido B-Claim HighQuality
a I-Claim HighQuality
su I-Claim HighQuality
buena I-Claim HighQuality
eficacia I-Claim HighQuality
y I-Claim HighQuality
tolerabilidad, I-Claim HighQuality
el I-Claim HighQuality
régimen I-Claim HighQuality
NL I-Claim HighQuality
ofreció I-Claim HighQuality
un I-Claim HighQuality
nuevo I-Claim HighQuality
candidato I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
del I-Claim HighQuality
CPNM I-Claim HighQuality
avanzado. I-Claim HighQuality

El O -
restablecimiento O -
de O -
la O -
inervación O -
sensorial O -
puede O -
ser O -
un O -
complemento O -
útil O -
en O -
la O -
reconstrucción O -
de O -
cabeza O -
y O -
cuello O -
con O -
colgajo O -
libre, O -
pero, O -
hasta O -
ahora, O -
no O -
se O -
ha O -
demostrado O -
que O -
mejore O -
los O -
resultados O -
de O -
la O -
reconstrucción O -
mamaria. O -

El O -
estudio O -
anterior O -
de O -
los O -
autores O -
demostró O -
una O -
mejora O -
objetiva O -
de O -
la O -
sensibilidad O -
en O -
un O -
grupo O -
de O -
pacientes O -
de O -
reconstrucción O -
mamaria O -
con O -
colgajo O -
musculocutáneo O -
del O -
recto O -
abdominal O -
transverso O -
(TRAM) O -
inervado O -
en O -
comparación O -
con O -
los O -
colgajos O -
no O -
inervados. O -

Este O -
estudio O -
comparó O -
los O -
resultados O -
calificados O -
por O -
las O -
pacientes O -
de O -
la O -
reconstrucción O -
mamaria O -
TRAM O -
libre O -
en O -
colgajos O -
inervados O -
versus O -
no O -
inervados O -
. O -

Veintisiete O -
mujeres O -
fueron O -
aleatorizadas O -
prospectivamente O -
para O -
someterse O -
a O -
una O -
reconstrucción O -
mamaria O -
con O -
colgajo O -
TRAM O -
libre O -
inervado O -
o O -
no O -
inervado O -
. O -

Para O -
los O -
colgajos O -
inervados, O -
el O -
nervio O -
intercostal O -
T10 O -
se O -
cosechó O -
con O -
el O -
colgajo O -
TRAM O -
y O -
se O -
neurotizó O -
al O -
nervio O -
sensorial O -
T4 O -
en O -
el O -
sitio O -
receptor. O -

Se O -
administraron O -
tres O -
herramientas O -
de O -
resultados O -
validadas O -
después O -
de O -
la O -
cirugía: O -
el O -
Medical O -
Outcomes O -
Study O -
36-Item O -
Short O -
Form O -
Health O -
Survey O -
, O -
el O -
Body O -
Image O -
after O -
Breast O -
Cancer O -
Questionnaire O -
y O -
el O -
Functional O -
Assessment O -
of O -
Cancer O -
Therapy-Breast O -
. O -

Los B-Premise HighQuality
resultados I-Premise HighQuality
se I-Premise HighQuality
correlacionaron I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
resultados I-Premise HighQuality
de I-Premise HighQuality
sensibilidad I-Premise HighQuality
objetiva I-Premise HighQuality
comunicados I-Premise HighQuality
anteriormente. I-Premise HighQuality

Dieciocho O -
de O -
27 O -
mujeres O -
devolvieron O -
sus O -
cuestionarios O -
una O -
media O -
de O -
48 O -
meses O -
después O -
de O -
la O -
reconstrucción O -
con O -
colgajo O -
TRAM O -
libre. O -

El O -
análisis O -
demográfico O -
no O -
reveló O -
diferencias O -
significativas O -
en O -
cuanto O -
a O -
la O -
edad O -
de O -
las O -
pacientes, O -
la O -
altura, O -
el O -
tabaquismo, O -
la O -
radioterapia O -
y O -
la O -
reconstrucción O -
del O -
complejo O -
areola-pezón O -
entre O -
los O -
grupos O -
de O -
pacientes O -
aleatorios. O -

Hubo B-Premise HighQuality
una I-Premise HighQuality
mejora I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativa I-Premise HighQuality
en I-Premise HighQuality
las I-Premise HighQuality
tres I-Premise HighQuality
medidas I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
fueron I-Premise HighQuality
aleatorizados I-Premise HighQuality
para I-Premise HighQuality
recibir I-Premise HighQuality
colgajos I-Premise HighQuality
TRAM I-Premise HighQuality
libres I-Premise HighQuality
inervados I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
los I-Premise HighQuality
que I-Premise HighQuality
recibieron I-Premise HighQuality
colgajos I-Premise HighQuality
no I-Premise HighQuality
inervados I-Premise HighQuality
. I-Premise HighQuality

Este B-Claim HighQuality
estudio I-Claim HighQuality
demuestra I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
inervación I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
colgajos I-Claim HighQuality
TRAM I-Claim HighQuality
libres I-Claim HighQuality
utilizados I-Claim HighQuality
para I-Claim HighQuality
la I-Claim HighQuality
reconstrucción I-Claim HighQuality
mamaria I-Claim HighQuality
no I-Claim HighQuality
sólo I-Claim HighQuality
mejora I-Claim HighQuality
la I-Claim HighQuality
sensibilidad, I-Claim HighQuality
sino I-Claim HighQuality
que I-Claim HighQuality
también I-Claim HighQuality
tiene I-Claim HighQuality
un I-Claim HighQuality
efecto I-Claim HighQuality
positivo I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
calificada I-Claim HighQuality
por I-Claim HighQuality
las I-Claim HighQuality
pacientes. I-Claim HighQuality

A O -
pesar O -
de O -
las O -
mejoras O -
en O -
las O -
técnicas O -
quirúrgicas O -
, O -
la O -
incontinencia O -
urinaria O -
( O -
IU O -
) O -
no O -
es O -
infrecuente O -
después O -
de O -
la O -
prostatectomía O -
radical O -
( O -
PR O -
) O -
, O -
y O -
puede O -
empeorar O -
dramáticamente O -
la O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
. O -

Determinar O -
el O -
beneficio O -
de O -
comenzar O -
a O -
realizar O -
ejercicios O -
para O -
los O -
músculos O -
del O -
suelo O -
pélvico O -
( O -
PFME O -
) O -
30 O -
días O -
antes O -
de O -
la O -
RP O -
y O -
de O -
continuar O -
con O -
los O -
PFME O -
en O -
el O -
postoperatorio O -
para O -
la O -
recuperación O -
temprana O -
de O -
la O -
continencia O -
. O -

Se O -
diseñó O -
un O -
estudio O -
aleatorio O -
y O -
prospectivo. O -

Se O -
incluyeron O -
hombres O -
con O -
cáncer O -
de O -
próstata O -
localizado O -
( O -
PCa O -
) O -
que O -
se O -
sometieron O -
a O -
una O -
prostatectomía O -
radical O -
retropúbica O -
( O -
RRP O -
) O -
abierta O -
en O -
nuestro O -
departamento O -
de O -
urología O -
. O -

Los O -
pacientes O -
fueron O -
asignados O -
aleatoriamente O -
a O -
iniciar O -
la O -
EPF O -
antes O -
de O -
la O -
operación O -
y O -
a O -
continuar O -
en O -
el O -
postoperatorio O -
( O -
grupo O -
activo O -
: O -
A O -
) O -
o O -
a O -
iniciar O -
la O -
EPF O -
sólo O -
en O -
el O -
postoperatorio O -
( O -
grupo O -
de O -
control O -
: O -
B O -
) O -
. O -

La O -
medida O -
de O -
resultado O -
primaria O -
fue O -
la O -
continencia O -
autodeclarada O -
tras O -
la O -
cirugía. O -

Las O -
medidas O -
de O -
resultado O -
secundarias O -
fueron O -
evaluadas O -
por O -
el O -
grado O -
de O -
IU O -
basado O -
en O -
una O -
prueba O -
de O -
almohadillas O -
de O -
24 O -
horas O -
e O -
instrumentos O -
de O -
calidad O -
de O -
vida O -
( O -
Sociedad O -
Internacional O -
de O -
Continencia O -
[ O -
ICS O -
] O -
formulario O -
corto O -
masculino O -
[ O -
SF O -
] O -
) O -
. O -

De O -
los O -
143 O -
hombres O -
evaluados O -
para O -
el O -
estudio, O -
118 O -
fueron O -
asignados O -
aleatoriamente O -
a O -
iniciar O -
la O -
EMSP O -
antes O -
de O -
la O -
operación O -
y O -
continuar O -
después O -
de O -
la O -
misma O -
(grupo O -
A, O -
n=59) O -
o O -
a O -
iniciar O -
la O -
EMSP O -
después O -
de O -
la O -
operación O -
(grupo O -
B, O -
n=59). O -

Después B-Premise HighQuality
de I-Premise HighQuality
1 I-Premise HighQuality
mes, I-Premise HighQuality
el I-Premise HighQuality
44,1% I-Premise HighQuality
( I-Premise HighQuality
26 I-Premise HighQuality
de I-Premise HighQuality
59 I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
eran I-Premise HighQuality
continentes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
A I-Premise HighQuality
, I-Premise HighQuality
mientras I-Premise HighQuality
que I-Premise HighQuality
el I-Premise HighQuality
20,3% I-Premise HighQuality
( I-Premise HighQuality
12 I-Premise HighQuality
de I-Premise HighQuality
59 I-Premise HighQuality
) I-Premise HighQuality
lo I-Premise HighQuality
eran I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
B I-Premise HighQuality
( I-Premise HighQuality
p=0,018 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

A B-Premise HighQuality
los I-Premise HighQuality
3 I-Premise HighQuality
meses, I-Premise HighQuality
el I-Premise HighQuality
59,3% I-Premise HighQuality
( I-Premise HighQuality
35 I-Premise HighQuality
de I-Premise HighQuality
59 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
37,3% I-Premise HighQuality
( I-Premise HighQuality
22 I-Premise HighQuality
de I-Premise HighQuality
59 I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
eran I-Premise HighQuality
continente I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
A I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
B I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
( I-Premise HighQuality
p=0,028 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
puntuación I-Premise HighQuality
media I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
SF I-Premise HighQuality
masculina I-Premise HighQuality
del I-Premise HighQuality
ICS I-Premise HighQuality
mostró I-Premise HighQuality
mejores I-Premise HighQuality
resultados I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
A I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
B I-Premise HighQuality
tanto I-Premise HighQuality
a I-Premise HighQuality
1 I-Premise HighQuality
mes I-Premise HighQuality
( I-Premise HighQuality
14,6 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
18,3 I-Premise HighQuality
) I-Premise HighQuality
como I-Premise HighQuality
a I-Premise HighQuality
3 I-Premise HighQuality
meses I-Premise HighQuality
( I-Premise HighQuality
8,1 I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
12,2 I-Premise HighQuality
) I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
RP I-Premise HighQuality
( I-Premise HighQuality
p=0,002 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

En B-Premise HighQuality
los I-Premise HighQuality
análisis I-Premise HighQuality
de I-Premise HighQuality
regresión I-Premise HighQuality
logística I-Premise HighQuality
ajustados I-Premise HighQuality
por I-Premise HighQuality
edad, I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
que I-Premise HighQuality
realizaron I-Premise HighQuality
una I-Premise HighQuality
PFME I-Premise HighQuality
preoperatoria I-Premise HighQuality
tenían I-Premise HighQuality
un I-Premise HighQuality
riesgo I-Premise HighQuality
0,41 I-Premise HighQuality
veces I-Premise HighQuality
menor I-Premise HighQuality
de I-Premise HighQuality
sufrir I-Premise HighQuality
incontinencia I-Premise HighQuality
un I-Premise HighQuality
mes I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
RP I-Premise HighQuality
y I-Premise HighQuality
un I-Premise HighQuality
riesgo I-Premise HighQuality
0,38 I-Premise HighQuality
veces I-Premise HighQuality
menor I-Premise HighQuality
de I-Premise HighQuality
sufrir I-Premise HighQuality
incontinencia I-Premise HighQuality
tres I-Premise HighQuality
meses I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
RP I-Premise HighQuality
( I-Premise HighQuality
p≤0,001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Claim HighQuality
PFME I-Claim HighQuality
preoperatorio I-Claim HighQuality
puede I-Claim HighQuality
mejorar I-Claim HighQuality
la I-Claim HighQuality
continencia I-Claim HighQuality
temprana I-Claim HighQuality
y I-Claim HighQuality
los I-Claim HighQuality
resultados I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
después I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
RP I-Claim HighQuality
. I-Claim HighQuality

Se B-Claim HighQuality
necesitan I-Claim HighQuality
más I-Claim HighQuality
estudios I-Claim HighQuality
para I-Claim HighQuality
corroborar I-Claim HighQuality
nuestros I-Claim HighQuality
resultados. I-Claim HighQuality

El O -
papel O -
de O -
la O -
quimioterapia O -
en O -
pacientes O -
con O -
CPNM O -
avanzado O -
y O -
ECOG O -
PS2 O -
sigue O -
siendo O -
controvertido O -
. O -

Evaluamos O -
4 O -
dosis O -
de O -
docetaxel O -
de O -
3 O -
semanas O -
para O -
identificar O -
una O -
dosis O -
menos O -
tóxica O -
y O -
clínicamente O -
efectiva. O -

Setenta O -
y O -
tres O -
pacientes O -
con O -
CPNM O -
en O -
estadio O -
III O -
( O -
22 O -
% O -
) O -
( O -
no O -
aptos O -
para O -
cirugía/radioterapia O -
radical O -
) O -
y O -
IV O -
( O -
78 O -
% O -
) O -
fueron O -
asignados O -
al O -
azar O -
para O -
recibir O -
4 O -
dosis O -
de O -
docetaxel O -
cada O -
3 O -
semanas O -
, O -
durante O -
4 O -
ciclos O -
: O -
brazo O -
( O -
A O -
) O -
40 O -
mg/m O -
( O -
2 O -
) O -
( O -
n=17 O -
) O -
, O -
brazo O -
( O -
B O -
) O -
50 O -
mg/m O -
( O -
2 O -
) O -
( O -
n=17 O -
) O -
, O -
brazo O -
( O -
C O -
) O -
60 O -
mg/m O -
( O -
2 O -
) O -
( O -
n=19 O -
) O -
, O -
brazo O -
( O -
D O -
) O -
50 O -
mg/m O -
( O -
2 O -
) O -
escalados O -
en O -
10 O -
mg/m O -
( O -
2 O -
) O -
hasta O -
un O -
máximo O -
de O -
70 O -
mg/m O -
( O -
2 O -
) O -
( O -
n=19 O -
) O -
. O -

Criterios O -
de O -
valoración O -
primarios: O -
dosis O -
máxima O -
tolerada, O -
RR, O -
duración O -
de O -
la O -
respuesta, O -
mejora O -
de O -
los O -
síntomas, O -
toxicidad O -
y O -
calidad O -
de O -
vida. O -

Criterio O -
de O -
valoración O -
secundario: O -
supervivencia O -
global O -
(SG). O -

Las O -
características O -
de O -
los O -
pacientes O -
y O -
de O -
la O -
enfermedad O -
estaban O -
bien O -
equilibradas. O -

La O -
mediana O -
de O -
edad O -
era O -
de O -
67 O -
años O -
( O -
rango O -
45-81 O -
) O -
, O -
había O -
32 O -
hombres O -
y O -
41 O -
mujeres O -
, O -
subtipo O -
de O -
histología O -
: O -
escamoso/adenocarcinoma/mixto/NOS=42 O -
% O -
/49 O -
% O -
/4 O -
% O -
/5 O -
% O -
. O -

Siete O -
pacientes O -
no O -
recibieron O -
ningún O -
tratamiento O -
debido O -
al O -
deterioro O -
del O -
PS O -
o O -
a O -
la O -
muerte. O -

El O -
50 O -
% O -
de O -
los O -
pacientes O -
del O -
brazo O -
D O -
, O -
que O -
recibieron O -
más O -
de O -
un O -
ciclo, O -
recibieron O -
una O -
escalada O -
de O -
dosis O -
. O -

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
estadísticas I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
número I-Premise HighQuality
de I-Premise HighQuality
ciclos I-Premise HighQuality
administrados I-Premise HighQuality
( I-Premise HighQuality
brazos I-Premise HighQuality
A I-Premise HighQuality
, I-Premise HighQuality
B I-Premise HighQuality
y I-Premise HighQuality
D I-Premise HighQuality
: I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
2 I-Premise HighQuality
ciclos I-Premise HighQuality
y I-Premise HighQuality
brazo I-Premise HighQuality
C I-Premise HighQuality
: I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
3 I-Premise HighQuality
ciclos I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
RR I-Premise HighQuality
: I-Premise HighQuality
brazo I-Premise HighQuality
A=6 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
brazo I-Premise HighQuality
B=6 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
brazo I-Premise HighQuality
C=10 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
brazo I-Premise HighQuality
D=0 I-Premise HighQuality
% I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
neutropenia I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
trombocitopenia I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
3/4 I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
cuatro I-Premise HighQuality
brazos. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
tasa I-Premise HighQuality
de I-Premise HighQuality
hospitalización, I-Premise HighQuality
las I-Premise HighQuality
transfusiones I-Premise HighQuality
de I-Premise HighQuality
sangre, I-Premise HighQuality
la I-Premise HighQuality
administración I-Premise HighQuality
de I-Premise HighQuality
antibióticos I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
toxicidad I-Premise HighQuality
no I-Premise HighQuality
hematológica. I-Premise HighQuality

Calidad O -
de O -
vida: O -
no O -
hay O -
diferencias O -
en O -
las O -
puntuaciones O -
totales O -
entre O -
el O -
inicio O -
y O -
los O -
ciclos O -
1-4. O -

Hubo B-Premise HighQuality
una I-Premise HighQuality
disminución I-Premise HighQuality
significativa I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
puntuaciones I-Premise HighQuality
de I-Premise HighQuality
dolor I-Premise HighQuality
desde I-Premise HighQuality
la I-Premise HighQuality
línea I-Premise HighQuality
de I-Premise HighQuality
base I-Premise HighQuality
hasta I-Premise HighQuality
los I-Premise HighQuality
ciclos I-Premise HighQuality
2 I-Premise HighQuality
y I-Premise HighQuality
3 I-Premise HighQuality
( I-Premise HighQuality
p=0,025 I-Premise HighQuality
y I-Premise HighQuality
p=0,002 I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
SG I-Premise HighQuality
( I-Premise HighQuality
p=0,992 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
fueron I-Premise HighQuality
de I-Premise HighQuality
61 I-Premise HighQuality
, I-Premise HighQuality
86 I-Premise HighQuality
, I-Premise HighQuality
88 I-Premise HighQuality
y I-Premise HighQuality
97 I-Premise HighQuality
días I-Premise HighQuality
y I-Premise HighQuality
del I-Premise HighQuality
29 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
33 I-Premise HighQuality
% I-Premise HighQuality
, I-Premise HighQuality
21 I-Premise HighQuality
% I-Premise HighQuality
y I-Premise HighQuality
26 I-Premise HighQuality
% I-Premise HighQuality
para I-Premise HighQuality
los I-Premise HighQuality
brazos I-Premise HighQuality
A I-Premise HighQuality
, I-Premise HighQuality
B I-Premise HighQuality
, I-Premise HighQuality
C I-Premise HighQuality
y I-Premise HighQuality
D I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
. I-Premise HighQuality

La B-Claim HighQuality
eficacia I-Claim HighQuality
clínica I-Claim HighQuality
del I-Claim HighQuality
docetaxel I-Claim HighQuality
se I-Claim HighQuality
observó I-Claim HighQuality
en I-Claim HighQuality
todos I-Claim HighQuality
los I-Claim HighQuality
niveles I-Claim HighQuality
de I-Claim HighQuality
dosis. I-Claim HighQuality

Los B-Claim HighQuality
niveles I-Claim HighQuality
de I-Claim HighQuality
dosis I-Claim HighQuality
más I-Claim HighQuality
altos I-Claim HighQuality
no I-Claim HighQuality
se I-Claim HighQuality
asociaron I-Claim HighQuality
a I-Claim HighQuality
un I-Claim HighQuality
aumento I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
toxicidades, I-Claim HighQuality
del I-Claim HighQuality
uso I-Claim HighQuality
de I-Claim HighQuality
antibióticos I-Claim HighQuality
intravenosos I-Claim HighQuality
o I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
tasas I-Claim HighQuality
de I-Claim HighQuality
hospitalización. I-Claim HighQuality

Sin O -
embargo, O -
la B-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
observada I-Premise HighQuality
es I-Premise HighQuality
más I-Premise HighQuality
corta I-Premise HighQuality
que I-Premise HighQuality
los I-Premise HighQuality
datos I-Premise HighQuality
históricos I-Premise HighQuality
y I-Premise HighQuality
no I-Premise HighQuality
apoyan I-Premise HighQuality
una I-Premise HighQuality
mayor I-Premise HighQuality
evaluación I-Premise HighQuality
de I-Premise HighQuality
estas I-Premise HighQuality
dosis I-Premise HighQuality
de I-Premise HighQuality
docetaxel I-Premise HighQuality
como I-Premise HighQuality
agente I-Premise HighQuality
único I-Premise HighQuality
en I-Premise HighQuality
esta I-Premise HighQuality
población. I-Premise HighQuality

Los O -
análogos O -
de O -
la O -
somatostatina O -
están O -
indicados O -
para O -
el O -
control O -
de O -
los O -
síntomas O -
en O -
pacientes O -
con O -
tumores O -
neuroendocrinos O -
gastroenteropancreáticos O -
( O -
NETs O -
) O -
. O -

La O -
capacidad O -
de O -
los O -
análogos O -
de O -
la O -
somatostatina O -
para O -
controlar O -
el O -
crecimiento O -
de O -
los O -
NETs O -
metastásicos O -
bien O -
diferenciados O -
es O -
objeto O -
de O -
debate. O -

Realizamos O -
un O -
estudio O -
de O -
fase O -
IIIB, O -
doble O -
ciego O -
y O -
controlado O -
con O -
placebo O -
en O -
pacientes O -
con O -
TNE O -
de O -
intestino O -
medio O -
bien O -
diferenciados. O -

La O -
hipótesis O -
era O -
que O -
la O -
octreotida O -
LAR O -
prolonga O -
el O -
tiempo O -
de O -
progresión O -
del O -
tumor O -
y O -
la O -
supervivencia. O -

Los O -
pacientes O -
sin O -
tratamiento O -
fueron O -
asignados O -
aleatoriamente O -
a O -
placebo O -
o O -
a O -
octreotida O -
LAR O -
30 O -
mg O -
por O -
vía O -
intramuscular O -
en O -
intervalos O -
mensuales O -
hasta O -
la O -
progresión O -
del O -
tumor O -
o O -
la O -
muerte. O -

El O -
criterio O -
de O -
valoración O -
primario O -
de O -
la O -
eficacia O -
fue O -
el O -
tiempo O -
hasta O -
la O -
progresión O -
del O -
tumor. O -

Los O -
criterios O -
de O -
valoración O -
secundarios O -
fueron O -
el O -
tiempo O -
de O -
supervivencia O -
y O -
la O -
respuesta O -
tumoral. O -

Este O -
informe O -
se O -
basa O -
en O -
67 O -
progresiones O -
tumorales O -
y O -
16 O -
muertes O -
observadas O -
en O -
85 O -
pacientes O -
en O -
el O -
momento O -
del O -
análisis O -
intermedio O -
previsto. O -

La B-Premise HighQuality
mediana I-Premise HighQuality
del I-Premise HighQuality
tiempo I-Premise HighQuality
hasta I-Premise HighQuality
la I-Premise HighQuality
progresión I-Premise HighQuality
del I-Premise HighQuality
tumor I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
octreotida I-Premise HighQuality
LAR I-Premise HighQuality
y I-Premise HighQuality
placebo I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
14,3 I-Premise HighQuality
y I-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
, I-Premise HighQuality
respectivamente I-Premise HighQuality
( I-Premise HighQuality
hazard I-Premise HighQuality
ratio I-Premise HighQuality
[ I-Premise HighQuality
HR I-Premise HighQuality
] I-Premise HighQuality
= I-Premise HighQuality
0,34 I-Premise HighQuality
; I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,20 I-Premise HighQuality
a I-Premise HighQuality
0,59 I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
.000072 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Tras B-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
de I-Premise HighQuality
tratamiento, I-Premise HighQuality
se I-Premise HighQuality
observó I-Premise HighQuality
una I-Premise HighQuality
enfermedad I-Premise HighQuality
estable I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
66,7% I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
octreotida I-Premise HighQuality
LAR I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
37,2% I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
del I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
placebo. I-Premise HighQuality

Los O -
tumores O -
funcionalmente O -
activos O -
e O -
inactivos O -
respondieron O -
de O -
forma O -
similar. O -

El B-Premise HighQuality
efecto I-Premise HighQuality
más I-Premise HighQuality
favorable I-Premise HighQuality
se I-Premise HighQuality
observó I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
con I-Premise HighQuality
baja I-Premise HighQuality
carga I-Premise HighQuality
tumoral I-Premise HighQuality
hepática I-Premise HighQuality
y I-Premise HighQuality
tumor I-Premise HighQuality
primario I-Premise HighQuality
resecado I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
observaron I-Premise HighQuality
siete I-Premise HighQuality
y I-Premise HighQuality
nueve I-Premise HighQuality
muertes I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
octreotida I-Premise HighQuality
LAR I-Premise HighQuality
y I-Premise HighQuality
placebo I-Premise HighQuality
, I-Premise HighQuality
respectivamente. I-Premise HighQuality

El B-Premise HighQuality
HR I-Premise HighQuality
para I-Premise HighQuality
la I-Premise HighQuality
supervivencia I-Premise HighQuality
global I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
0,81 I-Premise HighQuality
( I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
CI I-Premise HighQuality
, I-Premise HighQuality
0,30 I-Premise HighQuality
a I-Premise HighQuality
2,18 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Octreotide B-Claim HighQuality
LAR I-Claim HighQuality
alarga I-Claim HighQuality
significativamente I-Claim HighQuality
el I-Claim HighQuality
tiempo I-Claim HighQuality
hasta I-Claim HighQuality
la I-Claim HighQuality
progresión I-Claim HighQuality
del I-Claim HighQuality
tumor I-Claim HighQuality
en I-Claim HighQuality
comparación I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
placebo I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
NETs I-Claim HighQuality
de I-Claim HighQuality
intestino I-Claim HighQuality
medio I-Claim HighQuality
funcionalmente I-Claim HighQuality
activos I-Claim HighQuality
e I-Claim HighQuality
inactivos. I-Claim HighQuality

Debido B-Premise HighQuality
al I-Premise HighQuality
bajo I-Premise HighQuality
número I-Premise HighQuality
de I-Premise HighQuality
muertes I-Premise HighQuality
observadas, I-Premise HighQuality
el I-Premise HighQuality
análisis I-Premise HighQuality
de I-Premise HighQuality
supervivencia I-Premise HighQuality
no I-Premise HighQuality
fue I-Premise HighQuality
confirmatorio. I-Premise HighQuality

En B-Claim HighQuality
el I-Claim HighQuality
contexto I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
enfermedades I-Claim HighQuality
físicas I-Claim HighQuality
crónicas, I-Claim HighQuality
como I-Claim HighQuality
el I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama, I-Claim HighQuality
la I-Claim HighQuality
depresión I-Claim HighQuality
se I-Claim HighQuality
asocia I-Claim HighQuality
con I-Claim HighQuality
una I-Claim HighQuality
mayor I-Claim HighQuality
morbilidad, I-Claim HighQuality
períodos I-Claim HighQuality
más I-Claim HighQuality
largos I-Claim HighQuality
de I-Claim HighQuality
hospitalización I-Claim HighQuality
y I-Claim HighQuality
una I-Claim HighQuality
mayor I-Claim HighQuality
discapacidad I-Claim HighQuality
general. I-Claim HighQuality

Por B-Claim HighQuality
lo I-Claim HighQuality
tanto, I-Claim HighQuality
es I-Claim HighQuality
esencial I-Claim HighQuality
un I-Claim HighQuality
diagnóstico I-Claim HighQuality
rápido I-Claim HighQuality
y I-Claim HighQuality
un I-Claim HighQuality
tratamiento I-Claim HighQuality
eficaz. I-Claim HighQuality

Varios O -
estudios O -
pequeños O -
han O -
establecido O -
la O -
eficacia O -
de O -
los O -
antidepresivos O -
tricíclicos O -
( O -
ATC O -
) O -
en O -
este O -
contexto O -
, O -
y O -
los O -
inhibidores O -
selectivos O -
de O -
la O -
recaptación O -
de O -
serotonina O -
( O -
ISRS O -
) O -
parecen O -
ser O -
una O -
opción O -
terapéutica O -
alternativa O -
debido O -
a O -
su O -
eficacia O -
establecida O -
y O -
mejor O -
perfil O -
de O -
tolerabilidad O -
. O -

Se O -
trata O -
de O -
un O -
estudio O -
multicéntrico. O -

Estudio O -
doble O -
ciego O -
de O -
grupos O -
paralelos O -
en O -
el O -
que O -
179 O -
mujeres O -
con O -
cáncer O -
de O -
mama O -
fueron O -
asignadas O -
al O -
azar O -
a O -
un O -
tratamiento O -
con O -
el O -
ISRS O -
paroxetina O -
( O -
20-40 O -
mg/día O -
) O -
, O -
o O -
el O -
ATC O -
, O -
amitriptilina O -
( O -
75-150 O -
mg/día O -
) O -
. O -

Después B-Premise HighQuality
de I-Premise HighQuality
8 I-Premise HighQuality
semanas I-Premise HighQuality
de I-Premise HighQuality
tratamiento, I-Premise HighQuality
la I-Premise HighQuality
sintomatología I-Premise HighQuality
depresiva I-Premise HighQuality
había I-Premise HighQuality
mejorado I-Premise HighQuality
notablemente I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
grado I-Premise HighQuality
similar I-Premise HighQuality
en I-Premise HighQuality
ambos I-Premise HighQuality
grupos I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
Escala I-Premise HighQuality
de I-Premise HighQuality
Calificación I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
Depresión I-Premise HighQuality
de I-Premise HighQuality
Montgomery I-Premise HighQuality
Asberg. I-Premise HighQuality

Las B-Premise HighQuality
escalas I-Premise HighQuality
de I-Premise HighQuality
impresión I-Premise HighQuality
clínica I-Premise HighQuality
global I-Premise HighQuality
( I-Premise HighQuality
CGI I-Premise HighQuality
) I-Premise HighQuality
de I-Premise HighQuality
mejora I-Premise HighQuality
global I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
evaluación I-Premise HighQuality
global I-Premise HighQuality
del I-Premise HighQuality
paciente I-Premise HighQuality
indicaron I-Premise HighQuality
que I-Premise HighQuality
los I-Premise HighQuality
pacientes I-Premise HighQuality
mejoraron I-Premise HighQuality
de I-Premise HighQuality
forma I-Premise HighQuality
mínima I-Premise HighQuality
a I-Premise HighQuality
considerable I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
punto I-Premise HighQuality
final I-Premise HighQuality
del I-Premise HighQuality
estudio: I-Premise HighQuality
un I-Premise HighQuality
cambio I-Premise HighQuality
de I-Premise HighQuality
moderado/leve I-Premise HighQuality
a I-Premise HighQuality
límite I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
escala I-Premise HighQuality
de I-Premise HighQuality
gravedad I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
enfermedad I-Premise HighQuality
CGI I-Premise HighQuality
. I-Premise HighQuality

También B-Claim HighQuality
se I-Claim HighQuality
observó I-Claim HighQuality
una I-Claim HighQuality
mejora I-Claim HighQuality
constante I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
en I-Claim HighQuality
ambos I-Claim HighQuality
grupos. I-Claim HighQuality

No B-Premise HighQuality
hubo I-Premise HighQuality
diferencias I-Premise HighQuality
clínicamente I-Premise HighQuality
significativas I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
grupos. I-Premise HighQuality

En B-Premise HighQuality
total, I-Premise HighQuality
47 I-Premise HighQuality
( I-Premise HighQuality
53,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
pacientes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
paroxetina I-Premise HighQuality
y I-Premise HighQuality
53 I-Premise HighQuality
( I-Premise HighQuality
59,6 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
pacientes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
amitriptilina I-Premise HighQuality
tuvieron I-Premise HighQuality
experiencias I-Premise HighQuality
adversas, I-Premise HighQuality
las I-Premise HighQuality
más I-Premise HighQuality
comunes I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
cuales I-Premise HighQuality
fueron I-Premise HighQuality
los I-Premise HighQuality
efectos I-Premise HighQuality
secundarios I-Premise HighQuality
bien I-Premise HighQuality
conocidos I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
medicamentos I-Premise HighQuality
antidepresivos I-Premise HighQuality
o I-Premise HighQuality
la I-Premise HighQuality
quimioterapia I-Premise HighQuality
. I-Premise HighQuality

Los B-Premise HighQuality
efectos I-Premise HighQuality
anticolinérgicos I-Premise HighQuality
fueron I-Premise HighQuality
casi I-Premise HighQuality
dos I-Premise HighQuality
veces I-Premise HighQuality
más I-Premise HighQuality
frecuentes I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
amitriptilina I-Premise HighQuality
( I-Premise HighQuality
19,1 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
paroxetina I-Premise HighQuality
( I-Premise HighQuality
11,4 I-Premise HighQuality
% I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Este O -
estudio O -
ha O -
demostrado O -
que O -
la B-Claim HighQuality
paroxetina I-Claim HighQuality
es I-Claim HighQuality
una I-Claim HighQuality
alternativa I-Claim HighQuality
adecuada I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
amitriptilina I-Claim HighQuality
para I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
depresión I-Claim HighQuality
en I-Claim HighQuality
pacientes I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
. I-Claim HighQuality

En O -
los O -
pacientes O -
con O -
cáncer O -
anorrectal, O -
un O -
efecto O -
secundario O -
agudo O -
de O -
la O -
quimiorradioterapia O -
es O -
la O -
toxicidad O -
gastrointestinal, O -
que O -
a O -
menudo O -
impide O -
la O -
administración O -
del O -
tratamiento. O -

Basándose O -
en O -
ensayos O -
anteriores, O -
el O -
acetato O -
de O -
octreotida O -
se O -
recomienda O -
ampliamente O -
para O -
el O -
control O -
de O -
la O -
diarrea O -
inducida O -
por O -
la O -
quimioterapia. O -

Sin O -
embargo, O -
se O -
desconoce O -
la O -
eficacia O -
de O -
la O -
octreotida O -
para O -
prevenir O -
o O -
controlar O -
la O -
diarrea O -
inducida O -
por O -
la O -
radiación O -
y O -
la O -
quimiorradiación. O -

Se O -
diseñó O -
un O -
ensayo O -
aleatorizado, O -
doble O -
ciego O -
y O -
controlado O -
con O -
placebo O -
para O -
determinar O -
la O -
eficacia O -
del O -
acetato O -
de O -
octreotida O -
de O -
acción O -
prolongada O -
( O -
LAO O -
) O -
en O -
la O -
prevención O -
de O -
la O -
aparición O -
de O -
diarrea O -
aguda O -
en O -
pacientes O -
sometidos O -
a O -
quimiorradioterapia O -
por O -
cáncer O -
rectal O -
o O -
anal O -
. O -

Entre O -
4 O -
y O -
7 O -
días O -
antes O -
del O -
inicio O -
de O -
la O -
radioterapia O -
, O -
los O -
pacientes O -
recibieron O -
una O -
dosis O -
de O -
30 O -
mg O -
de O -
LAO O -
( O -
109 O -
pacientes O -
) O -
o O -
de O -
placebo O -
( O -
106 O -
pacientes O -
) O -
mediante O -
inyección O -
intramuscular O -
. O -

Se O -
administró O -
una O -
segunda O -
dosis O -
el O -
día O -
22 O -
( O -
+/-3 O -
días O -
) O -
de O -
la O -
radioterapia O -
. O -

Un O -
total O -
de O -
215 O -
pacientes O -
fueron O -
incluidos O -
en O -
el O -
análisis O -
final. O -

El O -
criterio O -
de O -
valoración O -
primario O -
fue O -
la O -
incidencia O -
de O -
diarrea O -
aguda O -
de O -
grado O -
2-4; O -
los O -
criterios O -
de O -
valoración O -
secundarios O -
incluyeron O -
el O -
cumplimiento O -
del O -
tratamiento, O -
la O -
utilización O -
de O -
recursos O -
médicos, O -
la O -
función O -
intestinal O -
informada O -
por O -
el O -
paciente O -
y O -
la O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
. O -

Las O -
pruebas O -
estadísticas O -
fueron O -
de O -
una O -
o O -
dos O -
caras, O -
según O -
se O -
especifique. O -

Tras B-Premise HighQuality
una I-Premise HighQuality
mediana I-Premise HighQuality
de I-Premise HighQuality
seguimiento I-Premise HighQuality
de I-Premise HighQuality
9,64 I-Premise HighQuality
meses, I-Premise HighQuality
las I-Premise HighQuality
tasas I-Premise HighQuality
de I-Premise HighQuality
incidencia I-Premise HighQuality
de I-Premise HighQuality
diarrea I-Premise HighQuality
aguda I-Premise HighQuality
de I-Premise HighQuality
grado I-Premise HighQuality
2-4 I-Premise HighQuality
fueron I-Premise HighQuality
similares I-Premise HighQuality
en I-Premise HighQuality
ambos I-Premise HighQuality
grupos I-Premise HighQuality
( I-Premise HighQuality
49 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
placebo I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
44 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
LAO I-Premise HighQuality
; I-Premise HighQuality
P I-Premise HighQuality
= I-Premise HighQuality
0,21 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
de I-Premise HighQuality
tratamiento I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
administración I-Premise HighQuality
de I-Premise HighQuality
quimioterapia I-Premise HighQuality
o I-Premise HighQuality
radiación, I-Premise HighQuality
la I-Premise HighQuality
utilización I-Premise HighQuality
de I-Premise HighQuality
recursos I-Premise HighQuality
médicos, I-Premise HighQuality
la I-Premise HighQuality
función I-Premise HighQuality
intestinal I-Premise HighQuality
informada I-Premise HighQuality
por I-Premise HighQuality
el I-Premise HighQuality
paciente I-Premise HighQuality
o I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida. I-Premise HighQuality

En B-Claim HighQuality
este I-Claim HighQuality
estudio, I-Claim HighQuality
el I-Claim HighQuality
uso I-Claim HighQuality
profiláctico I-Claim HighQuality
de I-Claim HighQuality
LAO I-Claim HighQuality
no I-Claim HighQuality
previno I-Claim HighQuality
la I-Claim HighQuality
incidencia I-Claim HighQuality
ni I-Claim HighQuality
redujo I-Claim HighQuality
la I-Claim HighQuality
gravedad I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
diarrea I-Claim HighQuality
y I-Claim HighQuality
no I-Claim HighQuality
tuvo I-Claim HighQuality
un I-Claim HighQuality
impacto I-Claim HighQuality
notable I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
función I-Claim HighQuality
intestinal I-Claim HighQuality
o I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
informada I-Claim HighQuality
por I-Claim HighQuality
los I-Claim HighQuality
pacientes. I-Claim HighQuality

Una O -
proporción O -
significativa O -
de O -
pacientes O -
desarrolla O -
incontinencia O -
urinaria O -
al O -
principio O -
de O -
la O -
prostatectomía O -
radical. O -

Se O -
ha O -
comprobado O -
que O -
la O -
reconstrucción O -
posterior O -
de O -
los O -
tejidos O -
de O -
soporte O -
reduce O -
la O -
incontinencia O -
en O -
las O -
series O -
de O -
prostatectomía O -
laparoscópica O -
abierta O -
y O -
convencional O -
. O -

Investigar O -
si O -
nuestra O -
versión O -
de O -
una O -
reconstrucción O -
musculofascial O -
posterior O -
reducirá O -
la O -
incontinencia O -
precoz O -
y O -
tendrá O -
un O -
efecto O -
beneficioso O -
en O -
la O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
de O -
las O -
pacientes. O -

Ciento O -
siete O -
pacientes O -
consecutivos O -
sometidos O -
a O -
prostatectomía O -
radical O -
laparoscópica O -
primaria O -
asistida O -
por O -
robot O -
( O -
RALP O -
) O -
realizada O -
por O -
un O -
único O -
cirujano O -
en O -
una O -
institución O -
oncológica O -
de O -
referencia O -
terciaria O -
fueron O -
asignados O -
alternativamente O -
( O -
no O -
aleatorizados O -
) O -
a O -
los O -
grupos O -
de O -
intervención O -
( O -
n=53 O -
) O -
o O -
de O -
control O -
( O -
n=54 O -
) O -
. O -

RALP O -
con O -
reconstrucción O -
del O -
rafe O -
fibroso O -
medio O -
( O -
MFRR O -
) O -
seguido O -
de O -
la O -
formación O -
de O -
la O -
anastomosis O -
uretrovesical O -
( O -
grupo O -
de O -
intervención O -
) O -
frente O -
a O -
la O -
anastomosis O -
estándar O -
sin O -
reconstrucción O -
posterior O -
( O -
grupo O -
de O -
control O -
) O -
. O -

Las O -
mediciones O -
incluyeron O -
la O -
incontinencia O -
al O -
inicio O -
y O -
a O -
intervalos O -
de O -
3 O -
meses; O -
la O -
calidad O -
de O -
vida O -
medida O -
por O -
un O -
cuestionario O -
simple, O -
el O -
cuestionario O -
de O -
la O -
Organización O -
Europea O -
para O -
la O -
Investigación O -
y O -
el O -
Tratamiento O -
del O -
Cáncer O -
( O -
EORTC O -
) O -
Quality O -
of O -
Life-Core O -
30 O -
( O -
QLQ-C30 O -
) O -
y O -
el O -
Módulo O -
de O -
Cáncer O -
de O -
Próstata O -
( O -
PR25 O -
) O -
antes O -
de O -
la O -
operación O -
y O -
a O -
los O -
6 O -
meses O -
después O -
del O -
procedimiento; O -
las O -
características O -
del O -
tumor; O -
el O -
tiempo O -
de O -
la O -
operación; O -
la O -
puntuación O -
de O -
preservación O -
de O -
la O -
fascia; O -
la O -
duración O -
del O -
sondaje; O -
y O -
la O -
fuga O -
anastomótica O -
en O -
el O -
cistograma. O -

Para B-Premise HighQuality
los I-Premise HighQuality
grupos I-Premise HighQuality
de I-Premise HighQuality
intervención I-Premise HighQuality
y I-Premise HighQuality
de I-Premise HighQuality
control, I-Premise HighQuality
respectivamente, I-Premise HighQuality
la I-Premise HighQuality
duración I-Premise HighQuality
media I-Premise HighQuality
del I-Premise HighQuality
catéter I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
11,74 I-Premise HighQuality
días I-Premise HighQuality
y I-Premise HighQuality
12,74 I-Premise HighQuality
días I-Premise HighQuality
( I-Premise HighQuality
p=0,451 I-Premise HighQuality
) I-Premise HighQuality
; I-Premise HighQuality
la I-Premise HighQuality
fuga I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
cistograma I-Premise HighQuality
estuvo I-Premise HighQuality
presente I-Premise HighQuality
en I-Premise HighQuality
seis I-Premise HighQuality
y I-Premise HighQuality
ocho I-Premise HighQuality
casos I-Premise HighQuality
( I-Premise HighQuality
p=0,28 I-Premise HighQuality
) I-Premise HighQuality
; I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
incontinencia I-Premise HighQuality
( I-Premise HighQuality
cualquier I-Premise HighQuality
pérdida I-Premise HighQuality
involuntaria I-Premise HighQuality
de I-Premise HighQuality
orina I-Premise HighQuality
) I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
3 I-Premise HighQuality
meses I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
75% I-Premise HighQuality
y I-Premise HighQuality
69% I-Premise HighQuality
( I-Premise HighQuality
p=0,391 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
fue I-Premise HighQuality
de I-Premise HighQuality
51% I-Premise HighQuality
y I-Premise HighQuality
43% I-Premise HighQuality
( I-Premise HighQuality
p=0,686 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Sólo B-Premise HighQuality
se I-Premise HighQuality
produjo I-Premise HighQuality
retención I-Premise HighQuality
urinaria I-Premise HighQuality
en I-Premise HighQuality
un I-Premise HighQuality
caso I-Premise HighQuality
( I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
control I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Premise HighQuality
porcentaje I-Premise HighQuality
de I-Premise HighQuality
casos I-Premise HighQuality
que I-Premise HighQuality
volvieron I-Premise HighQuality
a I-Premise HighQuality
la I-Premise HighQuality
línea I-Premise HighQuality
de I-Premise HighQuality
base I-Premise HighQuality
en I-Premise HighQuality
todos I-Premise HighQuality
los I-Premise HighQuality
dominios I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
( I-Premise HighQuality
excepto I-Premise HighQuality
el I-Premise HighQuality
insomnio I-Premise HighQuality
) I-Premise HighQuality
fue I-Premise HighQuality
similar I-Premise HighQuality
a I-Premise HighQuality
los I-Premise HighQuality
6 I-Premise HighQuality
meses I-Premise HighQuality
entre I-Premise HighQuality
los I-Premise HighQuality
dos I-Premise HighQuality
grupos I-Premise HighQuality
. I-Premise HighQuality

Se B-Premise HighQuality
identificaron I-Premise HighQuality
como I-Premise HighQuality
limitaciones I-Premise HighQuality
significativas I-Premise HighQuality
el I-Premise HighQuality
corto I-Premise HighQuality
seguimiento, I-Premise HighQuality
la I-Premise HighQuality
falta I-Premise HighQuality
de I-Premise HighQuality
cegamiento I-Premise HighQuality
y I-Premise HighQuality
las I-Premise HighQuality
probables I-Premise HighQuality
pequeñas I-Premise HighQuality
diferencias I-Premise HighQuality
en I-Premise HighQuality
nuestro I-Premise HighQuality
método I-Premise HighQuality
de I-Premise HighQuality
MFRR I-Premise HighQuality
realizado I-Premise HighQuality
en I-Premise HighQuality
comparación I-Premise HighQuality
con I-Premise HighQuality
otros I-Premise HighQuality
estudios. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
observaron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
ninguna I-Premise HighQuality
de I-Premise HighQuality
las I-Premise HighQuality
medidas I-Premise HighQuality
de I-Premise HighQuality
resultado I-Premise HighQuality
analizadas. I-Premise HighQuality

La B-Claim HighQuality
reconstrucción I-Claim HighQuality
posterior I-Claim HighQuality
del I-Claim HighQuality
complejo I-Claim HighQuality
musculofascial I-Claim HighQuality
no I-Claim HighQuality
parece I-Claim HighQuality
mejorar I-Claim HighQuality
la I-Claim HighQuality
incontinencia I-Claim HighQuality
urinaria I-Claim HighQuality
precoz I-Claim HighQuality
tras I-Claim HighQuality
la I-Claim HighQuality
RALP I-Claim HighQuality
. I-Claim HighQuality

En O -
el O -
ensayo O -
Gynecologic O -
Cancer O -
Intergroup O -
International O -
Collaboration O -
on O -
Ovarian O -
Neoplasms O -
7 O -
( O -
ICON7 O -
) O -
, O -
bevacizumab O -
mejoró O -
la O -
supervivencia O -
libre O -
de O -
progresión O -
en O -
pacientes O -
con O -
cáncer O -
de O -
ovario O -
cuando O -
se O -
utilizó O -
en O -
combinación O -
con O -
quimioterapia O -
de O -
primera O -
línea O -
y O -
como O -
tratamiento O -
de O -
continuación O -
con O -
un O -
solo O -
fármaco O -
durante O -
18 O -
ciclos O -
. O -

En O -
un O -
análisis O -
preliminar O -
de O -
un O -
subgrupo O -
de O -
pacientes O -
de O -
alto O -
riesgo O -
, O -
también O -
hubo O -
una O -
mejora O -
en O -
la O -
supervivencia O -
global O -
. O -

Este O -
estudio O -
tiene O -
como O -
objetivo O -
describir O -
los O -
resultados O -
de O -
la O -
calidad O -
de O -
vida O -
relacionada O -
con O -
la O -
salud O -
( O -
QoL O -
) O -
de O -
ICON7 O -
. O -

ICON7 O -
es O -
un O -
ensayo O -
aleatorio, O -
multicéntrico O -
y O -
abierto O -
de O -
fase O -
3. O -

Entre O -
el O -
18 O -
de O -
diciembre O -
de O -
2006 O -
y O -
el O -
16 O -
de O -
febrero O -
de O -
2009, O -
tras O -
una O -
intervención O -
quirúrgica O -
destinada O -
a O -
eliminar O -
la O -
enfermedad, O -
las O -
mujeres O -
con O -
cáncer O -
de O -
ovario O -
epitelial O -
en O -
estadio O -
I-IV O -
de O -
alto O -
riesgo O -
de O -
la O -
Federación O -
Internacional O -
de O -
Ginecología O -
y O -
Obstetricia O -
(FIGO) O -
fueron O -
asignadas O -
aleatoriamente O -
( O -
1:1 O -
) O -
por O -
programa O -
informático O -
y O -
aleatorización O -
en O -
bloque O -
a O -
recibir O -
seis O -
ciclos O -
de O -
quimioterapia O -
estándar O -
( O -
total O -
18 O -
semanas O -
) O -
con O -
carboplatino O -
( O -
área O -
bajo O -
la O -
curva O -
5 O -
o O -
6 O -
) O -
y O -
paclitaxel O -
( O -
175 O -
mg/m O -
( O -
2 O -
) O -
) O -
solo O -
o O -
con O -
bevacizumab O -
( O -
7-5 O -
mg/kg O -
) O -
administrado O -
por O -
vía O -
intravenosa O -
con O -
la O -
quimioterapia O -
y O -
continuado O -
como O -
fármaco O -
único O -
después O -
( O -
total O -
54 O -
semanas O -
) O -
. O -

El O -
criterio O -
de O -
valoración O -
primario O -
de O -
la O -
calidad O -
de O -
vida O -
fue O -
la O -
calidad O -
de O -
vida O -
global O -
del O -
cuestionario O -
de O -
calidad O -
de O -
vida O -
30 O -
de O -
la O -
Organización O -
Europea O -
para O -
la O -
Investigación O -
y O -
el O -
Tratamiento O -
del O -
Cáncer O -
en O -
la O -
semana O -
54, O -
analizada O -
mediante O -
ANOVA O -
y O -
ajustada O -
a O -
la O -
puntuación O -
inicial. O -

Los O -
análisis O -
fueron O -
por O -
intención O -
de O -
tratar. O -

El O -
ensayo O -
ICON7 O -
ha O -
completado O -
el O -
reclutamiento O -
y O -
sigue O -
en O -
seguimiento. O -

Este O -
estudio O -
está O -
registrado O -
con O -
el O -
número O -
ISRCTN91273375. O -

Se O -
asignaron O -
aleatoriamente O -
764 O -
mujeres O -
al O -
grupo O -
de O -
quimioterapia O -
estándar O -
y O -
764 O -
al O -
grupo O -
de O -
bevacizumab O -
. O -

Al O -
inicio O -
del O -
estudio, O -
684 O -
( O -
90% O -
) O -
de O -
las O -
mujeres O -
del O -
grupo O -
de O -
quimioterapia O -
estándar O -
y O -
691 O -
( O -
90% O -
) O -
de O -
las O -
del O -
grupo O -
de O -
bevacizumab O -
habían O -
completado O -
los O -
cuestionarios O -
de O -
calidad O -
de O -
vida. O -

En O -
la O -
semana O -
54, O -
502 O -
( O -
66 O -
% O -
) O -
mujeres O -
del O -
grupo O -
de O -
bevacizumab O -
y O -
388 O -
( O -
51 O -
% O -
) O -
mujeres O -
del O -
grupo O -
de O -
quimioterapia O -
estándar O -
proporcionaron O -
datos O -
de O -
calidad O -
de O -
vida O -
. O -

En B-Premise HighQuality
general, I-Premise HighQuality
la I-Premise HighQuality
puntuación I-Premise HighQuality
media I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
global I-Premise HighQuality
mejoró I-Premise HighQuality
durante I-Premise HighQuality
la I-Premise HighQuality
quimioterapia I-Premise HighQuality
en I-Premise HighQuality
7-2 I-Premise HighQuality
puntos I-Premise HighQuality
( I-Premise HighQuality
SD I-Premise HighQuality
24-4 I-Premise HighQuality
) I-Premise HighQuality
cuando I-Premise HighQuality
se I-Premise HighQuality
analizaron I-Premise HighQuality
todas I-Premise HighQuality
las I-Premise HighQuality
mujeres I-Premise HighQuality
con I-Premise HighQuality
datos I-Premise HighQuality
al I-Premise HighQuality
inicio I-Premise HighQuality
y I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
semana I-Premise HighQuality
18 I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
puntuación I-Premise HighQuality
media I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
global I-Premise HighQuality
a I-Premise HighQuality
las I-Premise HighQuality
54 I-Premise HighQuality
semanas I-Premise HighQuality
fue I-Premise HighQuality
mayor I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
quimioterapia I-Premise HighQuality
estándar I-Premise HighQuality
que I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
de I-Premise HighQuality
bevacizumab I-Premise HighQuality
( I-Premise HighQuality
76-1 I-Premise HighQuality
[ I-Premise HighQuality
SD I-Premise HighQuality
18-2 I-Premise HighQuality
] I-Premise HighQuality
frente I-Premise HighQuality
a I-Premise HighQuality
69-7 I-Premise HighQuality
[ I-Premise HighQuality
19-1 I-Premise HighQuality
] I-Premise HighQuality
puntos I-Premise HighQuality
; I-Premise HighQuality
diferencia I-Premise HighQuality
6-4 I-Premise HighQuality
puntos I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
3-7-9-0 I-Premise HighQuality
, I-Premise HighQuality
p I-Premise HighQuality
< I-Premise HighQuality
0-0001 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Claim HighQuality
tratamiento I-Claim HighQuality
de I-Claim HighQuality
continuación I-Claim HighQuality
con I-Claim HighQuality
bevacizumab I-Claim HighQuality
parece I-Claim HighQuality
estar I-Claim HighQuality
asociado I-Claim HighQuality
a I-Claim HighQuality
una I-Claim HighQuality
disminución I-Claim HighQuality
pequeña I-Claim HighQuality
pero I-Claim HighQuality
clínicamente I-Claim HighQuality
significativa I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
CdV I-Claim HighQuality
en I-Claim HighQuality
comparación I-Claim HighQuality
con I-Claim HighQuality
el I-Claim HighQuality
tratamiento I-Claim HighQuality
estándar I-Claim HighQuality
para I-Claim HighQuality
las I-Claim HighQuality
mujeres I-Claim HighQuality
con I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
ovario I-Claim HighQuality
. I-Claim HighQuality

La O -
compensación O -
entre O -
la O -
prolongación O -
de O -
la O -
supervivencia O -
libre O -
de O -
progresión O -
y O -
la O -
calidad O -
de O -
ese O -
periodo O -
de O -
tiempo O -
debe O -
tenerse O -
en O -
cuenta O -
en O -
la O -
práctica O -
clínica O -
a O -
la O -
hora O -
de O -
tomar O -
decisiones O -
de O -
tratamiento O -
. O -

Se O -
examinaron O -
los O -
mecanismos O -
de O -
mediación O -
de O -
una O -
intervención O -
de O -
ejercicio O -
en O -
grupo O -
de O -
12 O -
semanas O -
sobre O -
la O -
calidad O -
de O -
vida O -
( O -
QoL O -
) O -
de O -
los O -
supervivientes O -
de O -
cáncer O -
para O -
informar O -
sobre O -
el O -
desarrollo O -
de O -
futuras O -
intervenciones O -
de O -
ejercicio. O -

Doscientos O -
nueve O -
supervivientes O -
de O -
cáncer O -
≥ O -
3 O -
meses O -
después O -
del O -
tratamiento O -
( O -
57 O -
% O -
cáncer O -
de O -
mama O -
) O -
de O -
49,5 O -
( O -
± O -
10,4 O -
) O -
años O -
de O -
edad O -
fueron O -
asignados O -
a O -
ejercicio O -
físico O -
( O -
n O -
= O -
147 O -
) O -
o O -
a O -
control O -
en O -
lista O -
de O -
espera O -
( O -
n O -
= O -
62 O -
) O -
. O -

La O -
calidad O -
de O -
vida, O -
la O -
fatiga, O -
el O -
malestar O -
emocional, O -
la O -
actividad O -
física, O -
la O -
autoeficacia O -
general O -
y O -
el O -
dominio O -
se O -
evaluaron O -
al O -
inicio O -
y O -
después O -
de O -
la O -
intervención O -
mediante O -
cuestionarios. O -

Se O -
llevó O -
a O -
cabo O -
un O -
análisis O -
de O -
trayectorias O -
utilizando O -
Mplus O -
para O -
explorar O -
si O -
la O -
mejora O -
de O -
la O -
actividad O -
física, O -
la O -
autoeficacia O -
general O -
y O -
el O -
dominio O -
mediaban O -
los O -
efectos O -
del O -
ejercicio O -
sobre O -
la O -
fatiga O -
y O -
la O -
angustia O -
y, O -
en O -
consecuencia, O -
la O -
calidad O -
de O -
vida. O -

La B-Premise HighQuality
intervención I-Premise HighQuality
se I-Premise HighQuality
asoció I-Premise HighQuality
con I-Premise HighQuality
un I-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
actividad I-Premise HighQuality
física I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
0,46 I-Premise HighQuality
, I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
) I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
0,14 I-Premise HighQuality
; I-Premise HighQuality
0,59 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
autoeficacia I-Premise HighQuality
general I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
2,41 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
0,35 I-Premise HighQuality
; I-Premise HighQuality
4,73 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
dominio I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
1,75 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
0,36 I-Premise HighQuality
; I-Premise HighQuality
2,78 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Además O -
, O -
la B-Premise HighQuality
intervención I-Premise HighQuality
tuvo I-Premise HighQuality
tanto I-Premise HighQuality
un I-Premise HighQuality
efecto I-Premise HighQuality
directo I-Premise HighQuality
sobre I-Premise HighQuality
la I-Premise HighQuality
fatiga I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-1,09 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-2,12 I-Premise HighQuality
; I-Premise HighQuality
0,01 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
como I-Premise HighQuality
un I-Premise HighQuality
efecto I-Premise HighQuality
indirecto I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-0,54 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-1,00 I-Premise HighQuality
; I-Premise HighQuality
-0,21 I-Premise HighQuality
) I-Premise HighQuality
a I-Premise HighQuality
través I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
actividad I-Premise HighQuality
física I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-0,29 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-0,64 I-Premise HighQuality
; I-Premise HighQuality
-0,07 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
autoeficacia I-Premise HighQuality
general I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-0,25 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-0,61 I-Premise HighQuality
; I-Premise HighQuality
-0,05 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

La B-Premise HighQuality
intervención I-Premise HighQuality
tuvo I-Premise HighQuality
un I-Premise HighQuality
efecto I-Premise HighQuality
directo I-Premise HighQuality
casi I-Premise HighQuality
significativo I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
reducción I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
angustia I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-1,32 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-2,68 I-Premise HighQuality
; I-Premise HighQuality
0,11 I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
y I-Premise HighQuality
un I-Premise HighQuality
efecto I-Premise HighQuality
indirecto I-Premise HighQuality
significativo I-Premise HighQuality
a I-Premise HighQuality
través I-Premise HighQuality
del I-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
autoeficacia I-Premise HighQuality
general I-Premise HighQuality
y I-Premise HighQuality
el I-Premise HighQuality
dominio I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-1,06 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-1,89 I-Premise HighQuality
; I-Premise HighQuality
-0,38 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

Las B-Premise HighQuality
reducciones I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
fatiga I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-1,33 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
=-1,85 I-Premise HighQuality
; I-Premise HighQuality
-0,83 I-Premise HighQuality
) I-Premise HighQuality
y I-Premise HighQuality
la I-Premise HighQuality
angustia I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
-0,86 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
-1,25 I-Premise HighQuality
; I-Premise HighQuality
-0,52 I-Premise HighQuality
) I-Premise HighQuality
se I-Premise HighQuality
asociaron I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
mejora I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
. I-Premise HighQuality

Además O -
, O -
el B-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
actividad I-Premise HighQuality
física I-Premise HighQuality
se I-Premise HighQuality
asoció I-Premise HighQuality
directamente I-Premise HighQuality
con I-Premise HighQuality
la I-Premise HighQuality
mejora I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
CdV I-Premise HighQuality
( I-Premise HighQuality
β I-Premise HighQuality
= I-Premise HighQuality
3,37 I-Premise HighQuality
, I-Premise HighQuality
IC I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
= I-Premise HighQuality
1,01 I-Premise HighQuality
; I-Premise HighQuality
5,54 I-Premise HighQuality
) I-Premise HighQuality
. I-Premise HighQuality

El B-Claim HighQuality
efecto I-Claim HighQuality
beneficioso I-Claim HighQuality
del I-Claim HighQuality
ejercicio I-Claim HighQuality
físico I-Claim HighQuality
en I-Claim HighQuality
grupo I-Claim HighQuality
sobre I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
estuvo I-Claim HighQuality
mediado I-Claim HighQuality
por I-Claim HighQuality
el I-Claim HighQuality
aumento I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
actividad I-Claim HighQuality
física, I-Claim HighQuality
la I-Claim HighQuality
autoeficacia I-Claim HighQuality
general I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
dominio, I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
consiguiente I-Claim HighQuality
reducción I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
fatiga I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
angustia. I-Claim HighQuality

Además B-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
actividad I-Claim HighQuality
física, I-Claim HighQuality
las I-Claim HighQuality
futuras I-Claim HighQuality
intervenciones I-Claim HighQuality
deberían I-Claim HighQuality
centrarse I-Claim HighQuality
en I-Claim HighQuality
la I-Claim HighQuality
autoeficacia I-Claim HighQuality
y I-Claim HighQuality
el I-Claim HighQuality
dominio. I-Claim HighQuality

Esto B-Claim HighQuality
puede I-Claim HighQuality
conducir I-Claim HighQuality
a I-Claim HighQuality
la I-Claim HighQuality
reducción I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
angustia I-Claim HighQuality
y I-Claim HighQuality
la I-Claim HighQuality
fatiga I-Claim HighQuality
, I-Claim HighQuality
y I-Claim HighQuality
por I-Claim HighQuality
lo I-Claim HighQuality
tanto I-Claim HighQuality
la I-Claim HighQuality
mejora I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
de I-Claim HighQuality
los I-Claim HighQuality
sobrevivientes I-Claim HighQuality
de I-Claim HighQuality
cáncer I-Claim HighQuality
. I-Claim HighQuality

Evaluar O -
si O -
la O -
omisión O -
de O -
la O -
radioterapia O -
( O -
RT O -
) O -
postoperatoria O -
en O -
mujeres O -
con O -
cáncer O -
de O -
mama O -
de O -
"bajo O -
riesgo" O -
con O -
ganglios O -
axilares O -
negativos O -
[ O -
tamaño O -
del O -
tumor O -
inferior O -
a O -
5 O -
cm O -
( O -
T0-2 O -
) O -
aunque O -
los O -
criterios O -
de O -
elegibilidad O -
reducen O -
aún O -
más O -
el O -
tamaño O -
elegible O -
a O -
un O -
máximo O -
de O -
3 O -
cm O -
] O -
tratadas O -
mediante O -
cirugía O -
conservadora O -
de O -
la O -
mama O -
y O -
terapia O -
endocrina O -
mejora O -
la O -
calidad O -
de O -
vida O -
y O -
es O -
más O -
rentable O -
. O -

Se O -
realizó O -
un O -
ensayo O -
clínico O -
controlado O -
y O -
aleatorizado, O -
utilizando O -
un O -
método O -
de O -
minimización O -
equilibrado O -
por O -
centro, O -
grado O -
de O -
cáncer, O -
edad, O -
invasión O -
linfovascular O -
y O -
terapia O -
endocrina O -
preoperatoria. O -

Clínicas O -
de O -
cáncer O -
de O -
mama O -
en O -
centros O -
oncológicos O -
del O -
Reino O -
Unido O -
. O -

Las O -
pacientes O -
de O -
edad O -
≥ O -
65 O -
años O -
fueron O -
elegibles O -
siempre O -
que O -
sus O -
cánceres O -
de O -
mama O -
se O -
consideraran O -
de O -
bajo O -
riesgo O -
de O -
recurrencia O -
local O -
, O -
fueran O -
adecuadas O -
para O -
la O -
cirugía O -
de O -
conservación O -
de O -
la O -
mama O -
, O -
estuvieran O -
recibiendo O -
terapia O -
endocrina O -
y O -
estuvieran O -
dispuestas O -
y O -
fueran O -
capaces O -
de O -
dar O -
su O -
consentimiento O -
informado O -
. O -

El O -
tratamiento O -
estándar O -
de O -
la O -
irradiación O -
mamaria O -
completa O -
postoperatoria O -
o O -
la O -
omisión O -
de O -
la O -
RT O -
. O -

La O -
calidad O -
de O -
vida O -
fue O -
la O -
principal O -
medida O -
de O -
resultado, O -
junto O -
con O -
la O -
ansiedad O -
y O -
la O -
depresión O -
y O -
la O -
rentabilidad. O -

Las O -
medidas O -
de O -
resultado O -
secundarias O -
fueron O -
las O -
tasas O -
de O -
recidiva O -
y O -
supervivencia O -
, O -
y O -
la O -
morbilidad O -
relacionada O -
con O -
el O -
tratamiento O -
. O -

El O -
método O -
principal O -
de O -
recogida O -
de O -
datos O -
fue O -
un O -
cuestionario, O -
completado O -
en O -
casa O -
con O -
una O -
enfermera O -
de O -
investigación O -
en O -
cuatro O -
ocasiones O -
durante O -
15 O -
meses, O -
y O -
luego O -
por O -
cuestionario O -
postal O -
a O -
los O -
3 O -
y O -
5 O -
años O -
después O -
de O -
la O -
cirugía. O -

La O -
hipotética O -
mejora O -
de O -
la O -
calidad O -
de O -
vida O -
global O -
con O -
la O -
omisión O -
de O -
la O -
RT O -
no O -
se O -
observó O -
en O -
los O -
dominios O -
de O -
resumen O -
de O -
las O -
escalas O -
de O -
la O -
Organización O -
Europea O -
para O -
la O -
Investigación O -
en O -
el O -
Tratamiento O -
del O -
Cáncer O -
( O -
EORTC O -
) O -
. O -

Se O -
observaron O -
algunas O -
diferencias O -
dentro O -
de O -
las O -
subescalas O -
de O -
los O -
cuestionarios O -
de O -
la O -
EORTC O -
, O -
y O -
los O -
datos O -
cualitativos O -
obtenidos O -
mediante O -
preguntas O -
abiertas O -
añadidas O -
por O -
el O -
equipo O -
del O -
ensayo O -
también O -
aportaron O -
información O -
sobre O -
el O -
impacto O -
del O -
tratamiento. O -

Las O -
diferencias O -
fueron O -
más O -
evidentes O -
poco O -
después O -
de O -
la O -
hora O -
de O -
finalización O -
de O -
la O -
RT O -
. O -

La B-Premise HighQuality
RT I-Premise HighQuality
se I-Premise HighQuality
asoció I-Premise HighQuality
entonces I-Premise HighQuality
con I-Premise HighQuality
un I-Premise HighQuality
aumento I-Premise HighQuality
de I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
mamarios I-Premise HighQuality
y I-Premise HighQuality
con I-Premise HighQuality
una I-Premise HighQuality
mayor I-Premise HighQuality
fatiga I-Premise HighQuality
( I-Premise HighQuality
autodeclarada I-Premise HighQuality
) I-Premise HighQuality
, I-Premise HighQuality
pero I-Premise HighQuality
con I-Premise HighQuality
menores I-Premise HighQuality
niveles I-Premise HighQuality
de I-Premise HighQuality
insomnio I-Premise HighQuality
y I-Premise HighQuality
efectos I-Premise HighQuality
secundarios I-Premise HighQuality
endocrinos I-Premise HighQuality
. I-Premise HighQuality

Estas B-Premise HighQuality
diferencias I-Premise HighQuality
estadísticamente I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
los I-Premise HighQuality
síntomas I-Premise HighQuality
mamarios I-Premise HighQuality
persistieron I-Premise HighQuality
hasta I-Premise HighQuality
5 I-Premise HighQuality
años I-Premise HighQuality
después I-Premise HighQuality
de I-Premise HighQuality
la I-Premise HighQuality
RT I-Premise HighQuality
[la I-Premise HighQuality
diferencia I-Premise HighQuality
media I-Premise HighQuality
, I-Premise HighQuality
la I-Premise HighQuality
RT I-Premise HighQuality
fue I-Premise HighQuality
5,27 I-Premise HighQuality
unidades I-Premise HighQuality
mayor I-Premise HighQuality
que I-Premise HighQuality
la I-Premise HighQuality
no I-Premise HighQuality
RT I-Premise HighQuality
, I-Premise HighQuality
intervalo I-Premise HighQuality
de I-Premise HighQuality
confianza I-Premise HighQuality
( I-Premise HighQuality
IC I-Premise HighQuality
) I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
% I-Premise HighQuality
de I-Premise HighQuality
1,46 I-Premise HighQuality
a I-Premise HighQuality
9,07 I-Premise HighQuality
] I-Premise HighQuality
, I-Premise HighQuality
con I-Premise HighQuality
tendencias I-Premise HighQuality
similares I-Premise HighQuality
, I-Premise HighQuality
aunque I-Premise HighQuality
no I-Premise HighQuality
significativas I-Premise HighQuality
, I-Premise HighQuality
en I-Premise HighQuality
el I-Premise HighQuality
insomnio I-Premise HighQuality
. I-Premise HighQuality

No B-Premise HighQuality
se I-Premise HighQuality
encontraron I-Premise HighQuality
diferencias I-Premise HighQuality
significativas I-Premise HighQuality
en I-Premise HighQuality
la I-Premise HighQuality
medida I-Premise HighQuality
global I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida, I-Premise HighQuality
ya I-Premise HighQuality
que I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
sin I-Premise HighQuality
RT I-Premise HighQuality
tenía I-Premise HighQuality
0,36 I-Premise HighQuality
unidades I-Premise HighQuality
más I-Premise HighQuality
de I-Premise HighQuality
calidad I-Premise HighQuality
de I-Premise HighQuality
vida I-Premise HighQuality
que I-Premise HighQuality
el I-Premise HighQuality
grupo I-Premise HighQuality
con I-Premise HighQuality
RT I-Premise HighQuality
(IC I-Premise HighQuality
del I-Premise HighQuality
95 I-Premise HighQuality
%: I-Premise HighQuality
-5,09 I-Premise HighQuality
a I-Premise HighQuality
5,81). I-Premise HighQuality

La B-Claim HighQuality
RT I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
es I-Claim HighQuality
bien I-Claim HighQuality
tolerada I-Claim HighQuality
por I-Claim HighQuality
la I-Claim HighQuality
mayoría I-Claim HighQuality
de I-Claim HighQuality
las I-Claim HighQuality
pacientes I-Claim HighQuality
de I-Claim HighQuality
cáncer I-Claim HighQuality
de I-Claim HighQuality
mama I-Claim HighQuality
de I-Claim HighQuality
edad I-Claim HighQuality
avanzada I-Claim HighQuality
sin I-Claim HighQuality
perjudicar I-Claim HighQuality
su I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
general I-Claim HighQuality
relacionada I-Claim HighQuality
con I-Claim HighQuality
la I-Claim HighQuality
salud I-Claim HighQuality
( I-Claim HighQuality
HRQoL I-Claim HighQuality
) I-Claim HighQuality
. I-Claim HighQuality

Aunque O -
la O -
CVRS O -
debe O -
tenerse O -
siempre O -
en O -
cuenta O -
a O -
la O -
hora O -
de O -
determinar O -
el O -
tratamiento, O -
nuestros B-Claim HighQuality
resultados I-Claim HighQuality
muestran I-Claim HighQuality
que I-Claim HighQuality
la I-Claim HighQuality
adición I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
RT I-Claim HighQuality
no I-Claim HighQuality
perjudica I-Claim HighQuality
la I-Claim HighQuality
calidad I-Claim HighQuality
de I-Claim HighQuality
vida I-Claim HighQuality
en I-Claim HighQuality
general. I-Claim HighQuality

Es B-Claim HighQuality
necesario I-Claim HighQuality
elaborar I-Claim HighQuality
más I-Claim HighQuality
modelos I-Claim HighQuality
económicos I-Claim HighQuality
sobre I-Claim HighQuality
los I-Claim HighQuality
costes I-Claim HighQuality
y I-Claim HighQuality
las I-Claim HighQuality
consecuencias I-Claim HighQuality
a I-Claim HighQuality
largo I-Claim HighQuality
plazo I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
omisión I-Claim HighQuality
de I-Claim HighQuality
la I-Claim HighQuality
RT. I-Claim HighQuality

